Here's Why You Should Add Cencora Stock to Your Portfolio Now
- COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 05/30/2025
|
Cencora Elects Lori J. Ryerkerk to Its Board of Directors
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Lori J. Ryerkerk as a new independent director, effective June 1, 2025. “Ms. Ryerkerk's experience in complex, global supply chains will further strengthen the Board's expertise as we continue supporting the company's long-term growth. Her appointment reflects the Cencora Board's ongoing commitment to leaders who can help us contribute to driving stakeholder value,” said Mark Du.
- 05/28/2025
|
Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs
- Cencora gets a buy rating, agreeing with today's consensus from Wall St. The sector and macro environment points to continued demand for the healthcare supplies and niche specialty drugs Cencora can distribute. Future share price targets point to significant potential upside over 3 years, justifying a buy despite the stock trading above average now.
- 05/16/2025
|
Here's Why Cencora (COR) is a Strong Momentum Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 05/09/2025
|
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?
- Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 05/08/2025
|
Cencora (COR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 05/07/2025
|
COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised
- COR's second-quarter fiscal 2025 results showcase a strong segmental performance. The company's earnings guidance for fiscal 2025 looks encouraging.
- 05/07/2025
|
Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings
- Cencora, Inc COR on Wednesday reported second-quarter 2025 sales increased 10.3% to $75.5 billion, missing the consensus of $75.68 billion, primarily due to an 11.4% increase in revenue within the U.S. Healthcare Solutions segment.
- 05/07/2025
|
Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript
- Cencora, Inc. (NYSE:COR ) Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head of Investor Relations & Treasury Bob Mauch - President & Chief Executive Officer Jim Cleary - Executive Vice President & Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Michael Cherny - Leerink Capital Lisa Gill - JPMorgan George Hill - Deutsche Bank Charles Rhyee - TD Cowen Eric Percher - Nephron Research Steven Valiquette - Mizuho Securities Allen Lutz - Bank of America Daniel Grosslight - Citi Kevin Caliendo - UBS Erin Wright - Morgan Stanley Operator Hello, everyone, and thank you for joining the Cencora Fiscal 2025 Second Quarter Results Conference Call. My name is Lucy, and I will be coordinating your call today.
- 05/07/2025
|
Cencora (COR) Beats Q2 Earnings and Revenue Estimates
- Cencora (COR) came out with quarterly earnings of $4.42 per share, beating the Zacks Consensus Estimate of $4.08 per share. This compares to earnings of $3.80 per share a year ago.
- 05/07/2025
|
Cencora raises annual profit forecast on strong demand for specialty drugs
- U.S. drug distributor Cencora raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.
- 05/07/2025
|
Cencora Reports Fiscal 2025 Second Quarter Results
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year to $75.5 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.68 for the second quarter of fiscal 2025 compared to $2.09 in the prior year second quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below.
- 05/07/2025
|
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN
- The medical device sector saw steady sales growth in the first quarter of 2025, supported by innovation in AI, wearables, and personalized care. However, earnings gains were more modest as global tariffs, inflationary costs, and supply chain disruptions continued to pressure margins.
- 05/06/2025
|
Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
- VANCOUVER, BC / ACCESS Newswire / May 6, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) (WKN: A116E1) ("Camino" or the "Company") is pleased to announce exploration results at its Copper-Silver stratabound Los Chapitos copper project ("Los Chapitos" or the "Project"), including drilling and additional mapping, trenching, and sampling along both the La Estancia and Diva copper mineralized trends. The Company is targeting large-scale disseminated manto-type copper-silver mineralization to support resource delineation studies at Los Chapitos.
- 05/06/2025
|
Will Speciality and GLP-1 Drugs Help COR Beat Q2 Earnings Estimates?
- COR's fiscal second-quarter results are likely to reflect decent U.S. Healthcare Solutions segmental performance.
- 05/05/2025
|
Unveiling Cencora (COR) Q2 Outlook: Wall Street Estimates for Key Metrics
- Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Cencora (COR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
- 05/02/2025
|
Cencora (COR) Earnings Expected to Grow: Should You Buy?
- Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/30/2025
|
Is Cencora, Inc. (COR) Outperforming Other Medical Stocks This Year?
- Here is how Cencora (COR) and Intensity Therapeutics Inc. (INTS) have performed compared to their sector so far this year.
- 04/21/2025
|
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?
- Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/17/2025
|
3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes
- Here, we discuss three medical device stocks ,COR, HIMS and PBH, that offer cheap valuations, making them attractive bets amid tariff risks.
- 04/17/2025
|
Why Cencora (COR) is a Top Momentum Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 04/17/2025
|
Camino and Nittetsu Complete Acquisition of Permitted Puquios Copper Project in Chile
- VANCOUVER, BC / ACCESS Newswire / April 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ( "Camino" or the "Company" ) is pleased to announce the completion of its previously announced 1 acquisition (the " Acquisition ") of all of the issued and outstanding shares of Cuprum Resources Chile SpA (" Cuprum "), which owns the construction-ready Puquios copper project located in Chile (the " Puquios Project "). "Camino is building a copper production platform, and Puquios is the right sized, long life, copper asset with primary permits in place to be the next copper mine in the world's largest copper jurisdiction 2 , Chile.
- 04/17/2025
|
Here's Why You Should Add Cencora Stock to Your Portfolio Now
- COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 04/10/2025
|
Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence
- In the present market turbulence, investors may want to consider discounted stocks, such as FMS, PAHC and COR.
- 04/09/2025
|
Top 3 S&P 500 Winners in a Losing Market
- Fear and uncertainty have dominated the markets in 2025, with U.S. equities entering a significant correction. What began as a cautious retreat in February, sparked by policy concerns and underwhelming performance from former market leaders and Magnificent Seven stocks, like Tesla and Alphabet, has now escalated into broader selling pressure.
- 04/09/2025
|
Sellers Rule The Roost Amid Tariff Wars, But This Stock Hits A High
- Cencora hit an all-time high on Friday. The post Sellers Rule The Roost Amid Tariff Wars, But This Stock Hits A High appeared first on Investor's Business Daily.
- 04/04/2025
|
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues
- Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.
- 04/04/2025
|
Has Cencora, Inc. (COR) Outpaced Other Medical Stocks This Year?
- Here is how Cencora (COR) and Intensity Therapeutics Inc. (INTS) have performed compared to their sector so far this year.
- 04/03/2025
|
Cencora (COR) is a Top-Ranked Growth Stock: Should You Buy?
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 03/31/2025
|
Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 7, 2025. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President & Chief Fin.
- 03/28/2025
|
3 Medical Services Industry Stocks to Buy as AI Fuels Growth
- The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most.
- 03/27/2025
|
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 03/27/2025
|
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?
- Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 03/27/2025
|
Here is Why Growth Investors Should Buy Cencora (COR) Now
- Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.
- 03/18/2025
|
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
- Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. NVDA, COR, JBL and KLAC hold promise.
- 03/18/2025
|
Camino Announces Filing of Pre-Feasibility Study Technical Report and Provides Update on Previously Announced Acquisition of the Puquios Copper Project
- VANCOUVER, BC / ACCESS Newswire / March 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) (" Camino " or the " Company ") is pleased to provide an update on its previously announced 1 acquisition (the " Proposed Transaction ") of all of the issued and outstanding shares of Cuprum Resources Chile SpA (" Cuprum "), which owns the construction-ready Puquios copper project located in Chile (the " Puquios Project "). The Company is pleased to announce that it has filed an independent technical report (the " Puquios Project Technical Report ") entitled " Puquios Project - NI 43-101 Technical Report and Pre-feasibilityStudy, La Higuera, Coquimbo Region, Chile " with respect to the Puquios Project, which is expected to be one of the Company's principal material properties for the purposes of Canadian securities laws upon completion of the Proposed Transaction.
- 03/17/2025
|
Here's Why You Should Add Cencora Stock to Your Portfolio Now
- COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 03/11/2025
|
Why Is Cencora (COR) Up 3.1% Since Last Earnings Report?
- Cencora (COR) reported earnings 30 days ago. What's next for the stock?
- 03/07/2025
|
Scoop Up These 3 GARP Stocks to Receive Handsome Returns
- The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. SFM, COR and AXP are some stocks that hold promise.
- 02/28/2025
|
3 Reasons Why Growth Investors Shouldn't Overlook Cencora (COR)
- Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.
- 02/27/2025
|
Cencora: Higher Potential Returns After Reduced Walgreens Stake
- Cencora offers steady revenue growth from pharmaceutical distribution, benefiting from rising healthcare demand and an aging population. The company has a strong economic moat, low leverage, BBB+ credit rating, and an active share repurchase program, enhancing shareholder returns. Strategic acquisitions like Retina Consultants of America position Cencora for long-term success, with management guiding for 10% annual EPS growth.
- 02/26/2025
|
Why Cencora (COR) is a Top Growth Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 02/21/2025
|
Here's Why Cencora (COR) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 02/20/2025
|
3 GARP Stocks That Investors Can Scoop Up for Maximum Returns
- Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. AXP, COR and TPX hold promise.
- 02/13/2025
|
Walgreens Sells Another Stake In Distributor Cencora For $300 Million
- Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said Thursday night.
- 02/06/2025
|
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance's sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended. Cencora intends to repurchase shares from Walgreens Boots Alliance at the price per share equal to the price in the Rule 144 sale. The con.
- 02/06/2025
|
Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds
- DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) has agreed to the early settlement of certain prepaid variable share forward transactions it had previously entered into with various financial institutions, with respect to shares of Cencora, Inc. (NYSE: COR). Under these transactions, the Company had previously received cash payments in an aggregate amount of approximately $1.1 billion on or about the dates of first entering into them. The transactions were schedul.
- 02/06/2025
|
COR Stock Gains on Q1 Earnings & Revenue Beat & Upbeat '25 Outlook
- COR's first-quarter fiscal 2025 results showcase a strong segmental performance. The company's sales and earnings guidance for fiscal 2025 looks encouraging.
- 02/05/2025
|
Cencora (COR) Q1 2025 Earnings Call Transcript
- Cencora Inc. (NYSE:COR ) Q1 2025 Earnings Conference Call February 5, 2025 8:30 AM ET Company Participants Robert Mauch - President, Chief Executive Officer James Cleary - Executive Vice President, Chief Financial Officer Bennett Murphy - Senior Vice President, Head of Investor Relations Conference Call Participants Michael Cherny - Leerink Partners Lisa Gill - JP Morgan Elizabeth Anderson - Evercore ISI Steven Valiquette - Mizuho Securities Eric Percher - Nephron Research Daniel Grosslight - Citi Stephen Baxter - Wells Fargo Charles Rhyee - TD Cowen Allen Lutz - Bank of America George Hill - Deutsche Bank Erin Wright - Morgan Stanley Kevin Caliendo - UBS Eric Coldwell - Baird Operator Hello and welcome everyone to the Cencora Q1 fiscal year 2025 earnings call. My name is Becky and I'll be your Operator today.
- 02/05/2025
|
Here's What Key Metrics Tell Us About Cencora (COR) Q1 Earnings
- The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 02/05/2025
|
Cencora (COR) Surpasses Q1 Earnings and Revenue Estimates
- Cencora (COR) came out with quarterly earnings of $3.73 per share, beating the Zacks Consensus Estimate of $3.50 per share. This compares to earnings of $3.28 per share a year ago.
- 02/05/2025
|
Cencora raises 2025 profit forecast on specialty drug demand
- Drug distributor Cencora raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines.
- 02/05/2025
|
Cencora Reports Fiscal 2025 First Quarter Results
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year to $81.5 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.50 for the first quarter of fiscal 2025 compared to $2.98 in the prior year first quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below.
- 02/05/2025
|
Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
- Not for Distribution to U.S. Newswire Services for Dissemination in the United States VANCOUVER, BC / ACCESS Newswire / February 5, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of the final tranche (the "Final Tranche") of its non-brokered private placement (the "Financing") of common shares in the capital of the Company (the "Common Shares") previously announced on January 10, 2025. Under the Final Tranche, the Company issued an aggregate of 1,781,047 Common Shares at an issue price of $0.21 per Common Share, for aggregate gross proceeds of approximately $374,020.
- 02/05/2025
|
Why Cencora (COR) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 02/03/2025
|
Stay Ahead of the Game With Cencora (COR) Q1 Earnings: Wall Street's Insights on Key Metrics
- Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Cencora (COR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
- 02/03/2025
|
Cencora to Report Q1 Earnings: Is a Beat Likely for the Stock?
- COR's fiscal first-quarter results are likely to reflect decent U.S. Healthcare Solutions segmental performance.
- 02/03/2025
|
4 Healthcare Stocks Poised to Crush Q4 Earnings Estimates
- Rising patient volumes, technological advancements, rate hikes and other factors are likely to have benefited healthcare players during Q4. Companies like AMGN, COR, HUM and ARDT are likely to outperform.
- 01/31/2025
|
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
- Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. AXP, POOL, RJF and COR hold promise.
- 01/30/2025
|
Here's Why You Should Add Cencora Stock to Your Portfolio Now
- COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 01/30/2025
|
Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/29/2025
|
Camino Announces Closing of First Tranche of Non-Brokered Private Placement
- Not for Distribution to U.S. Newswire Services for Dissemination in the United States VANCOUVER, BC / ACCESS Newswire / January 29, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of the first tranche (the "First Tranche") of its non-brokered private placement (the "Financing") of common shares in the capital of the Company (the "Common Shares") previously announced on January 10, 2025. Under the First Tranche, the Company issued an aggregate of 7,741,665 Common Shares at an issue price of $0.21 per Common Share, for aggregate gross proceeds of approximately $1,625,750.
- 01/29/2025
|
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?
- Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 01/28/2025
|
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?
- Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/27/2025
|
Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients
- NASHVILLE, Tenn.--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced the launch of its “Harrow Cares” program through a strategic partnership with Cencora (NYSE: COR). Harrow Cares delivers a comprehensive suite of high‑quality access and affordability services, enhancing support for retina specialists, their staff, and patients. Through a state-of-the-art patient support services hub, Harrow Cares ensures seamless enrollment, rapid.
- 01/27/2025
|
The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC
- Doximity, Omnicell, Embecta, Cencora and EDOC are included in this Analyst Blog.
- 01/23/2025
|
4 MedTech Stocks Poised to Thrive Under Second Trump Presidency
- Four MedTech stocks that are set to benefit from Trump 2.0 are DOCS, OMCL, EMBC and COR.
- 01/22/2025
|
Camino Commences Copper Discovery Exploration Drilling at the Los Chapitos Project in Peru
- VANCOUVER, BC / ACCESS Newswire / January 22, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce the commencement of its exploration campaign at the Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru. The campaign is fully funded through a CAD$1.5 million earn-in payment by Camino's exploration partner at Los Chapitos, Nittetsu Mining Co., Ltd.
- 01/22/2025
|
5 Broker-Loved Stocks to Monitor Amid Signs of Slowing Inflation
- Investors should keep a tab on stocks like National Vision, Cencora, ABM, Arrow Electronics and Bunge Global for high returns.
- 01/21/2025
|
Here's Why Cencora (COR) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 01/16/2025
|
Bet on 5 Stocks With High ROE as Markets Surge on Cooling Inflation
- DIS, LDOS, RJF, COR and DAL are some of the stocks with high ROE to profit on signs of decelerating inflationary pressures.
- 01/16/2025
|
Camino Announces Effective Date of Share Consolidation
- VANCOUVER, BC / ACCESS Newswire / January 16, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce that, further to its news release of January 10, 2025, it will implement the consolidation (the "Consolidation") of the common shares in the capital of the Company (the "Common Shares") on the basis of six (6) pre-Consolidation Common Shares for every one (1) post-Consolidation Common Share. The Consolidation will take effect at market open on Monday, January 20, 2025.
- 01/16/2025
|
Scoop Up These 4 GARP Stocks to Receive Handsome Returns
- The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. OUT, COR, RJF and RMD are some stocks that hold promise.
- 01/14/2025
|
Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth
- Seeking Alpha's Quant Valuation and Growth Grades identify 6 blue-chip stocks with extremely high valuations matched against limited operating growth potential. Costco, Cencora, West Pharmaceutical Services, Danaher, Madison Square Garden Sports, and Estée Lauder appear to be at risk of disappointing investors in 2025. Weakening technical performance vs. the S&P 500 is part of the bearish sell/avoid equation for each since summer.
- 01/13/2025
|
Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
- VANCOUVER, BC / ACCESSWIRE / January 10, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") today announced that, following discussions with the TSX Venture Exchange (the "TSXV"), the Company has restructured its previously announced C$2 million non-brokered private placement (as restructured, the "Financing"), as announced in its news release dated November 28, 2024. The Company also announced today a proposed consolidation of the common shares of the Company on a 6:1 basis, which is expected to be completed prior to closing of the Financing, subject to TSXV acceptance.
- 01/10/2025
|
Here's Why Cencora (COR) is a Strong Momentum Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 01/09/2025
|
Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on February 5, 2025. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President &.
- 01/08/2025
|
Cencora Stock May Gain Following the Strategic Acquisition of RCA
- COR completes the acquisition of Retina Consultants of America, marking a significant step in expanding its specialty healthcare and MSO solutions.
- 01/03/2025
|
Cencora raises annual profit forecast
- Drug distributor Cencora raised its annual adjusted profit forecast on Thursday.
- 01/02/2025
|
Cencora Completes Acquisition of Retina Consultants of America
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the completion of its previously announced acquisition of Retina Consultants of America (“RCA”), a leading management services organization (MSO) of retina specialists. Cencora has acquired an interest in RCA of approximately 85%, with certain RCA physicians and members of the management team retaining a minority equity interest in the company. After giving effect to the equity rollover, a cash capitalization of RCA t.
- 01/02/2025
|
Cencora (COR) Upgraded to Buy: Here's What You Should Know
- Cencora (COR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 01/01/2025
|
Here's Why Cencora (COR) is a Strong Growth Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 01/01/2025
|
Why Cencora (COR) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 12/31/2024
|
Is the Options Market Predicting a Spike in Cencora (COR) Stock?
- Investors need to pay close attention to Cencora (COR) stock based on the movements in the options market lately.
- 12/31/2024
|
Why Cencora (COR) is a Top Growth Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 12/16/2024
|
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
- COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 12/13/2024
|
Here's Why Cencora (COR) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 12/12/2024
|
Nittetsu Mining Provides $1.5 Million Fourth Earn-in Payment for Upcoming Drilling Campaign at Camino's Los Chapitos Project
- VANCOUVER, BC / ACCESSWIRE / December 12, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce the receipt of CAD$1.5 million from exploration partner Nittetsu Mining CO., Ltd. ("Nittetsu") to support the upcoming drilling campaign at Camino's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru, expected to start in January 2025.
- 12/12/2024
|
Cencora Closes $1.8 Billion Senior Notes Offering
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500,000,000 aggregate principal amount of its 4.625% Senior Notes due December 15, 2027 (the “2027 Notes”), $600,000,000 aggregate principal amount of its 4.850% Senior Notes due December 15, 2029 (the “2029 Notes”) and $700,000,000 aggregate principal amount of its 5.150% Senior Notes due February 15, 2035 (the “2035 Notes” and, together with the 2027 Notes and the 2029 Notes, t.
- 12/09/2024
|
Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global healthcare company, announced the launch of Accelerate Pharmacy Solutions, a unified portfolio of solutions designed to help hospital and health systems customers optimize operations and improve financial performance. Accelerate Pharmacy Solutions brings together Cencora's suite of pharmacy and supply chain solutions, enabling Cencora to deliver an enhanced customer experience and integrated support to address customers' evolving needs. The.
- 12/06/2024
|
Cencora: Competitive Advantages Defined
- Cencora is a 'super cash cow' with high capital turnover and low margins, generating substantial free cash flow from its competitive advantages. COR's business model thrives on low-cost operations, ensuring resilience in both high and low pricing environments. Despite inflation risks, COR's negative net working capital and efficient capital allocation enhance its ability to grow and generate cash.
- 12/05/2024
|
Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it priced $500 million aggregate principal amount of its 4.625% Senior Notes due December 15, 2027 (the “2027 Notes”), $600 million aggregate principal amount of its 4.850% Senior Notes due December 15, 2029 (the “2029 Notes”) and $700 million aggregate principal amount of its 5.150% Senior Notes due February 15, 2035 (the “2035 Notes” and, together with the 2027 Notes and the 2029 Notes, the “Notes”), in an unde.
- 12/02/2024
|
Here's Why Cencora (COR) is a Strong Momentum Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 12/02/2024
|
Camino Announces a Private Placement of up to CAD$2.0 Million
- VANCOUVER, BC / ACCESSWIRE / November 28, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce that, further to its news release dated October 7, 2024 regarding the Company's proposed joint acquisition of the Puquios copper project ("Puquios") in Chile and the financing referenced therein, it is arranging a non-brokered private placement to raise total gross proceeds of up to CAD$2,000,000 (the "Financing"). The Financing will consist of the issue of up to 57,142,857 common shares of the Company (each, a "Share") at a price per Share of CAD$0.035.
- 11/28/2024
|
Cencora to Host Inaugural Product Showcase
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global healthcare company, will host its inaugural Product Showcase, an event that will provide increased visibility into the company's portfolio of solutions and the products it's developing to support the evolving needs of its customers. During the virtual event, scheduled for December 3 at 11:00am ET, Cencora executives and leaders from across the organization will highlight innovative partnerships and provide updates on new product offerings. T.
- 11/26/2024
|
Why Cencora (COR) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 11/25/2024
|
Scoop up These 3 GARP Stocks to Receive Handsome Returns
- The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. COR, RJF and CTAS are some stocks that hold promise.
- 11/25/2024
|
Cencora Rallies 19.7% Year to Date: What's Driving the Stock?
- COR is gaining traction from the robust U.S. Healthcare Solutions segment, which raises optimism about the stock.
- 11/22/2024
|
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
- Here is how Cencora (COR) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
- 11/19/2024
|
Here's Why Cencora (COR) is a Strong Growth Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 11/13/2024
|
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?
- Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 11/13/2024
|
Why Cencora (COR) is a Top Momentum Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 11/11/2024
|
Cencora Q4 Earnings & Revenues Beat Estimates, Margins Decline Y/Y
- COR's fourth-quarter fiscal 2024 results showcase a strong segmental performance.
- 11/06/2024
|
Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings
- On Wednesday, Cencora, Inc.'s COR fourth-quarter 2024 sales increased 14.7% to $79.1 billion, beating the consensus of $77.65 billion.
- 11/06/2024
|
Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript
- Cencora, Inc. (NYSE:COR ) Q4 2024 Earnings Call Transcript November 6, 2024 8:30 AM ET Company Participants Bennett Murphy - SVP, Head of IR Bob Mauch - President and CEO Laz Krikorian - SVP and CAO Conference Call Participants Lisa Gill - JPMorgan Michael Cherny - Leerink Partners Elizabeth Anderson - Evercore ISI George Hill - Deutsche Bank Eric Percher - Nephron Research Stephanie Davis - Barclays Kevin Caliendo - UBS Eric Coldwell - Baird Erin Wright - Morgan Stanley Allen Lutz - Bank of America Charles Rhyee - TD Cowen Operator Hello, everyone, and welcome to today's Cencora Q4 Full Year 2024 Earnings Call. My name is Drew, and I'll be the operator today.
- 11/06/2024
|
Here's Why Cencora (COR) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 11/06/2024
|
Cencora (COR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Although the revenue and EPS for Cencora (COR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 11/06/2024
|
Cencora (COR) Tops Q4 Earnings and Revenue Estimates
- Cencora (COR) came out with quarterly earnings of $3.34 per share, beating the Zacks Consensus Estimate of $3.21 per share. This compares to earnings of $2.86 per share a year ago.
- 11/06/2024
|
Cencora to buy Retina Consultants of America for $4.6 bln
- Drug distributor Cencora said on Wednesday it would acquire Retina Consultants of America (RCA) for $4.6 billion in cash, gaining access to its network of eye specialists.
- 11/06/2024
|
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent to $79.1 billion. Revenue increased 12.1 percent to $294.0 billion for the fiscal year. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $0.02 for the September quarter of fiscal 2024, compared to $1.72 in the prior year quarter. Adjusted diluted EPS, which is a.
- 11/06/2024
|
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America (“RCA”), a leading management services organization (MSO) of retina specialists, from Webster Equity Partners. “The acquisition of RCA will allow Cencora to broaden our relationships with community providers in a high growth segment and build on our leadership in specialty,” said Bob Mauch, President & CEO of Cencora. “With a.
- 11/06/2024
|
Cencora to Report Q4 Earnings: What's in Store for the Stock?
- COR's fiscal fourth-quarter results are likely to reflect decent U.S. Healthcare Solutions segmental performance.
- 11/04/2024
|
Dividend Aristocrats Of The Future - Part 3
- This is the final group of 10 companies scheduled to reach dividend aristocrat status, sometime over the next five years. There are a variety of companies listed, some of whom may not be able to reach the coveted dividend aristocrat title. 3 companies listed below have 10-year dividend growth rates that exceed 10%, and one occasionally provides investors with special dividends every few years.
- 11/01/2024
|
Cencora (COR) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
- Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Cencora (COR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
- 11/01/2024
|
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth
- Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/30/2024
|
Why Cencora (COR) is a Top Growth Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 10/28/2024
|
Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru
- VANCOUVER, BC / ACCESSWIRE / October 28, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to provide a summary of the summer drilling and exploration campaign at its Maria Cecilia porphyry project ("Maria Cecilia" or the "Project") in Ancash, Peru. The 2024 summer campaign included the construction of access roads and the drilling of one diamond drillhole (MC24-001) at Porphyry 1.
- 10/28/2024
|
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
- COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 10/23/2024
|
Why Cencora (COR) is a Top Value Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 10/21/2024
|
Cencora Rallies 14.7% Year to Date: What's Driving the Stock?
- COR is gaining traction from the robust U.S. Healthcare Solutions segment, which raises optimism about the stock.
- 10/18/2024
|
Strength Seen in Cencora (COR): Can Its 3.7% Jump Turn into More Strength?
- Cencora (COR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- 10/16/2024
|
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?
- Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/15/2024
|
Here's Why Cencora (COR) is a Strong Growth Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 10/11/2024
|
Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile
- VANCOUVER, BC / ACCESSWIRE / October 7, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce that, further to its news release on June 27, 2024, it has entered into a definitive share purchase agreement dated October 4, 2024 ("Agreement") with Nittetsu Mining Co., Ltd. ("Nittetsu") and Santiago Metals Investment Holdings II SL and Santiago Metals Investment Holdings II-A LLC (together, the "Vendors"), pursuant to which Camino and Nittetsu will jointly acquire (through a Chilean entity co-owned 50/50 by Camino and Nittetsu) all of the issued and outstanding shares of Cuprum Resources Chile SpA ("Cuprum"), a Chilean incorporated company and the owner of the Puquios Project ("Puquios" or the "Project"), a construction-ready copper project located in Chile (the "Transaction").
- 10/07/2024
|
Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2024 on Wednesday, November 6, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 6, 2024. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President &.
- 10/01/2024
|
Why Cencora (COR) is a Top Growth Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 09/25/2024
|
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
- COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 09/20/2024
|
Here's Why Cencora (COR) is a Strong Growth Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 09/09/2024
|
Camino and Nittetsu Extend Again by One Additional Week Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
- VANCOUVER, BC / ACCESSWIRE / September 6, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) (WKN:A116E1) ("Camino" or the "Company") and Nittetsu Mining Co., Ltd. ("Nittetsu") announce a one-week extension to their exclusive rights to finalize negotiations and documentation for the acquisition of the Puquios Project (the "Proposed Acquisition"), a construction-ready copper mine located in Chile (see news release dated June 27, 2024).
- 09/06/2024
|
Why Is Cencora (COR) Down 2.8% Since Last Earnings Report?
- Cencora (COR) reported earnings 30 days ago. What's next for the stock?
- 08/30/2024
|
Here's Why Cencora (COR) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 08/30/2024
|
Camino and Nittetsu Extend by One Week Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
- VANCOUVER, BC / ACCESSWIRE / August 30, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF)(WKN:A116E1) (" Camino " or the " Company ") and Nittetsu Mining Co., Ltd. (" Nittetsu ") announce a one-week extension to their exclusive rights to finalize negotiations and documentation for the acquisition of the Puquios Project (the " Proposed Acquisition "), a construction-ready copper mine located in Chile (see news release dated June 27, 2024 ).
- 08/30/2024
|
Is Walgreens Ready To Rebound?
- Walgreens issued $750 million in senior unsecured notes at 8.125%, refinancing 3.800% notes due in 2024, leading to a $32.4 million increase in annual interest costs. Walgreens sold its remaining Cencora shares for $1.1 billion, with a potential $55 million annual interest expense savings, reducing its ownership in Cencora from 12% to 10%. The $750 million raised will primarily reduce Walgreens' existing debt, signaling confidence in handling higher debt servicing costs. The funds will also be allocated for potential growth investments.
- 08/23/2024
|
Cencora (COR) Gains 16.6% YTD: What's Driving the Stock?
- Cencora (COR) gaining traction from the robust U.S. Healthcare Solutions segment raises optimism about the stock.
- 08/22/2024
|
Why Cencora (COR) is a Top Growth Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 08/22/2024
|
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
- Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 08/21/2024
|
Here's Why Cencora (COR) is a Strong Momentum Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 08/16/2024
|
Why Cencora (COR) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 08/14/2024
|
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?
- Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 08/05/2024
|
Walgreens continues to shed stake in Cencora as it looks to bolster turnaround
- Struggling drug-store chain Walgreens Boots Alliance Inc. has sold off shares of drug distributor Cencora Inc., handing the retailer some $1.1 billion in proceeds as it tries to carry out a turnaround plan and pay down debt.
- 08/02/2024
|
All You Need to Know About Cencora (COR) Rating Upgrade to Buy
- Cencora (COR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 08/02/2024
|
Pharma giant Cencora is alerting millions about its data breach
- Cencora has so far notified over a million people around the U.S. that their personal and protected health information was compromised in a data breach earlier this year, TechCrunch has found.
- 08/02/2024
|
Walgreens Sells Another Stake In Distributor Cencora For $1.1 Billion
- Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $1.1 billion, which will be used “primarily for debt paydown and general corporate purposes.”
- 08/01/2024
|
Walgreens further reduces stake in Cencora
- Walgreens Boots Alliance said on Thursday it has sold shares in drug distributor Cencora for proceeds of about $1.1 billion.
- 08/01/2024
|
Compared to Estimates, Cencora (COR) Q3 Earnings: A Look at Key Metrics
- The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 07/31/2024
|
Cencora says additional data stolen in February cyberattack
- U.S. drug distributor Cencora said on Wednesday additional data on patients, beyond what was initially identified, had been stolen in a cyberattack and data breach that happened in February.
- 07/31/2024
|
Cencora (COR) Q3 Earnings Beat Estimates, '24 View Raised
- Cencora's (COR) third-quarter fiscal 2024 results benefit from overall market growth, including rising demand for GLP-1 drugs and COVID-19 vaccines. Inflationary pressure remains.
- 07/31/2024
|
Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript
- Cencora, Inc. (NYSE:COR ) Q3 2024 Earnings Conference Call July 31, 2024 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head of Investor Relations & Treasury Steve Collis - Chairman, President & Chief Executive Officer Bob Mauch - Executive Vice President & Chief Operating Officer Jim Cleary - Executive Vice President & Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Michael Cherny - Leerink Partners Elizabeth Anderson - Evercore ISI Allen Lutz - Bank of America Eric Percher - Nephron Research Charles Rhyee - TD Cowen Erin Wright - Morgan Stanley Daniel Grosslight - Citi George Hill - Deutsche Bank Stephanie Davis - Barclays Eric Coldwell - Baird Kevin Caliendo - UBS Operator Good morning and good afternoon, ladies and gentlemen. Welcome to the Cencora Q3 Earnings Call.
- 07/31/2024
|
Cencora (COR) Surpasses Q3 Earnings and Revenue Estimates
- Cencora (COR) came out with quarterly earnings of $3.34 per share, beating the Zacks Consensus Estimate of $3.18 per share. This compares to earnings of $2.92 per share a year ago.
- 07/31/2024
|
Will These 4 MedTech Stocks Beat Forecasts This Earnings Season?
- Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how COR, XRAY, GEHC and GKOS are placed ahead of their earnings release.
- 07/30/2024
|
Why Cencora (COR) is a Top Momentum Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 07/30/2024
|
Here's Why Cencora (COR) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 07/29/2024
|
Countdown to Cencora (COR) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
- Evaluate the expected performance of Cencora (COR) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 07/29/2024
|
Cencora (COR) to Report Q3 Earnings: Is a Beat in Store?
- Cencora's (COR) third-quarter fiscal 2024 results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.
- 07/29/2024
|
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth
- Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/24/2024
|
Why Cencora (COR) is a Top Value Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 07/12/2024
|
Why Cencora (COR) is Poised to Beat Earnings Estimates Again
- Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/11/2024
|
The Highest Quality Dividend Growth Stocks In 2024
- This article updates one I wrote in August 2022, which was based on a template article by David Van Knapp published in June 2020. I use an adapted quality scoring system to assess the quality of dividend growth stocks. The system employs six quality indicators from independent sources and assigns 0-5 points to each quality indicator, for a maximum of 30 points.
- 07/09/2024
|
Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2024 on Wednesday, July 31, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on July 31, 2024. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executive Vice President &.
- 07/05/2024
|
3 Dividend Compounding Machines Poised for 30%+ Total Returns by 2026
- Investors always praise compounder-type stocks, which are known for their proven ability to exponentially grow wealth over time. These companies usually achieve a high return on capital invested (ROCE) and return on equity (ROE).
- 07/03/2024
|
Cencora (COR) Stock Nosedives: Here's What Caused the Decline
- Cencora (COR) shares declined on Jun 27, following an unfavorable ruling from the Supreme Court related to a previously settled litigation. Here we discuss the key factors that likely led to the decline.
- 06/28/2024
|
Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court
- Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement.
- 06/27/2024
|
Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
- VANCOUVER, BC / ACCESSWIRE / June 27, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF)(WKN:A116E1) ("Camino" or the "Company") is pleased to announce that it has been granted exclusivity to complete due diligence and negotiate documentation by August 31, 2024, to acquire (the "Proposed Acquisition") the Puquios Project, a construction-ready copper project located in Chile, approximately 130 km northeast of La Serena, Coquimbo region (the "Project"). Camino has signed a non-binding Letter-of-Intent ("LOI") dated May 29, 2024, to acquire the Project in a 50:50 joint venture with Nittetsu Mining Co., Ltd.
- 06/27/2024
|
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
- Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 06/26/2024
|
Cencora: Long-Term Compounder With Mouth-Watering Economics
- COR shares have advanced 13% since my last publication, adding conviction to the long-term thesis. The company has exceptional economic characteristics with abnormally high ROICs and negative working capital benefits. I have updated my price objectives to $270-$285 with a long-term intrinsic valuation of over $360 per share.
- 06/24/2024
|
Cencora (COR) Gains 13.2% YTD: What's Driving the Stock?
- Cencora (COR) gaining traction from the robust U.S. Healthcare Solutions segment raises optimism about the stock.
- 06/17/2024
|
Here's Why Cencora (COR) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 06/10/2024
|
Nittetsu Mining Provides $1.5 Million Third Option Payment for Camino's Los Chapitos Project
- VANCOUVER, BC / ACCESSWIRE / June 5, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF)(WKN:A116E1) ("Camino" or the "Company") is pleased to announce the receipt of the third option payment of CAD$1.5 million from exploration partner Nittetsu Mining CO., Ltd. ("Nittetsu") to support the next phase of exploration of Camino's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru.
- 06/05/2024
|
AmerisourceBergen Specialty Group Substitute Notice of Data Incident to Affected Individuals
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Specialty Group (ABSG) is issuing a substitute notice to individuals who may have been impacted by a data security incident. ABSG's parent company previously announced the data security incident, which is fully contained. An investigation with the assistance of law enforcement, cybersecurity experts, and outside lawyers has now identified certain individuals whose personal information was involved in the incident. ABSG maintained this inform.
- 06/04/2024
|
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
- Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 05/27/2024
|
AmerisourceBergen Specialty Group Provides Substitute Notice of Data Incident to Affected Individuals
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Specialty Group, LLC (ABSG) is issuing notice to individuals who may have been impacted by a data security incident. ABSG's parent company previously announced the data security incident, which is fully contained. Through an investigation with the assistance of law enforcement, cybersecurity experts and outside lawyers, ABSG has now identified certain individuals whose personal information was involved in the incident. This information was m.
- 05/24/2024
|
Cencora notifies individuals about data stolen earlier this year
- U.S. drug distributor Cencora has notified affected individuals that their personal and highly sensitive medical information was stolen during a cyberattack and data breach earlier this year, the company said on Friday.
- 05/24/2024
|
Why Cencora (COR) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 05/23/2024
|
Walgreens Sells Another Stake In Distributor Cencora For $400 Million
- Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $400 million, which will be used for “debt paydown and general corporate purposes.”
- 05/22/2024
|
Cencora to buy $400 million in stock back from Walgreens
- Cencora has agreed to buy about $400 million in stock back from Walgreens Boots Alliance, the second time the pharmacy chain has reduced its stake in the company this year as it looks to free up cash to pare down debt.
- 05/22/2024
|
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $400 million in a private transaction. Cencora is also raising its fiscal year 2024 adjusted diluted earnings per share guidance to $13.35 to $13.55, up from the previous range of $13.30 to $13.50, to reflect a lower weighted average diluted share count, partially offset by higher net i.
- 05/22/2024
|
Walgreens Boots Alliance Sells Shares of Cencora for $400 Million of Proceeds
- DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold shares of Cencora, Inc. (NYSE: COR) pursuant to a share repurchase by Cencora in the amount of approximately $400 million. With the transaction, Walgreens Boots Alliance's ownership of Cencora's common stock has decreased from approximately 13 percent to approximately 12 percent. Proceeds to Walgreens Boots Alliance will be used primarily for debt paydown and general corporate purpose.
- 05/22/2024
|
Camino and Rio Tinto Both Acquire New Claims at Auction Nar the Los Chapitos Copper Project in Peru
- VANCOUVER, BC / ACCESSWIRE / May 17, 2024 / Camino Corp. (TSXV:COR)(OTC PINK:CAMZF)(WKN:A116E1) ("Camino" or the "Company") is pleased to announce that it has increased its claims at its Los Chapitos copper property ("Los Chapitos" or the "Project") by an additional 1,700 hectares. In a land auction, Camino successfully competed against other bidders that included Rio Tinto, to gain titles to new exploration claims immediately adjacent to the Company's Los Chapitos copper claims.
- 05/17/2024
|
Cencora To Host Inaugural ThinkLive Cell and Gene Therapy Summit
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global healthcare company, will convene leaders from across the healthcare and biopharmaceutical industries for its inaugural ThinkLive Cell and Gene Therapy (CGT) Summit, an event designed to explore the latest developments in the CGT sector and strategies to accelerate product commercialization and patient access. The two-day virtual event, which kicks off May 14, will feature panel discussions and presentations that cover key topics and consider.
- 05/14/2024
|
Cencora To Host Inaugural ThinkLive Cell and Gene Therapy Summit
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global healthcare company, will convene leaders from across the healthcare and biopharmaceutical industries for its inaugural ThinkLive Cell and Gene Therapy (CGT) Summit, an event designed to explore the latest developments in the CGT sector and strategies to accelerate product commercialization and patient access. The two-day virtual event, which kicks off May 14, will feature panel discussions and presentations that cover key topics and consider.
- 05/08/2024
|
Cencora (COR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- While the top- and bottom-line numbers for Cencora (COR) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 05/01/2024
|
Cencora, Inc. (COR) Q2 2024 Earnings Call Transcript
- Cencora, Inc. (NYSE:COR ) Q2 2024 Earnings Call Transcript May 1, 2024 8:30 AM ET Company Participants Bennett Murphy - SVP, Head of IR and Treasury Steve Collis - Chairman, President, and CEO Bob Mauch - EVP and COO Jim Cleary - EVP and CFO Conference Call Participants Elizabeth Anderson - Evercore Lisa Gill - JPMorgan Daniel Grosslight - Citi Eric Percher - Nephron Research Allen Lutz - Bank of America Stephanie Davis - Barclays Charles Rhyee - TD Cowen Michael Cherny - Leerink George Hill - Deutsche Bank Eric Coldwell - Baird Operator Hello and welcome to the Cencora Q2 2024 Earnings Call. My name is Alex and I'll be coordinating the call today.
- 05/01/2024
|
Cencora (COR) Q2 Earnings Top Estimates, 2024 View Raised
- Cencora's (COR) second-quarter fiscal 2024 results benefit from overall market growth, including rising demand for GLP-1 drugs and COVID-19 vaccines. Inflationary pressure remains.
- 05/01/2024
|
Cencora (COR) Q2 Earnings Top Estimates
- Cencora (COR) came out with quarterly earnings of $3.80 per share, beating the Zacks Consensus Estimate of $3.65 per share. This compares to earnings of $3.50 per share a year ago.
- 05/01/2024
|
Cencora beats profit estimates on strong demand for costly specialty drugs
- Cencora beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for costly specialty medicines that treat complex diseases such as cancer and rheumatoid arthritis.
- 05/01/2024
|
Cencora Reports Fiscal 2024 Second Quarter Results
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 second quarter ended March 31, 2024, revenue increased 7.8 percent year-over-year to $68.4 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.09 for the second quarter of fiscal 2024 compared to $2.13 in the prior year second quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described.
- 05/01/2024
|
Cencora (COR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
- Beyond analysts' top -and-bottom-line estimates for Cencora (COR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
- 04/26/2024
|
3 High-Quality Stocks That Will Never Put You in the Red
- Every portfolio needs a solid foundation of high-quality stocks that can provide steady returns through all market environments. While I often discuss more speculative growth and penny stock plays in my articles that some view as high-risk, high-reward bets, the core of your portfolio should revolve around a select few tried-and-true companies.
- 04/23/2024
|
Here's Why Cencora (COR) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 04/15/2024
|
Here's Why Cencora (COR) is a Strong Growth Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 04/12/2024
|
Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2024 on Wednesday, May 1, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 1, 2024. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executive Vice President &.
- 04/05/2024
|
Cencora, Inc. (COR) Soars to 52-Week High, Time to Cash Out?
- Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 04/04/2024
|
Here's Why Cencora (COR) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 03/29/2024
|
Why Cencora (COR) is a Top Growth Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 03/27/2024
|
5 Broker-Loved Stocks That Hold Promise Despite Volatility
- We believe that stocks like General Motors (GM), Cardinal Health (CAH), Cencora (COR), Alta Equipment (ALTG) and Asbury (ABG) should be on an investor's watchlist.
- 03/27/2024
|
Reasons to Add Cencora (COR) Stock in Your Portfolio Now
- Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 03/27/2024
|
Cencora Remains Chronically Undervalued, With Material Growth Potential
- Cencora, formerly known as AmerisourceBergen, has achieved a 14.97% YoY increase in total revenue, a 25.38% increase in net income, and a 27.84% increase in free cash flow. The company aims to become the underlying healthcare infrastructure for institutions and organizations, expanding its leadership in the healthcare wholesaler and distribution business. Cencora is investing in margin-enhancing businesses, leveraging its infrastructure for cost efficiency, and focusing on strategic M&A and in-house investment to support expanded leadership opportunities.
- 03/25/2024
|
Cencora (COR) Hits 52-Week High: What's Driving the Stock?
- Investors are optimistic about Cencora's (COR) strength in the U.S. Healthcare Solutions business.
- 03/19/2024
|
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?
- Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 03/19/2024
|
3 Medical Services Stocks to Buy as Industry Trends Improve
- The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and ICLR are set to gain the most.
- 03/13/2024
|
Why Cencora (COR) is a Top Value Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 03/13/2024
|
Cencora (COR) Is Up 2.40% in One Week: What You Should Know
- Does Cencora (COR) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 02/28/2024
|
Cencora says hit by cyber attack on its information systems
- Cencora Inc said it has learned that data from its information systems had been exfiltrated, some of which may contain personal information, the drug distributor said in a filing on Tuesday.
- 02/27/2024
|
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?
- Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 02/27/2024
|
Cencora Stock Building Bullish Chart Pattern After Earnings Jump
- Cencora stock reached new highs after its earnings report late January. The drug stock is trading tightly and may be poised for a move.
- 02/22/2024
|
3 Medical Services Stocks to Buy Amid Industry Headwinds
- The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and HQY are set to gain the most.
- 02/09/2024
|
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?
- Here is how Cencora (COR) and Cigna (CI) have performed compared to their sector so far this year.
- 02/07/2024
|
Cencora (COR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 02/01/2024
|
Cencora (COR) Beats on Q1 Earnings & Revenues, Ups 2024 Outlook
- Cencora's (COR) first-quarter fiscal 2024 results benefit from overall market growth, including rising demand for GLP-1 drugs and COVID-19 vaccines. Inflationary pressure remains.
- 01/31/2024
|
Cencora (COR) Q1 Earnings and Revenues Surpass Estimates
- Cencora (COR) came out with quarterly earnings of $3.28 per share, beating the Zacks Consensus Estimate of $2.86 per share. This compares to earnings of $2.71 per share a year ago.
- 01/31/2024
|
Cencora raises profit outlook due to robust demand for high-priced specialty drug
- Drug distributor Cencora raised its annual profit outlook on Wednesday, betting on strong demand for costly specialty medicines that treat diseases such as cancer and rheumatoid arthritis.
- 01/31/2024
|
Why Cencora (COR) Could Beat Earnings Estimates Again
- Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/30/2024
|
Unlocking Q1 Potential of Cencora (COR): Exploring Wall Street Estimates for Key Metrics
- Besides Wall Street's top -and-bottom-line estimates for Cencora (COR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
- 01/26/2024
|
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?
- Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 01/22/2024
|
Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2024 on Wednesday, January 31, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on January 31, 2024. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executive Vice Presi.
- 01/04/2024
|
5 Broker-Favored Stocks to Keep an Eye on in the Current Year
- We believe that stocks like American Airlines (AAL), Alaska Air Group (ALK), Cencora (COR), Cleveland-Cliffs (CLF) and Avnet (AVT) should be on an investor's watchlist.
- 01/04/2024
|
Cencora: Continued Economic Value On The Table Across All Investment Horizons
- We have increased our price objective on Cencora to $226/share for the next 6-12 months. The company has exhibited continued earnings growth with minimal capital recycling and strategic use of leverage. COR has attractive economic characteristics and is trading at 16x forward earnings.
- 01/04/2024
|
Cencora (COR) Hits 52-Week High: What's Aiding the Stock?
- Investors are optimistic about Cencora's (COR) strength in the U.S. Healthcare Solutions business.
- 01/03/2024
|
Reasons to Retain Cencora (COR) Stock in Your Portfolio for Now
- Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 12/22/2023
|
Why Cencora (COR) is a Top Growth Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 12/18/2023
|
5 Broker-Favorite Stocks to Keep an Eye on as 2024 Approaches
- We believe that stocks like American Airlines (AAL), ABM Industries (ABM), Cardinal Health (CAH), Cleveland-Cliffs (CLF) and Cencora (COR) should be on an investor's watchlist.
- 12/18/2023
|
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 12/14/2023
|
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
- Medical distributors are seeing increased demand for certain medicines. Drugs for weight loss made by Novo Nordisk and Eli Lilly are what's driving growth.
- 12/04/2023
|
Cencora (COR) Hits 52-Week High: What's Aiding the Stock?
- Investors are optimistic about Cencora's (COR) strength in the U.S. Healthcare Solutions business.
- 11/27/2023
|
Reasons to Retain Cencora (COR) Stock in Your Portfolio for Now
- Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 11/24/2023
|
Here's Why Cencora (COR) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 11/22/2023
|
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
- Here is how Cencora (COR) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
- 11/22/2023
|
3 Biotech Stocks You'll Regret Not Buying Soon: November 2023
- Biotechnology is a booming industry recently focused on synthetic biology, biomanufacturing and gene editing. Biotech is seen as the key to the future, as it has the potential to cure diseases and save many lives.
- 11/14/2023
|
Walgreens sells shares of drug distributor Cencora
- Drugstore chain Walgreens Boots Alliance Inc. WBA, -2.62% on Thursday said it had sold shares of drug distributor Cencora Inc. COR, +0.02% for approximately $424 million. Walgreens also entered into a share repurchase by Cencora, formerly known as AmerisourceBergen, for proceeds of roughly $250 million.
- 11/09/2023
|
Judge trims US lawsuit accusing Cencora of fueling opioid epidemic
- A federal judge on Monday pared back a U.S. government lawsuit accusing drug distributor Cencora , formerly called AmerisourceBergen, of fueling the nation's deadly opioid epidemic by failing to report hundreds of thousands of suspicious orders of prescription painkillers.
- 11/06/2023
|
Why Cencora (COR) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 11/06/2023
|
Cencora, Inc. (COR) Q4 2023 Earnings Call Transcript
- Cencora, Inc. (COR) Q4 2023 Earnings Call Transcript
- 11/04/2023
|
Exploring Analyst Estimates for Cencora (COR) Q4 Earnings, Beyond Revenue and EPS
- Besides Wall Street's top -and-bottom-line estimates for Cencora (COR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2023.
- 11/01/2023
|
5 Broker-Loved Stocks to Watch in an Uncertain Scenario
- We believe that investors should keep a close watch on stocks like The Greenbrier Companies (GBX), AMC Entertainment (AMC), The Gap (GPS), Asbury Automotive (ABG) and Cencora (COR).
- 10/31/2023
|
Cencora (COR) is a Top-Ranked Growth Stock: Should You Buy?
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 10/23/2023
|
Here's Why You Should Add Cencora (COR) to Your Portfolio Now
- Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 10/18/2023
|
Is Cencora (COR) a Solid Growth Stock? 3 Reasons to Think "Yes"
- Cencora (COR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 10/09/2023
|
Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today announced that it plans to release its results for the Fourth Quarter of Fiscal 2023 on Thursday, November 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 2, 2023. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Offi.
- 10/02/2023
|
Here's Why Cencora (COR) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 09/29/2023
|
Here's Why You Should Retain Cencora (COR) Stock for Now
- Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 09/15/2023
|
Why AmerisourceBergen (COR) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 09/13/2023
|
Why AmerisourceBergen (COR) is a Top Growth Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 09/08/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 08/29/2023
|
Walgreens Sells AmerisourceBergen Shares To Raise $1.85 Billion To Pay Down Debt And Accelerate Health Strategy
- Walgreens Boots Alliance has sold shares of AmerisourceBergen for initial proceeds of $2.85 billion, which will be used to accelerate the drugstore giant's healthcare strategy.
- 08/03/2023
|
Walgreens sells $1.85 bln of AmerisourceBergen shares, further cutting stake
- Walgreens Boots Alliance has sold some AmerisourceBergen Corp's shares for proceeds of about $1.85 billion, the U.S. drugstore chain said on Thursday, further cutting its ownership in the drug distributor to about 16%.
- 08/03/2023
|
Walgreens Boots Alliance sells shares of AmerisourceBergen for $1.85 billion
- Drugstore chain Walgreens Boots Alliance Inc. WBA, -1.17% on Thursday said it sold shares of drug distributor AmerisourceBergen Corp. ABC, -0.04% for initial proceeds of $1.85 billion. Walgreens said it planned to use the proceeds it got from the deal largely to pay down debt and to handle general operations.
- 08/03/2023
|
AmerisourceBergen (ABC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
- Although the revenue and EPS for AmerisourceBergen (ABC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 08/02/2023
|
AmerisourceBergen forecasts upbeat annual profit as weight-loss drugs lift results
- Drug distributor AmerisourceBergen raised its full-year profit forecast on Wednesday, as soaring demand for weight-loss drugs and specialty medicines helped soften the blow from a fall in COVID-related drug sales in the third quarter.
- 08/02/2023
|
AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)
- AmerisourceBergen has seen a 3x return on investment in the past 3 years, outperforming the market. I think it's a very solid company in pharma and healthcare distribution. Investing in high-quality companies when they are cheap is crucial for maximizing returns. AmerisourceBergen is a conservative and safe option in the pharma and healthcare industry, but has now reached a valuation of where I would consider it a "HOLD".
- 07/28/2023
|
Is a Beat Likely for AmerisourceBergen (ABC) in Q3 Earnings?
- AmerisourceBergen's (ABC) fiscal third-quarter 2023 results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
- 07/26/2023
|
AmerisourceBergen Corporation (ABC) Soars to 52-Week High, Time to Cash Out?
- AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 07/21/2023
|
Hunting for Growth Mixed with Value: Buy These 3 Stocks Now
- Looking at three highly-ranked Zacks stocks that have outperformed the market over the last several years, while posting solid growth. All three stocks we dig into also offer investors great value at the moment.
- 07/20/2023
|
Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report?
- AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/19/2023
|
AmerisourceBergen (ABC) is an Incredible Growth Stock: 3 Reasons Why
- AmerisourceBergen (ABC) could produce exceptional returns because of its solid growth attributes.
- 07/17/2023
|
Is AmerisourceBergen (ABC) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 07/17/2023
|
Is AmerisourceBergen (ABC) Stock Outpacing Its Medical Peers This Year?
- Here is how AmerisourceBergen (ABC) and Hologic (HOLX) have performed compared to their sector so far this year.
- 07/17/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 07/05/2023
|
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2023 on Wednesday, August 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 2, 2023. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executiv.
- 06/29/2023
|
Why Is AmerisourceBergen (ABC) Up 2% Since Last Earnings Report?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
- 06/01/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 05/29/2023
|
Walgreens Sells AmerisourceBergen Shares To Raise $694 Million To Pay Down Debt
- Walgreens Boots Alliance has sold shares of AmerisourceBergen for proceeds of $694 million, which will be used "primarily for debt paydown and general corporate purposes."
- 05/12/2023
|
Should Value Investors Buy AmerisourceBergen (ABC) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/05/2023
|
3 Reasons Growth Investors Will Love AmerisourceBergen (ABC)
- AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 05/04/2023
|
Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Align Technology (ALGN) have performed compared to their sector so far this year.
- 05/03/2023
|
AmerisourceBergen (ABC) Beats on Q2 Earnings, Ups '23 EPS View
- AmerisourceBergen's (ABC) fiscal second-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.
- 05/02/2023
|
AmerisourceBergen (ABC) Beats Q2 Earnings and Revenue Estimates
- AmerisourceBergen (ABC) came out with quarterly earnings of $3.50 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $3.22 per share a year ago.
- 05/02/2023
|
AmerisourceBergen stock pops premarket after earnings blow past estimates
- AmerisourceBergen Corp.'s stock ABC rose 0.8% premarket Tuesday, after the pharmaceutical services company's fiscal second-quarter earnings blew past estimates. The company had net income of $435.4 million, or $2.13 a share, for the quarter to March 31, down from $548.0 million, or $2.59 a share, in the year-earlier period.
- 05/02/2023
|
AmerisourceBergen (ABC) to Post Q2 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal 2023 second-quarter results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.
- 04/26/2023
|
AmerisourceBergen's (ABC) New JV to Boost Oncology Care
- AmerisourceBergen's (ABC) new JV is expected to provide the independent community oncology network with additional resources and expertise to grow the platform and improve patient outcomes.
- 04/21/2023
|
TPG, AmerisourceBergen to OneOncology in a deal that values the oncology practices network at $2.1 billion
- Asset management firm TPG Inc. TPG, +3.12% and pharmaceutical services company AmerisourceBergen Corp. ABC, -1.75% announced Thursday an agreement to buy oncology practices network OneOncology from private equity firm General Atlantic in a deal that values OneOncology at $2.1 billion. After the deal closes, which is expected to occur by the end of September 2023, TPG will own a majority of OneOncology, and AmerisourceBergen will pay $685 million in cash for a 35% stake.
- 04/20/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 04/19/2023
|
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
- Medical stocks are holding up amid economic and market uncertainty. The post 5 S&P 500 Stocks Showing Strength As Recession Fears Rise appeared first on Investor's Business Daily.
- 04/07/2023
|
Magic Formula Dividend Portfolio For April
- The following is a dividend portfolio strategy for large caps that score the highest amongst Joel Greenblatt's Magic Formula screener. The list follows large caps that have dividends.
- 04/07/2023
|
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2023 on Tuesday, May 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 2, 2023. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F.
- 03/29/2023
|
Animal Spirits Are Returning
- This article is an excerpt from the InvestorPlace Digest newsletter. To get news like this delivered straight to your inbox, click here.
- 03/29/2023
|
7 Stocks Set to Soar When the Market Recovers
- While time in the market generally beats out timing the market, it's understandable that some investors may want to hold off on looking for stocks to buy. After all, equities continue to digest the sudden failure of a handful of financial institutions.
- 03/16/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a concern.
- 03/15/2023
|
AmerisourceBergen: A Strong Addition To Any Portfolio
- AmerisourceBergen Corporation is a strong company and leader in the industry it operates within, continuously offering value to shareholders by share buybacks. Revenues came in line with analysts in the last quarter and resulted in the company raising full-year guidance.
- 03/07/2023
|
3 Reasons Why Growth Investors Shouldn't Overlook AmerisourceBergen (ABC)
- AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market.
- 02/27/2023
|
Are Investors Undervaluing AmerisourceBergen (ABC) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/27/2023
|
Dividend Champion, Contender, And Challenger Highlights: Week Of February 19
- A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
- 02/19/2023
|
5 Stocks to Keep an Eye on Following Upgrade by Brokers
- We believe that broker-favorite stocks like Archer Daniels (ADM), Delek US (DK), Beazer Homes (BZH), AmerisourceBergen (ABC) and Avnet (AVT) are worth a look.
- 02/17/2023
|
Is This Warren Buffett Stock a Buy for Dividend Growth Investors?
- This Buffett-backed business leads the medical distribution industry.
- 02/16/2023
|
Should Value Investors Buy AmerisourceBergen (ABC) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/07/2023
|
Dividend Champion, Contender, And Challenger Highlights: Week Of February 5
- A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
- 02/05/2023
|
Here's Why AmerisourceBergen (ABC) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 02/03/2023
|
5 Dental Supplies Stocks to Buy Amid Recovering Prospects
- Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.
- 02/03/2023
|
AmerisourceBergen (ABC) Q1 Earnings Top, EPS View Raised
- AmerisourceBergen's (ABC) fiscal first-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.
- 02/02/2023
|
AmerisourceBergen Corporation (ABC) Q1 2023 Earnings Call Transcript
- AmerisourceBergen Corporation (NYSE:ABC ) Q1 2023 Earnings Conference Call February 1, 2023 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head, Investor Relations & Treasury Steve Collis - Chairman, President, & Chief Executive Officer Jim Cleary - Executive Vice President & Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore Michael Cherny - Bank of America Erin Wright - Morgan Stanley Eric Percher - Nephron Research Charles Rhyee - Cowen George Hill - Deutsche Bank Eric Coldwell - Baird Steven Valiquette - Barclays Brian Tanquilut - Jefferies Operator Hello, everyone, and welcome to the AmerisourceBergen Q1 FY 2023 Earnings Conference Call. My name is Bruno and I will be operating your call today.
- 02/01/2023
|
AmerisourceBergen (ABC) Surpasses Q1 Earnings and Revenue Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 3.44% and 0.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/01/2023
|
AmerisourceBergen Corp. stock rises on Q1 top line beat, raised guidance
- AmerisourceBergen Corp.'s ABC, +2.21% stock rose 0.6% before market open Wednesday after the drug distribution giant reported first-quarter results that beat analysts' revenue expectations and raised its guidance. The company posted net income of $479.8 million, or $2.33 a share, up from $449.1 million, or $2.13 a share in the year-ago period.
- 02/01/2023
|
AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
- 01/27/2023
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 01/25/2023
|
AmerisourceBergen to change name to Cencora later this year
- AmerisourceBergen Corp. ABC, -0.30% said Tuesday it plans to change its name to Cencora in the second half of the year. The drug distribution giant said the new name reflects a “future-oriented mindset.
- 01/24/2023
|
AmerisourceBergen Screams Quality At 15x Earnings, 60% ROIC
- AmerisourceBergen caught a strong bid in the back end of FY22. Diving underneath the hood of its earnings reveals strong evidence of outsized profitability, adding to ABC's ability to create future value for shareholders.
- 01/14/2023
|
Recession Coming? Don't Ask This Hot Fund's Managers
- Want to know what the market will do in 2023? Is a recession coming?
- 01/06/2023
|
Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report?
- AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/04/2023
|
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
- Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
- 01/04/2023
|
AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release
- CONSHOHOCKEN, Pa.--( BUSINESS WIRE )--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2023 on Wednesday, February 1, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on February 1, 2023.
- 01/03/2023
|
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
- Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- 01/02/2023
|
Feds sue drug wholesaler AmerisourceBergen over opioid sales
- HARRISBURG, Pa. — The U.S. Justice Department claimed in a lawsuit filed Thursday that a major drug wholesaler contributed to the deadly toll from opioids by turning a blind eye to warning signs about suspicious sales to its pharmacy customers.
- 12/29/2022
|
Final Trades: American Water, Boeing, Danaher & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 12/28/2022
|
5 Broker-Friendly Stocks to Bank On as Volatility Persists
- Broker-favorite stocks like Cardinal Health (CAH), American Airlines (AAL), Boise Cascade (BCC), AmerisourceBergen (ABC) and Centene (CNC) should be on an investors' watchlist.
- 12/27/2022
|
Buy This Warren Buffett-Owned Stock for 2023 and Beyond
- This healthcare products distributor's business model can withstand a recession.
- 12/26/2022
|
Red-Hot Fund Managers Expect Rocky Start To 2023
- Want to know how to invest in 2023? Red-hot fund manager Dale Harvey says individual investors should fasten their seat belts.
- 12/19/2022
|
Final Trades: UnitedHealth, AmerisourceBergen, Rockwell Automation & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 12/16/2022
|
AmerisourceBergen (ABC) to Repurchase Common Stock Worth $200M
- AmerisourceBergen (ABC) announces a share repurchase worth $200 million in concurrence with the sale of its shares by one of its shareholders, Walgreens Boots Alliance, under Rule 144.
- 12/12/2022
|
This Dividend Aristocrat's High Yield Looks Like a Safe Haven
- Investors shopping for income often begin by asking if a dividend, and particularly a high one, is sustainable. It's a logical and important question every investor should ask.
- 11/29/2022
|
AmerisourceBergen (ABC) Hits 52-Week High: What's Driving It?
- Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.
- 11/28/2022
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 11/22/2022
|
Merck, Nike Among 14 Companies To Announce Annual Dividend Increases In The Second Half Of November
- There were a few double-digit boosts in the first half of November. Most notably, ADP came through with a 20% increase and Snap-On Tools with a 14% increase. Emerson extended its dividend growth streak to 66 years with a 1% boost and Lancaster Colony started its 7th decade of dividend growth with a 6% increase.
- 11/13/2022
|
3 Dental Supplies Stocks to Watch Amid Industry Headwinds
- Here we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors - BDX, MCK and ABC.
- 11/09/2022
|
AmerisourceBergen (ABC) Q4 Earnings & Revenues Top Estimates
- AmerisourceBergen's (ABC) fiscal fourth-quarter 2022 results benefit from segmental growth.
- 11/03/2022
|
AmerisourceBergen Corporation (ABC) Q3 2022 Earnings Call Transcript
- AmerisourceBergen Corporation (NYSE:ABC ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Bennett Murphy - SVP, IR Steven Collis - Chairman, President & CEO James Cleary - EVP & CFO Conference Call Participants Lisa Gill - JPMorgan Chase & Co. Michael Cherny - Bank of America Merrill Lynch George Hill - Deutsche Bank Charles Rhyee - Cowen and Company Eric Percher - Nephron Research Eric Coldwell - Baird Kevin Caliendo - UBS Steven Valiquette - Barclays Bank A.J. Rice - Credit Suisse Operator Ladies and gentlemen, welcome to the AmerisourceBergen Q4 FY 2022 Earnings Call.
- 11/03/2022
|
AmerisourceBergen (ABC) Surpasses Q4 Earnings and Revenue Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 0.78% and 1.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/03/2022
|
AmerisourceBergen profit falls but tops estimates for Q4
- AmerisourceBergen Corp. ABC, -0.97% said Thursday it had net income of $294.7 million, or $1.40 a share, for its fiscal fourth quarter to Sept. 30, down from $437.7 million, or $2.08 a share, in the year-earlier period.
- 11/03/2022
|
The Importance Of Government Contracting For AmerisourceBergen
- AmerisourceBergen has won nearly $1.5bn in government contract awards in 2022 up until the end of Q3. 21.3% Y/Y adjusted EPS growth in Q3 2022 driven by strong operating performance & M&A.
- 11/02/2022
|
AmerisourceBergen (ABC) to Post Q4 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal fourth-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
- 10/25/2022
|
Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report?
- AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/18/2022
|
AmerisourceBergen Corporation: Looking Healthier
- After a few years of stagnation, shares of AmerisourceBergen have come to life again. AmerisourceBergen is seeing solid growth, leverage is low, and opioid settlements have been announced.
- 10/06/2022
|
AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2022 on Thursday, November 3, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 3, 2022. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Exec
- 09/28/2022
|
Outlook Therapeutics enters into commercialization agreement with AmerisourceBergen
- Outlook Therapeutics Inc (NASDAQ:OTLK) said it has entered into a strategic relationship with healthcare company AmerisourceBergen in preparation for the anticipated commercial launch in the United States of its ONS-5010 treatment for wet age-related macular degeneration (AMD). ONS-5010 is an investigational ophthalmic formulation of bevacizumab under development to be administered as an intravitreal injection for the treatment of wet AMD and other retinal diseases.
- 09/27/2022
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 09/26/2022
|
AmerisourceBergen (ABC) to Buy Germany's PharmaLex for $1.3B
- AmerisourceBergen (ABC) inks a deal to acquire PharmaLex to support its goal to become a strategic partner of choice for pharma customers for clinical and commercial enablement solutions.
- 09/13/2022
|
AmerisourceBergen agrees to acquire Germany's PharmaLex for 1.28 billion euros in cash
- AmerisourceBergen Corp. ABC, -0.18% said Monday it has agreed to acquire PharmaLex Holding GmbH, a German company offering specialized services for the life sciences industry, or 1.28 billion euros ($1.29 billion) in cash. The deal "will advance AmerisourceBergen's role as partner of choice for biopharmaceutical manufacturers by enhancing AmerisourceBergen's global portfolio of solutions to support manufacturer partners across the pharmaceutical development and commercialization journey," the company said in a statement.
- 09/12/2022
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 08/24/2022
|
Is WBA Stock A Buy Or Sell After Pivotal Court Ruling In Opioids Case?
- Walgreens faces legal challenges as rising costs eat into profit margins. Is Walgreens stock a buy?
- 08/19/2022
|
Back To The Future With AmerisourceBergen Corporation
- ABC has recently pulled back and provides a potential entry point for investors. Long term, the industry should maintain its 1% share of US expenditure on pharmaceuticals. The Inflation Reduction Act is mainly focused on Medicare Part D. ABC is more heavily exposed to Part B which will be impacted in 2028.
- 08/16/2022
|
Is AmerisourceBergen (ABC) a Solid Growth Stock? 3 Reasons to Think "Yes"
- AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market.
- 08/15/2022
|
Beat the Market the Zacks Way: Walt Disney (DIS), AmerisourceBergen (ABC), C.H. Robinson Worldwide (CHRW) in Focus
- Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week.
- 08/15/2022
|
Has AmerisourceBergen (ABC) Outpaced Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Aerie Pharmaceuticals (AERI) have performed compared to their sector so far this year.
- 08/10/2022
|
Are Investors Undervaluing AmerisourceBergen (ABC) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/10/2022
|
10 defensive stocks that can also provide you with growth and dividends over the long term
- The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.
- 08/10/2022
|
AmerisourceBergen (ABC) Q3 Earnings & Revenues Top Estimates
- AmerisourceBergen's (ABC) fiscal third-quarter results benefit from segmental growth.
- 08/03/2022
|
Amerisourcebergen Corp (ABC) CEO Steven Collis on Q3 2022 Results - Earnings Call Transcript
- Amerisourcebergen Corp (NYSE:ABC ) Q3 2022 Earnings Conference Call August 3, 2022 8:30 AM ET Company Participants Bennett Murphy - SVP, IR Steven Collis - Chairman, President & CEO James Cleary - EVP & CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Lisa Gill - JPMorgan Chase & Co. Eric Percher - Nephron Research A.J. Rice - Crédit Suisse George Hill - Deutsche Bank Steven Valiquette - Barclays Bank Kevin Caliendo - UBS Charles Rhyee - Cowen and Company Operator Hello, everyone, and welcome to the AmerisourceBergen Third Quarter Fiscal 2022 Earnings Call.
- 08/03/2022
|
AmerisourceBergen (ABC) Q3 Earnings and Revenues Surpass Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 1.95% and 1.47%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/03/2022
|
AmerisourceBergen beats profit and revenue expectations, raises full-year outlook
- AmerisourceBergen Corp. ABC, -2.14% reported Wednesday fiscal third-quarter profit and revenue that beat expectations and raised its full-year outlook, amid strength in its International Healthcare Solutions (IHS) business. Shares of the pharmaceuticals and healthcare products company were still inactive in premarket trading.
- 08/03/2022
|
Is a Beat Likely for AmerisourceBergen (ABC) in Q3 Earnings?
- AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
- 07/27/2022
|
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 07/12/2022
|
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2022 on Wednesday, August 3, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 3, 2022. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executiv
- 06/29/2022
|
Why AmerisourceBergen Is The Best-In-Class Pharmaceuticals Distributor
- AmerisourceBergen is one of the "big three" distributors of pharmaceuticals in the United States. In terms of 2021 revenues, it is almost as big as McKesson. The business is recession-resistant, and because it has high barriers to entry due to its heavy regulation and sophisticated distribution networks. AmerisourceBergen and its peers have an economic moat.
- 06/16/2022
|
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 06/07/2022
|
Why Is AmerisourceBergen (ABC) Down 4.5% Since Last Earnings Report?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
- 06/03/2022
|
AmerisourceBergen sets $1 billion stock buyback program
- AmerisourceBergen Corp. ABC, -1.32% said Wednesday that it set a new $1 billion stock repurchase program. That represents 3.1% of the pharmaceutical and health care products company's market capitalization of $32.42 billion at Tuesday's stock closing price.
- 06/01/2022
|
AmerisourceBergen: A Healthy, Wealthy Stock You Can Count On
- AmerisourceBergen is a leading global drug distributor with a strong focus on operational excellence. The company has recently resolved the majority of its legal troubles related to the Opioid crisis, and is now free to continue growing its business.
- 05/30/2022
|
AmerisourceBergen's stock tanks after largest investor sells $900 million worth of shares
- Shares of AmerisourceBergen Corp. suffered the biggest selloff in more than two years on Thursday, after the drug products and distribution company's largest investor sold off a chunk of its stake.
- 05/12/2022
|
What's Going On With AmerisourceBergen Shares Today
- Walgreens Boots Alliance Inc (NASDAQ: WBA) has sold 6.0 million shares of AmerisourceBergen Corp (NYSE: ABC) at $150 per share. After the sale, Walgreens Boots Alliance's ownership of AmerisourceBergen's common stock decreased from approximately 28.1% to 25.2%.
- 05/12/2022
|
AmerisourceBergen (ABC) Q2 Earnings & Revenues Top Estimates
- AmerisourceBergen's (ABC) fiscal second-quarter results benefit from segmental growth.
- 05/04/2022
|
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q2 2022 Results - Earnings Call Transcript
- AmerisourceBergen Corporation (NYSE:ABC ) Q2 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President-Investor Relations Steve Collis - Chairman, President & Chief Executive Officer Jim Cleary - Executive Vice President & Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore Lisa Gill - JPMorgan Charles Rhyee - Cowen Steven Valiquette - Barclays Eric Percher - Nephron Research Eric Coldwell - Baird George Hill - Deutsche Bank Michael Cherny - Bank of America Operator Good morning or good afternoon all. Welcome to the AmerisourceBergen Corporation Fiscal 2022 Second Quarter Earnings Call.
- 05/04/2022
|
AmerisourceBergen (ABC) Tops Q2 Earnings and Revenue Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 7.69% and 0.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/04/2022
|
AmerisourceBergen beats earnings expectations, and lifts full-year guidance
- AmerisourceBergen Corp. ABC, +1.20% reported first-quarter profit and revenue that rose above expectations, amid strength in international healthcare business, and raised its full-year outlook. The health care services company's stock was still inactive in premarket trading.
- 05/04/2022
|
AmerisourceBergen (ABC) Reports Next Week: Wall Street Expects Earnings Growth
- AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/27/2022
|
AmerisourceBergen's (ABC) Venture Capital Fund to Aid Healthcare
- AmerisourceBergen's (ABC) new corporate venture capital fund to help emerging healthcare startup companies change healthcare for people and animals globally.
- 04/11/2022
|
10 Stocks That Have Moved Over 20% Since The Indices Lost Over 12%!
- The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
- 04/08/2022
|
This Healthcare ETF Has Compelling Prognosis
- Broadly speaking, the healthcare sector isn't on fire this year, but analysts are increasingly bullish on the group, citing attractive quality and valuation traits, among other factors. While the sector isn't yet ablaze in 2022, some big names in the group are delivering for investors, underscoring the point that quality is a virtue.
- 04/04/2022
|
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
- 04/04/2022
|
5 Housing Market Predictions 2022: What Can Real Estate Stock Investors Expect
- Housing market predictions are a great way to understand where the markets are headed next, providing a nice indicator for the economy. The post 5 Housing Market Predictions 2022: What Can Real Estate Stock Investors Expect appeared first on InvestorPlace.
- 03/29/2022
|
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2022 Earnings Release; Announces 2022 Investor Day
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2022 on Wednesday, May 4, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 4, 2022. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executive Vic
- 03/28/2022
|
3 Healthcare Stocks With Healthy Fundamentals
- These three fundamentally sound companies will protect both your vitals and your financial livelihood for years to come.
- 03/25/2022
|
Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Catalyst Pharmaceutical (CPRX) have performed compared to their sector so far this year.
- 03/16/2022
|
AmerisourceBergen: Supplying The Growing Pharmaceutical Demand
- Even after its outperformance, the stock has 30%-plus upside and could be worth at least $182/share today.
- 03/15/2022
|
U.S. should review drugmakers' opioid settlement tax breaks - House panel
- The U.S. Justice and Treasury Departments should review the tax deductions four drugmakers made related to their $26 billion opioid settlement, the U.S. House Oversight and Reform Committee said in a statement on Monday.
- 03/14/2022
|
AmerisourceBergen (ABC) is an Incredible Growth Stock: 3 Reasons Why
- AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 03/09/2022
|
AmerisourceBergen: Supplying The Growing Pharmaceutical Demand
- This company is well-positioned to benefit from several trends that will drive long-term growth of pharmaceutical sales.
- 03/09/2022
|
AmerisourceBergen (ABC) Hits 52-Week High: What's Aiding It?
- Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.
- 03/07/2022
|
5 Dividend Growth Stocks for Safe and Consistent Income
- J.B. Hunt (JBHT), Archer-Daniels (ADM), NVIDIA (NVDA), Tractor Supply (TSCO) and AmerisourceBergen (ABC) could be compelling picks for investors seeking safe and consistent income.
- 03/07/2022
|
AmerisourceBergen (ABC) Up 5.5% Since Last Earnings Report: Can It Continue?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
- 03/04/2022
|
Here's Why You Should Invest in AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment.
- 03/03/2022
|
Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Celularity, Inc. (CELU) have performed compared to their sector so far this year.
- 02/28/2022
|
AmerisourceBergen - Another All Time High
- 100% technical buy signal.
- 02/19/2022
|
AmerisourceBergen (ABC) is a Great Momentum Stock: Should You Buy?
- Does AmerisourceBergen (ABC) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 02/17/2022
|
3 Reasons Growth Investors Will Love AmerisourceBergen (ABC)
- AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 02/14/2022
|
AmerisourceBergen (ABC) Upgraded to Buy: Here's Why
- AmerisourceBergen (ABC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 02/11/2022
|
The Stock-Picking Puzzle: Putting The Pieces Together
- The Stock-Picking Puzzle: Putting The Pieces Together
- 02/07/2022
|
AmerisourceBergen: A Steady Wealth Compounder You'll Want To Own
- AmerisourceBergen has a durable business model and is seeing revenue and margin growth. It has a strong track record of shareholder returns, and has tailwinds in COVID treatments and vaccines.
- 02/03/2022
|
AmerisourceBergen's (ABC) CEO Steve Collis on Q1 2022 Results - Earnings Call Transcript
- AmerisourceBergen's (ABC) CEO Steve Collis on Q1 2022 Results - Earnings Call Transcript
- 02/02/2022
|
AmerisourceBergen (ABC) Q1 Earnings Lag Estimates, Revenues Beat
- AmerisourceBergen's (ABC) fiscal first-quarter results benefit from segmental growth.
- 02/02/2022
|
AmerisourceBergen Q1 Earnings Beats By A Whisker
- AmerisourceBergen Corp's ABC Q1 FY22 adjusted EPS reached $2.58, up 18.3% Y/Y, marginally beating the consensus of $2.57. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School.
- 02/02/2022
|
AmerisourceBergen (ABC) Misses Q1 Earnings Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of -0.39% and 0.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/02/2022
|
AmerisourceBergen matches consensus for profit and revenue, raises full-year guidance
- AmerisourceBergen Corp. ABC, +1.07% matched consensus estimates for profit and revenue for its fiscal first quarter on Wednesday, and raised its full-year guidance. The Conshocken, Pa.
- 02/02/2022
|
AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
- 01/27/2022
|
AmerisourceBergen (ABC) Reports Next Week: Wall Street Expects Earnings Growth
- AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/26/2022
|
AmerisourceBergen (ABC) is a Top-Ranked Momentum Stock: Should You Buy?
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 01/24/2022
|
7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022
- These seven low-labor-cost stocks -- including Apple and PayPal -- are buys as the U.S. labor market tightens and wages rise in 2022. The post 7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022 appeared first on InvestorPlace.
- 01/21/2022
|
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment. However, stiff competition is a woe.
- 01/11/2022
|
AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2022 on Wednesday, February 2, 2022 prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on February 2, 2022. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Execu
- 01/04/2022
|
American Tower (AMT) Closes Acquisition of CoreSite Realty
- American Tower's (AMT) acquisition of CoreSite Realty offers the opportunity to capitalize on the latter's highly interconnected data center facilities and critical cloud on-ramps.
- 12/29/2021
|
AmerisourceBergen (ABC) Hits 52-Week High: What's Aiding It?
- Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.
- 12/27/2021
|
Options Income Series: Earn High Income Safely And Consistently - December 2021
- We explain why selling the cash-covered puts and covered calls is a safer choice and earns a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable.
- 12/25/2021
|
The Top 3 REITs in Mobile Towers
- From simple texts to the metaverse, this infrastructure is essential and growing.
- 12/21/2021
|
Has AmerisourceBergen (ABC) Outpaced Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
- 12/16/2021
|
Has AmerisourceBergen (ABC) Outpaced Other Medical Stocks This Year?
- Here is how AmerisourceBergen (ABC) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
- 12/16/2021
|
Switch Has Superior Data Center Growth
- Switch Has Superior Data Center Growth
- 12/14/2021
|
Here's Why You Should Invest in AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment.
- 12/08/2021
|
Dividend Champions For December 2021
- Monthly update of the Dividend Champions List. 75 companies declared higher dividends in the past month, with an average increase of 8.55% over their previous payouts.
- 12/02/2021
|
End of an Era: The Decade's Best REIT Is Disappearing
- The data center REIT delivered remarkable returns for investors.
- 11/20/2021
|
McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters
- A Washington state trial against McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) for the U.S. opioid epidemic is slated to kick off today, Reuters reported. Washington Attorney General Bob Ferguson declined to join a $26 billion nationwide settlement and has accused the drug distributors of creating a public nuisance by failing to prevent the diversion of prescription pills into illegal channels.
- 11/15/2021
|
Top Real Estate News for Monday, Nov. 15, 2021: Cell Tower Giant to Buy Data Center REIT
- American Tower to buy a data center operator; Trump reaches deal on marquee D.C. hotel, and more.
- 11/15/2021
|
Second Half Of November Brings Dividend Increases From Merck, Nike And 12 Others
- Investors saw a few very good dividend increases in the first half of November, with ADP, Snap-on, and Roper Technologies announcing double-digit boosts, and a massive 29% boost from HP. The second half of November will bring double-digit boosts from a few more companies including Nike, Motorola Solutions, Aflac, and Agilent Technologies.
- 11/15/2021
|
CoreSite Realty (COR) Stock: Why The Price Jumped Today
- The stock price of CoreSite Realty Corp (NYSE: COR) increased by over 8% pre-market today. This is why it happened.
- 11/15/2021
|
Dividend Increases: October 30-November 5, 2021
- In this article series, we provide a weekly summary of dividend changes. A summary table presents relevant data and key statistics of dividend increases.
- 11/11/2021
|
New REIT Alert: This Data Center Operator Is Making the Switch
- The data center REIT sector will soon have a new option for investors.
- 11/09/2021
|
AmerisourceBergen (ABC) Soars to 52-Week High, Time to Cash Out?
- AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 11/08/2021
|
3 Reasons AmerisourceBergen Is A SWAN Worth Buying Today
- 3 Reasons AmerisourceBergen Is A SWAN Worth Buying Today
- 11/05/2021
|
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 Fiscal 2021 Results - Earnings Call Transcript
- AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 Fiscal 2021 Results - Earnings Call Transcript
- 11/04/2021
|
AmerisourceBergen (ABC) Q4 Earnings and Revenues Surpass Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 1.27% and 3.92%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/04/2021
|
CoreSite Innovator to Present at the Infinity Festival November 2–4, 2021
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR) (“CoreSite,” or the “Company”), a premier provider of secure, reliable, high-uptime data center campuses with high-performance cloud access and interconnection solutions across the U.S., announced they are the proud co-presenting sponsor of the upcoming Infinity Festival 2021 in Hollywood, CA November 2-4. Now in its exciting fourth year, the forward-focused Infinity Festival is the place where Hollywood meets Silicon Valley. The m
- 10/28/2021
|
3 Stocks to Buy as the Economy Recovers
- These companies have been delivering strong results, and investors should expect that to continue next year.
- 10/21/2021
|
Trick Or Treat? The Data Center REITs
- Companies experiencing strong secular growth tailwinds should experience fundamental growth, regardless of the strength of the macro economy. These are the investment types that often outperform during uncertain times while the rest of the market lacks clear growth.
- 10/16/2021
|
Here's Why AmerisourceBergen (ABC) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 10/13/2021
|
Here's Why You Should Invest in AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment.
- 10/06/2021
|
CoreSite Announces Third Quarter 2021 Earnings Conference Call
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-uptime data center campuses with high-performance cloud access and interconnection solutions in major U.S. metropolitan areas, today announced it will host its third quarter 2021 earnings conference call on Thursday, October 28, 2021, at 12:00 p.m., Eastern Time, and will issue its financial results prior to market open on Thursday, October 28, 2021. The call will be accessible by diali
- 10/04/2021
|
September Slump, October Opportunity
- U.S. equity markets delivered their worst week since February - and worst month since the pandemic began - amid heightened concerns over potential stagflation, supply chain issues, and political dysfunction. Large-cap equities felt the brunt of the pressure this past week as S&P 500 slipped 2.2% while the tech-heavy Nasdaq dipped 3.6%. Mid-Caps declined 0.5% while Small Caps gained 0.9%.
- 10/03/2021
|
Drug Distributors Ink First Opioid Settlement With Cherokee Nation
- Cardinal Health Inc (NYSE: CAH), McKesson Corporation (NYSE: MCK), and AmerisourceBergen Corp (NYSE: ABC), accused of U.S. addiction crisis, have struck a settlement with a tribal government, Reuters reports. As part of the deal with Cherokee Nation's territory in Oklahoma, the three companies will pay $75 million over six and half years to resolve claims linked to the opioid epidemic in the region.
- 09/28/2021
|
AmerisourceBergen Unveils New Global Headquarters in Conshohocken, PA & Announces Great Place to Work® Recognition
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Today, AmerisourceBergen (AB), a global healthcare company, hosted a ribbon cutting ceremony to commemorate the opening of its new global headquarters in Conshohocken, Pa. The 429,000 sq. ft. facility designed by Gensler includes tech-enabled conference and business centers, a fitness center, and dining site services. The new building is part of SORA West -- a multi-faceted complex developed by Keystone Property Group which will include a 127-room boutique ho
- 09/28/2021
|
CoreSite Realty: Solid Niche Player With Heavy Debt Load And Perilous Payout
- CoreSite Realty: Solid Niche Player With Heavy Debt Load And Perilous Payout
- 09/22/2021
|
CoreSite Successfully Completes Annual Compliance Examinations
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR) (the “Company”), a premier provider of secure, reliable, high-uptime data center campuses with high-performance cloud access and interconnection solutions in major U.S. metropolitan areas, today announced it has successfully completed its annual compliance examinations for the colocation services offered across 22 operating multi-tenant data centers in its portfolio. The completion of these annual examinations positions CoreSite to
- 09/20/2021
|
3 Stock Ideas For An Expensive Market
- With most stock indices near all-time highs and lofty valuations on most mega-cap stocks, it can be difficult to find good long-term values right now in the overall stock market. At the individual stock level, however, there are a few solid values even within the components of the S&P 500 index that aren't cyclical in nature.
- 09/15/2021
|
Here's Why You Should Retain AmerisourceBergen (ABC) Stock Now
- AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment.
- 09/07/2021
|
Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase
- CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that, under the previously announced proposed settlement agreement and process designed to resolve the opioid claims of state and local governmental entities, they have determined that enough states have agreed to settle to proceed to the next phase. Under the proposed settlement agreement and process, all U.S. States, territories
- 09/04/2021
|
Why Is AmerisourceBergen (ABC) Up 2.5% Since Last Earnings Report?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
- 09/03/2021
|
CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-uptime data center campuses with high-performance cloud access and interconnection solutions in major U.S. metropolitan areas, today announced a cash dividend of $1.27 per share on common stock and common stock equivalents for the third quarter of 2021, consistent with the previous quarter. The dividend will be paid on October 15, 2021, to shareholders of record as of September 30, 2021
- 09/02/2021
|
AmerisourceBergen to Participate in Upcoming Investor Conferences
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate virtually in the following upcoming investor conferences: Morgan Stanley 19th Annual Global Healthcare Conference, to be held on September 9-10 & September 13-15, 2021; and Baird 2021 Global Healthcare Conference, to be held on September 14-15, 2021. Please check the website investor.amerisourcebergen.com for updates regarding the timing of live webcasts, if any, and for re
- 09/02/2021
|
AmerisourceBergen: Boring But Beautiful Buy For Your Rich Retirement
- AmerisourceBergen: Boring But Beautiful Buy For Your Rich Retirement
- 08/04/2021
|
AmerisourceBergen Stock Gains As Q3 Earnings Tops Wall Street Estimates; Raises FY21 EPS Guidance
- AmerisourceBergen Corporation's (NYSE: ABC) Q3 for fiscal 2021 reports an adjusted EPS of $2.16, topping the analyst consensus estimate of $2.03. Revenue of $53.4 billion increased 17.7% Y/Y, beating the analyst consensus estimate of $52.05 billion.
- 08/04/2021
|
AmerisourceBergen (ABC) Beats Q3 Earnings and Revenue Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 7.46% and 3.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/04/2021
|
AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 third quarter ended June 30, 2021, revenue increased 17.7 percent year-over-year to $53.4 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $1.40 for the June quarter of fiscal 2021, compared to $1.41 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described bel
- 08/04/2021
|
6 REITs That Could Cut The Cheese
- 6 REITs That Could Cut The Cheese
- 08/01/2021
|
CoreSite Realty Corporation (COR) CEO Paul Szurek on Q2 2021 Results - Earnings Call Transcript
- CoreSite Realty Corporation (COR) CEO Paul Szurek on Q2 2021 Results - Earnings Call Transcript
- 07/29/2021
|
CoreSite Reports Second Quarter 2021 Financial Results
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR) (“the Company”), a premier provider of secure, reliable high-uptime data center campuses with high-performance cloud access and interconnection solutions across the U.S., today announced financial results for quarter ended June 30, 2021. Q2 2021 Quarterly Highlights Key Financial Results – Grew operating revenues to $162.1 million, an increase of 7.7% year over year and 2.8% sequentially Delivered net income of $0.59 per common dil
- 07/29/2021
|
Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report?
- AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/26/2021
|
US States Get $26B Settlement Deal in Opioid Abuse Litigation
- Attorney generals of several states reach settlement deal with J&J (JNJ) and three drug distributors - MCK, CAH and ABC - related to thousands of opioid abuse litigations. Non-participating states may join the deal soon.
- 07/22/2021
|
States announce $26 billion settlement to resolve opioid lawsuits: RPT
- Chris Meekins, Healthcare Policy Research Analyst at Raymond James, joins Yahoo Finance's Kristin Myers and Alexis Christoforous to discuss healthcare talks in Washington this week and the latest news on the opioid lawsuits.
- 07/21/2021
|
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
- What did the stock market do today? It began to address the opioid crisis, it tuned in on Bitcoin and it saw a devastating Olympics loss.
- 07/21/2021
|
Distributors Announce Proposed Opioid Settlement Agreement
- CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. While the companies strongly dispute the allegations made in these lawsuits, they believe the pr
- 07/21/2021
|
AmerisourceBergen (ABC) Soars 3.5%: Is Further Upside Left in the Stock?
- AmerisourceBergen (ABC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- 07/21/2021
|
Drug distributors settle New York opioid claims for up to $1.18 bln
- NEW YORK, July 20 (Reuters) - The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid epidemic, the state's attorney general said on Tuesday.
- 07/20/2021
|
McKesson, Cardinal Health, AmerisourceBergen stocks surge after $1.1 billion opioid settlement with NY AG
- Shares of McKesson Corp. , Cardinal Health Inc. and AmerisourceBergen Corp. all surged more than 4% in morning trading Tuesday, after the New York Attorney General Letitia James announced a $1.1 billion settlement agreement with the drug distributors to combat the opioid epidemic. James said the agreement resolves claims for the companies' role in helping fuel the epidemic, and will remove the companies from the ongoing opioid trial.
- 07/20/2021
|
MedTech Thrives on Healthcare IT in 2021: 4 Stocks to Focus on
- Health IT stocks like HealthEquity (HQY), Veeva Systems (VEEV), Tabula Rasa (TRHC) and Allscripts (MDRX) are expected to continue their run over the next few months.
- 07/16/2021
|
Final Trades: Qualcomm, Salesforce.com, CoreSite Realty & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 07/09/2021
|
Why You Shouldn't Bet Against AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- 07/08/2021
|
Here's Why You Should Retain AmerisourceBergen (ABC) Now
- AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment.
- 07/08/2021
|
Brokers' Upgrade Adds to the Attractiveness of These 5 Stocks
- Investors should keep an eye on broker-friendly stocks like Atlas Air (AAWW), Caleres (CAL), AmerisourceBergen (ABC), Chico's FAS (CHS) and Builders FirstSource (BLDR) for impressive returns.
- 07/07/2021
|
New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid
- Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly marketed opioid drugs as having a low addiction risk, a lawyer for a New York county told jurors, urging them to hold the companies liable. Jayne Conroy, representing Suffolk County, also said that the drug distributors - AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and McKesson Corp (NYSE: MCK) failed to report suspicious opioid orders as required.
- 06/29/2021
|
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2021 on Wednesday, August 4, 2021, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 4, 2021. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executiv
- 06/24/2021
|
13 Upcoming Dividend Increases Including 2 Dividend Kings
- 13 Upcoming Dividend Increases Including 2 Dividend Kings
- 06/24/2021
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 06/21/2021
|
Overview Of Opportunities In Animal Companionship: A $200B Industry Growing At 6.1% Annually
- The physiological and psychological benefits that pets give us are meaningful. COVID has amplified our appreciation of this. Anticipating 6% annual growth until 2030 may be conservative, even across developed markets.
- 06/11/2021
|
Here's Why You Should Retain AmerisourceBergen (ABC) Now
- AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment.
- 06/09/2021
|
AmerisourceBergen to Participate in Upcoming Investor Conferences
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate virtually in the following upcoming investor conferences: Goldman Sachs 42nd Annual Global Healthcare Conference, to be held on June 8-11, 2021; and Baird Healthcare ESG Symposium, to be held on June 17, 2021. Please check the website investor.amerisourcebergen.com for updates regarding the timing of the live webcasts, if any, and for replay information. About AmerisourceBergen
- 06/04/2021
|
Walgreens Completes $6.5B Sale Of European Distribution Business To AmerisourceBergen
- The large drug wholesaler AmerisourceBergen completed its acquisition of the majority of Walgreens Boots Alliance's “Alliance Healthcare” wholesale distribution business for $6.5 billion.
- 06/02/2021
|
CoreSite Realty: A Lofty Firm But Not A Bad Prospect
- CoreSite Realty has done well to grow its business over the past several years, including through the COVID-19 pandemic.
- 05/28/2021
|
Pharmacy stocks tumble on report Amazon is weighing a push into physical pharmacies (AMZN, CVS, RAD, WAG, CAH, MCK, ABC)
- Shares of drug retailers including Walgreens Boots Alliance and CVS dropped on Wednesday, as Amazon was reported to be looking at options to set up physical pharmacy locations in the US. Talks at Amazon about setting up standalone pharmacies are mostly exploratory and there are no firm plans to open physical locations, three people familiar with the matter told Insider. Such a move would be part of a plan by the online retail behemoth to earn a larger share of the country's $370 billion prescription drug market.
- 05/26/2021
|
Dividend Increases: May 15-21, 2021
- Dividend Increases: May 15-21, 2021
- 05/26/2021
|
AmerisourceBergen: A-Rated Healthcare Blue Chip With 17 Years Of Dividend Growth
- ABC benefits from a very strong balance sheet. ABC has durable competitive advantages.
- 05/22/2021
|
CoreSite to Present at Two Upcoming Investor Conferences
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, high-uptime data center campuses with high-performance cloud access and interconnection solutions in major U.S. metropolitan areas, today announced it will present at two upcoming virtual investor conferences, including: RBC Capital Markets Global Datacenter, Cloud and Broadband Infrastructure Conference on Tuesday, May 25th. Paul Szurek, President and Chief Executive Officer, will present at 12:40 p.
- 05/20/2021
|
CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, high-uptime data center campuses with high-performance cloud access and interconnection solutions in major U.S. metropolitan areas, today announced a cash dividend of $1.27 per share on common stock and common stock equivalents for the second quarter of 2021, reflecting a 3.25% increase over the prior quarter dividend of $1.23. The dividend will be paid on July 15, 2021, to shareholders of record as o
- 05/19/2021
|
AmerisourceBergen Stock Dives After Q2 Earnings Fall Short Of Expectations
- AmerisourceBergen Corporation (NYSE: ABC) shares dropped after the company's Q2 for fiscal 2021 failed to meet the consensus estimates. It reported an adjusted EPS of $2.53 topped the analyst consensus estimate of $2.48.
- 05/05/2021
|
AmerisourceBergen (ABC) Q2 Earnings Beat, Revenues Miss
- AmerisourceBergen's (ABC) fiscal second-quarter results benefit from segmental growth.
- 05/05/2021
|
AmerisourceBergen (ABC) Q2 Earnings Top Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 0.80% and -1.58%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2021
|
AmerisourceBergen stock falls after profit beats forecasts but revenue was a bit light
- Shares of AmerisourceBergen Corp. fell 0.7% in premarket trading Wednesday, after the pharmaceuticals and health care products company reported a first-quarter profit that beat expectations but revenue that came up a bit light. Net income fell to $435.3 million, or $2.10 a share, from $960.3 million, or $4.64 a share, in the year-ago period.
- 05/05/2021
|
AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
- CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent year-over-year to $49.2 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.10 for the March quarter of fiscal 2021, compared to $4.64 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described b
- 05/05/2021
|
Why AmerisourceBergen (ABC) Might Surprise This Earnings Season
- AmerisourceBergen (ABC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 05/04/2021
|
AmerisourceBergen (ABC) to Post Q2 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal second-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
- 04/30/2021
|
CoreSite Realty Corp (COR) CEO Paul Szurek on Q1 2021 Results - Earnings Call Transcript
- CoreSite Realty Corp (COR) CEO Paul Szurek on Q1 2021 Results - Earnings Call Transcript
- 04/29/2021
|
CoreSite Realty (COR) Tops Q1 FFO and Revenue Estimates
- CoreSite (COR) delivered FFO and revenue surprises of 5.26% and 0.41%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 04/29/2021
|
CoreSite Reports First Quarter 2021 Financial Results
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR) (“the Company”), a premier provider of secure, reliable, high-uptime data center campuses with high-performance cloud access and interconnection solutions across the U.S., today announced financial results for quarter ended March 31, 2021. Q1 2021 Quarterly Highlights Key Financial Results – Grew operating revenues to $157.6 million, an increase of 7.0% year over year and 1.7% sequentially Delivered net income of $0.51 per common d
- 04/29/2021
|
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
- AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
- 04/21/2021
|
All You Need to Know About AmerisourceBergen (ABC) Rating Upgrade to Buy
- AmerisourceBergen (ABC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 04/08/2021
|
CoreSite Announces First Quarter 2021 Earnings Conference Call
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center, cloud access and interconnection solutions in major U.S. metropolitan areas, today announced it will host its first quarter 2021 earnings conference call on Thursday, April 29, 2021, at 12:00 p.m. Eastern Time, and will issue its financial results prior to market open on Thursday, April 29, 2021. The call will be accessible by dialing 1-877-407-3982 (domestic) o
- 04/05/2021
|
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2021 on Wednesday, May 5, 2021, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 5, 2021. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executive Vic
- 04/01/2021
|
AmerisourceBergen Closes $1,525,000,000 0.737% Senior Notes Due 2023 and $1,000,000,000 2.700% Senior Notes Due 2031
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $1,525,000,000 aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (the “2023 Notes”) and $1,000,000,000 aggregate principal amount of its 2.700% Senior Notes due March 15, 2031 (the “2031 Notes” and, together with the 2023 Notes, the “Notes”), in an underwritten registered public offering. The offering was made pursuant to an effective shelf r
- 03/30/2021
|
Final Trades: O'Reilly Auto Parts, Cleveland-Cliffs, Vuzix & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 03/26/2021
|
AmerisourceBergen (ABC) Hits New 52-Week High: What's Driving It?
- AmerisourceBergen (ABC) is optimistic about maintaining a robust segmental performance amid the pandemic-led business disruptions.
- 03/26/2021
|
AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $1.525 billion aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (the “2023 Notes”) and $1.0 billion aggregate principal amount of its 2.700% Senior Notes due March 15, 2031 (the “2031 Notes” and, together with the 2023 Notes, the “Notes”), in an underwritten registered public offering. The offering is being made pursuant to an effective shelf registration statemen
- 03/25/2021
|
AmerisourceBergen: This SWAN Is Still On Sale, Here's Why
- AmerisourceBergen has underperformed the market, despite strong and steady performance.
- 03/24/2021
|
CoreSite Realty Stock Is Estimated To Be Fairly Valued
- The stock of CoreSite Realty (NYSE:COR, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded.
- 03/23/2021
|
7 Dividend Stocks You Can Trust Your Retirement To
- Dividend stocks remain one of the most stable segments to pour your capital into. Here are seven companies will put your mind at ease.
- 03/19/2021
|
Building A Dividend Growth Portfolio From Scratch In Today's Expensive Market
- The current valuation suggests that investors purchasing the index today could suffer through negative returns for the next 2 to 3 years or longer. Low interest rates have generated strong demand for dividend growth stocks.
- 03/18/2021
|
3 Stocks to Capitalize on Promising Dental Supplies Industry
- 3 Stocks to Capitalize on Promising Dental Supplies Industry
- 03/10/2021
|
This analyst breaks down key data center stocks
- CNBC's Jon Fortt discusses the future of data centers and cloud computing with Nick Del Deo, senior analyst at Moffett Nathanson.
- 03/09/2021
|
Dividends Raised, Rents Paid: REIT Earnings Recap
- Dividends Raised, Rents Paid: REIT Earnings Recap
- 03/08/2021
|
Why Is AmerisourceBergen (ABC) Down 6.3% Since Last Earnings Report?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
- 03/06/2021
|
CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center, cloud access and interconnection solutions in major U.S. metropolitan areas, today announced a cash dividend of $1.23 per share on common stock and common stock equivalents for the first quarter of 2021, consistent with the previous quarter. The dividend will be paid on April 15, 2021, to shareholders of record as of March 31, 2021. About CoreSite CoreSite Realt
- 03/04/2021
|
AmerisourceBergen CEO on how U.S. vaccine distribution is going
- Steve Collis, AmerisourceBergen CEO, joins 'Squawk on the Street' to discuss the role his company has played in the federal retail pharmacy program and his thoughts on the vaccine distribution.
- 03/02/2021
|
CoreSite Empowers Enterprises to Innovate with Leading Local Cloud as a Service Solution – VMware Cloud on Dell EMC
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR) (the “Company”), a premier provider of secure, reliable, high-performance data center, cloud access and interconnection solutions across the U.S., and a VMware Technology Alliance Partner, today announced the availability of VMware® Cloud™ on Dell EMC®. This fully managed infrastructure as a service offering is available across CoreSite's national platform of enterprise-class, cloud-enabled data center campuses. CoreSite and VMware
- 03/02/2021
|
4.0%-Yielding CoreSite Is A Buy At The Right Price
- CoreSite has an impressive collection of data center assets in key markets across the U.S. It continues to grow its top line and bottom line, and its interconnection business results in sticky tenant relationships.
- 02/15/2021
|
CoreSite Realty Corporation (COR) CEO Paul Szurek on Q4 2020 Results - Earnings Call Transcript
- CoreSite Realty Corporation (COR) CEO Paul Szurek on Q4 2020 Results - Earnings Call Transcript
- 02/04/2021
|
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q1 2021 Results - Earnings Call Transcript
- AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q1 2021 Results - Earnings Call Transcript
- 02/04/2021
|
AmerisourceBergen (ABC) Q1 Earnings & Revenues Beat Estimates
- AmerisourceBergen's (ABC) fiscal first-quarter results benefit from segmental growth.
- 02/04/2021
|
AmerisourceBergen (ABC) Q1 Earnings and Revenues Top Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 12.37% and 3.84%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/04/2021
|
CoreSite Realty (COR) Q4 FFO and Revenues Top Estimates
- CoreSite (COR) delivered FFO and revenue surprises of 1.52% and 0.49%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/04/2021
|
AmerisourceBergen's stock surges after profit and revenue beats, raised outlook
- Shares of AmerisourceBergen Corp. rallied 2.9% in premarket trading Thursday, after the pharmaceuticals and health care products development and delivery company reported fiscal first-quarter profit and revenue that beat expectations and raised its full-year outlook. Net income for the quarter to Dec. 31 rose to $374.8 million, or $1.81 a share, from $187.6 million, or 90 cents a share, in the year-ago period.
- 02/04/2021
|
AmerisourceBergen Reports Fiscal 2021 First Quarter Results
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent year-over-year to $52.5 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $1.81 for the December quarter of fiscal 2021, compared to $0.90 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items descri
- 02/04/2021
|
CoreSite Reports Fourth Quarter 2020 Financial Results
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR) (“the Company”), a premier provider of secure, reliable, high-performance data center, cloud access and interconnection solutions across the U.S., today announced financial results for the year and quarter ended December 31, 2020. 2020 Annual Highlights Key Financial Results – Grew operating revenues to $606.8 million, an annual increase of 6.0% Delivered net income of $1.95 per common diluted share, an annual decrease of $0.10 per
- 02/04/2021
|
Why AmerisourceBergen (ABC) Might Surprise This Earnings Season
- AmerisourceBergen (ABC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 02/03/2021
|
AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
- 02/01/2021
|
Scared Money Never Wins
- The best analogy I can come with right now is something I learned playing blackjack. In my twenties, I regularly visited Las Vegas to attend conventions. On the side, I'd sit around the table playing blackjack.
- 01/30/2021
|
CoreSite Offering Google Cloud Dedicated Interconnect at its Reston, Virginia Campus
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR) (the “Company”), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions across the U.S., today announced it is now offering direct fiber connectivity to Google Cloud via Dedicated Interconnect and internet peering available natively on its Reston, Virginia data center campus. Adding Optionality, Value and Route Diversity at CoreSite's Reston Campus This additional option provides C
- 01/28/2021
|
A Trio of Low Price-to-Free-Cash-Flow Ratio Stocks to Consider
- When looking for value opportunities, one method is to choose stocks whose trailing 12-month price-to-free-cash-flow ratios are low compared to that of the S&P 500 index, which stands at 15.28 as of the writing of this article. In my view, these equities are more likely to be selling at a compelling price.
- 01/27/2021
|
Here's Why You Should Retain AmerisourceBergen (ABC) Now
- AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
- 01/25/2021
|
Is AmerisourceBergen (ABC) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/20/2021
|
CoreSite Announces Tax Treatment of 2020 Distributions
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR) (the “Company”), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, today announced the income tax allocation for federal income tax purposes of its 2020 distributions on its common stock. As shown in the table below, the common distributions allocable to tax year 2020 are composed of 64.2667% taxable ordinary dividends and 35.7333% non-dividen
- 01/20/2021
|
AmerisourceBergen Announces Quarterly Dividend
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors declared a quarterly dividend of $0.44 per common share, payable March 1, 2021, to stockholders of record at the close of business on February 12, 2021. About AmerisourceBergen AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and lives
- 01/14/2021
|
7 Hot Stocks That Will Keep You Energized With 3%-Plus Yields
- These hot stocks combine healthy dividends with lasting brand names, making them some of the smartest picks on the market. The post 7 Hot Stocks That Will Keep You Energized With 3%-Plus Yields appeared first on InvestorPlace.
- 01/11/2021
|
AmerisourceBergen (ABC), WBA Ink Deal to Focus on Core Arms
- AmerisourceBergen (ABC) and Walgreens (WBA) enter into a key strategic deal to boost focus on core businesses, while extending their partnership.
- 01/07/2021
|
Walgreens to sell its distribution unit to AmerisourceBergen for £4.78 billion
- In an announcement on Wednesday, Walgreens Boots Alliance Inc (NASDAQ: WBA) said it will sell its distribution business to AmerisourceBergen Corp (NYSE: ABC) for £4.78 billion. Walgreens shares were seen more than 2% up in premarket trading on Wednesday and jumped another 2.5% in the next few hours.
- 01/06/2021
|
Walgreens To Sell Wholesale Drug Operation To AmerisourceBergen For $6.5 Billion
- The large drug wholesaler AmerisourceBergen will acquire the majority of Walgreens Boots Alliance's “Alliance Healthcare business” for $6.5 billion, the companies announced Wednesday.
- 01/06/2021
|
Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
- AmerisourceBergen also raised its guidance, sending shares up more than 6% in early Wednesday trade
- 01/06/2021
|
AmerisourceBergen to buy Walgreens' distribution business in $6.5 billion deal
- Drug distributor AmerisourceBergen Corp said on Wednesday it would buy Walgreens Boots Alliance's distribution business, Alliance Healthcare, for $6.5 billion.
- 01/06/2021
|
AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today updated its fiscal year 2021 financial guidance to reflect the Company's continued strong operating income performance. The Company will be participating in upcoming investor discussions in which the updated outlook for fiscal year 2021 will be discussed. This updated financial guidance does not include any contribution from the proposed Alliance Healthcare acquisition or any incremental growth from the expanded
- 01/06/2021
|
AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
- VALLEY FORGE, Pa. & DEERFIELD, Ill.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) and Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced strategic agreements under which AmerisourceBergen will acquire the majority of Walgreens Boots Alliance's Alliance Healthcare businesses for approximately $6.5 billion, comprised of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock. AmerisourceBergen's acquisition of Alliance Healthcare will provide even str
- 01/06/2021
|
AmerisourceBergen Primed For A Bounce
- AmerisourceBergen is a pharmaceutical distribution company that has seen solid earnings and revenue growth. The company does have a deal with the CDC to handle the distribution of COVID vaccines to independent pharmacies.
- 01/05/2021
|
CoreSite Announces Fourth Quarter 2020 Earnings Conference Call
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, today announced it will host its fourth quarter 2020 earnings conference call on Thursday, February 4, 2021, at 12:00 p.m. Eastern Time, and will issue its financial results prior to market open on Thursday, February 4, 2021. The call will be accessible by dialing 1-877-407-3982 (domestic) or
- 01/04/2021
|
AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2021 Earnings Release and Participation in Upcoming Investor Conferences
- VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2021 on Thursday, February 4, 2021, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on February 4, 2021. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Execu
- 12/30/2020
|
Here's Why You Should Retain AmerisourceBergen (ABC) Now
- AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
- 12/23/2020
|
CoreSite Realty Corporation Announces Fourth-Quarter 2020 Dividend on Common Stock
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, today announced a cash dividend of $1.23 per share on common stock and common stock equivalents for the fourth quarter of 2020, reflecting a 0.8% increase over the prior quarter dividend of $1.22. The dividend will be paid on January 15, 2021, to shareholders of record as of December 31, 2020.
- 12/09/2020
|
When a COVID-19 Vaccine Is Ready, This Company Is Prepared for Action
- One medical distribution company has been through this before.
- 12/08/2020
|
CoreSite's Any2Exchange® Enhances Capabilities For Multi-Market Peering
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR) (the “Company”), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, today announced its enhanced Any2Exchange®. This internet peering service is now available for multi-market peering enabling customers to peer with other customers/participants in their regional exchange. “We are pleased to be able to offer this expanded regional peering capabi
- 12/08/2020
|
7 Real Estate Stocks to Tour Before Year's End
- You don't have to be an agent or a landlord to make money in real estate. Get in on these real estate stocks before the end of the year.
- 12/07/2020
|
CoreSite's Chicago Campus Enhances Connectivity to AWS
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR) (the “Company”), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, today announced enhanced cloud networking capabilities at their Chicago data center campus. Customers can now rapidly provision AWS Hosted Connections up to 10Gbps on the CoreSite Open Cloud Exchange®. CoreSite's scalable Chicago data center campus enables enterprises and IT se
- 12/03/2020
|
CoreSite Expands in Los Angeles with Opening of LA3 Data Center
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR) (the “Company”), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, today announced the opening of phase one of its new ground-up, enterprise class data center development in Los Angeles. CoreSite has designed a 160,000+ square foot facility with a total of 18 megawatts of capacity, referred to as LA3, in the heart of downtown Los Angeles, and
- 12/01/2020
|
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 2020 Results - Earnings Call Transcript
- AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 2020 Results - Earnings Call Transcript
- 11/05/2020
|
AmerisourceBergen Shares Pop Amid Strong 2020 Growth; Earnings Due As It Gets Closer To Key Technical Measure
- AmerisourceBergen shows rising price performance, earning an upgrade to its IBD Relative Strength Rating. The post AmerisourceBergen Shares Pop Amid Strong 2020 Growth; Earnings Due As It Gets Closer To Key Technical Measure appeared first on Investor's Business Daily.
- 11/04/2020
|
Were These Hedge Funds Right About AmerisourceBergen Corporation (ABC)?
- Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that's why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an individual investor's stock selection process, as it may offer great insights of how the brightest minds of the finance industry feel about specific stocks. After all, these people have access to smartest analysts and expensive data/information sources that individual investors can't match. So should one consider investing in AmerisourceBergen Corporation (NYSE:ABC)? The smart money sentiment can provide an answer to this question.
- 11/02/2020
|
15 High-Yield/Low Volatility Blue Chips For The Ultimate Crash-Proof Retirement Portfolio
- The pandemic is out of control all over the world, with daily records in new cases and a mounting death toll. Europe is beginning to lock down again and IHME expects up to 20 US states to follow suit starting in late November.
- 11/02/2020
|
CoreSite Realty Corporation (COR) CEO Paul Szurek on Q3 2020 Results - Earnings Call Transcript
- CoreSite Realty Corporation (COR) CEO Paul Szurek on Q3 2020 Results - Earnings Call Transcript
- 10/29/2020
|
IBM Retirement Fund Acquires 1,329 Shares of AmerisourceBergen Co. (NYSE:ABC)
- IBM Retirement Fund boosted its holdings in AmerisourceBergen Co. (NYSE:ABC) by 39.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,735 shares of the company’s stock after acquiring an additional 1,329 shares during the period. IBM Retirement Fund’s holdings in AmerisourceBergen […]
- 10/21/2020
|
Campbell & CO Investment Adviser LLC Purchases Shares of 2,851 AmerisourceBergen Co. (NYSE:ABC)
- Campbell & CO Investment Adviser LLC purchased a new stake in shares of AmerisourceBergen Co. (NYSE:ABC) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 2,851 shares of the company’s stock, valued at approximately $276,000. Other institutional investors have also recently bought and sold shares […]
- 10/19/2020
|
Flagship Harbor Advisors LLC Acquires 165 Shares of AmerisourceBergen Co. (NYSE:ABC)
- Flagship Harbor Advisors LLC increased its holdings in shares of AmerisourceBergen Co. (NYSE:ABC) by 27.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 777 shares of the company’s stock after buying an additional 165 shares during the quarter. Flagship Harbor Advisors […]
- 10/19/2020
|
CoreSite Realty (NYSE:COR) Downgraded to Hold at Zacks Investment Research
- Zacks Investment Research downgraded shares of CoreSite Realty (NYSE:COR) from a buy rating to a hold rating in a research note published on Wednesday morning, Zacks.com reports. According to Zacks, “Coresite Realty Corporation provides data center products and interconnection services. The data centers include ample and redundant power and advanced cooling and security systems, and […]
- 10/15/2020
|
CX Institutional Raises Position in AmerisourceBergen Co. (NYSE:ABC)
- CX Institutional grew its position in shares of AmerisourceBergen Co. (NYSE:ABC) by 44.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 27,023 shares of the company’s stock after buying an additional 8,302 shares during the quarter. CX Institutional’s holdings in AmerisourceBergen […]
- 10/14/2020
|
MWI Animal Health Selects CVP Impack Automated Packaging Solution to Create Greater Warehouse Efficiencies
- MWI Animal Health Selects CVP Impack Automated Packaging Solution to Create Greater Warehouse Efficiencies
- 10/13/2020
|
Global Healthcare Cold Chain Logistics Market Report 2020 with COVID-19 Impact Analysis - Vaccine Segment Expected to Reach $7.1 Billion by 2027 - ResearchAndMarkets.com
|
AmerisourceBergen Corp. (NYSE:ABC) Shares Bought by Carroll Financial Associates Inc.
- Carroll Financial Associates Inc. boosted its stake in shares of AmerisourceBergen Corp. (NYSE:ABC) by 9.5% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 1,316 shares of the company’s stock after acquiring an additional 114 shares during the period. Carroll Financial Associates Inc.’s holdings in AmerisourceBergen were worth […]
- 10/09/2020
|
Owens & Minor: A Treacherous Path To 10% Returns (NYSE:OMI)
- This might be the most treacherous path to double-digit returns that I have yet to see. Since I wrote my original article, the healthcare distribution sector overall faced many challenges that have affected the stock values of the entire sector.
- 10/09/2020
|
ION & IPN Solutions Collaborate with Annexus Health to Offer AssistPoint to Specialty Physician Practices
- Today, ION Solutions and IPN Solutions, both part of AmerisourceBergen, announced a collaboration with Annexus Health to offer AssistPoint to specialt
- 10/05/2020
|
Gilead takes over remdesivir distribution in the U.S.
- Shares of Gilead Sciences Inc. undefined were down 0.3% in trading on Thursday after the drugmaker announced it is now in charge of distributing remdesivir,...
- 10/01/2020
|
CoreSite Issues Annual Corporate Sustainability Report
- CoreSite Realty Corporation (NYSE:COR) (the “Company” or “CoreSite”), a premier provider of secure, reliable, high-performance data center, cloud and
- 09/30/2020
|
AmerisourceBergen Will Soon Be Rewarded For Quietly Growing Profits (NYSE:ABC)
- The current stock market is still expensive by historical standards, but deals do occasionally appear.
- 09/28/2020
|
Global Datacenters Market Trajectory & Analytics, 2020-2027: Market is Projected to Reach a Revised Size of US$197.1 Billion - ResearchAndMarkets.com
|
CoreSite Realty Corp (NYSE:COR) Shares Purchased by AQR Capital Management LLC
- AQR Capital Management LLC boosted its position in CoreSite Realty Corp (NYSE:COR) by 81.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,705 shares of the real estate investment trust’s stock after buying an additional 7,064 shares during the quarter. AQR […]
- 09/27/2020
|
Stephens Inc. AR Increases Holdings in CoreSite Realty Corp (NYSE:COR)
- Stephens Inc. AR lifted its holdings in CoreSite Realty Corp (NYSE:COR) by 35.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,254 shares of the real estate investment trust’s stock after purchasing an additional 1,633 shares during the quarter. Stephens Inc. […]
- 09/21/2020
|
CoreSite Supports Public Sector IT Initiatives
- CoreSite Realty Corporation (NYSE:COR) (the “Company”), a premier provider of secure, reliable, high-performance data center, cloud and interconnectio
- 09/17/2020
|
Global $3.6 Bn Healthcare Supply Chain Management Market to 2026 by Model, Function, Delivery Mode, Component, Technology, End-user, Region & Vendor Landscape - ResearchAndMarkets.com
|
Vanguard Group Inc. Reduces Holdings in CoreSite Realty Corp (NYSE:COR)
- Vanguard Group Inc. decreased its position in shares of CoreSite Realty Corp (NYSE:COR) by 1.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 5,418,680 shares of the real estate investment trust’s stock after selling 61,739 shares during the quarter. Vanguard Group Inc. owned approximately 0.13% of […]
- 09/14/2020
|
Here's Why My REITs Beat Your REITs
- Over the last several years we've seen larger equity REITs consistently outperform, but the gap becomes even larger with the recession.
- 09/14/2020
|
Dividends And Reasonable Price Appreciation: Introducing The 'DARPA' Portfolio
- Focusing exclusively on dividend income can lead to substantial erosion of a portfolio over time if the dividends are high because the companies are stagnant.
- 09/13/2020
|
September 2020 Stocks - Financials, Real Estate, Industrials, IT And Pharma
- The time has come once again to look at what sort of companies you'll want to be buying, this time as we move into September of 2020.
- 09/09/2020
|
August 2020 Dividend Portfolio Update
- Markets were racing to all-time highs in August fueled by technology stocks and the mega caps. I am continuing my monthly investment plans and suspiciously follow the massive rally in technology stocks.
- 09/05/2020
|
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
- Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
- 09/04/2020
|
AmerisourceBergen: The Highest Quality Healthcare Company On Sale
- I decided to take a closer look at and write my first article on AmerisourceBergen, a healthcare company I've held for about 1.5 years.
- 09/04/2020
|
Dividend Champion And Contender Highlights: Week Of August 30
|
CoreSite Successfully Completes Annual Compliance Examinations
- CoreSite Realty Corporation (NYSE:COR) (the “Company”), a premier provider of secure, reliable, high-performance data center, cloud and interconnectio
- 08/27/2020
|
Patricia Higgins Joins CoreSite Realty Corporation’s Board of Directors
- CoreSite Realty Corporation (NYSE:COR) (the “Company” or “CoreSite”), a premier provider of secure, reliable, high-performance data center, cloud and
- 08/26/2020
|
Amalgamated Bank Cuts Stock Position in CoreSite Realty Corp (NYSE:COR)
- Amalgamated Bank lessened its stake in shares of CoreSite Realty Corp (NYSE:COR) by 22.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,598 shares of the real estate investment trust’s stock after selling 2,163 shares during the quarter. Amalgamated Bank’s holdings […]
- 08/25/2020
|
Amalgamated Bank Trims Stake in AmerisourceBergen Corp. (NYSE:ABC)
- Amalgamated Bank trimmed its stake in AmerisourceBergen Corp. (NYSE:ABC) by 63.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,097 shares of the company’s stock after selling 16,111 shares during the period. Amalgamated Bank’s holdings in AmerisourceBergen were worth $917,000 at the […]
- 08/25/2020
|
Rafferty Asset Management LLC Acquires New Position in CoreSite Realty Corp (NYSE:COR)
- Rafferty Asset Management LLC bought a new stake in CoreSite Realty Corp (NYSE:COR) in the second quarter, Holdings Channel.com reports. The institutional investor bought 9,493 shares of the real estate investment trust’s stock, valued at approximately $1,149,000. A number of other hedge funds and other institutional investors have also bought and sold shares of COR. […]
- 08/25/2020
|
PRESS DIGEST - Wall Street Journal - Aug. 19
|
Drug-Distributor Stocks Rise as Opioid Settlement Looks Closer After Report on More Talks
- A group of state attorneys general are demanding more from Johnson & Johnson and the nation’s top drug distributors to settle the sprawling opioid litigation than the companies agreed to pay last year, according to a Tuesday report in The Wall Street Journal.
- 08/18/2020
|
Healthcare Dashboard For August
- A dashboard with metrics of value, quality and momentum by industries. Value and quality scores relative to historical averages.
- 08/18/2020
|
U.S. states seek $26.4 bln from drug firms in opioid litigation - WSJ
|
WSJ News Exclusive | States Seek $26.4 Billion From Drug Companies in Opioid Litigation
- States are asking for around $26.4 billion from major pharmaceutical industry players to help pay for damage wrought by the opioid crisis, the latest demand in yearslong litigation seeking to hold companies accountable for widespread drug addiction.
- 08/18/2020
|
McKesson (MCK) Gains on Potential Vaccine Role
- Here's why McKesson (MCK) shares shot higher Friday. Trade the stock, along with two other drug distributors, with these tactical ideas.
- 08/17/2020
|
Tracking Seth Klarman's Baupost Group Holdings - Q2 2020 Update
- Seth Klarman’s 13F portfolio value increased from $6.77B to $8.01B this quarter. Baupost Group increased Atara Biotherapeutics while dropping Cheniere Energy.
- 08/15/2020
|
AmerisourceBergen: Is This the Right Combination for Investors?
- Good financial strength and high profitability, but is the price suitable? Continue reading...
- 08/13/2020
|
Bandwidth IG Adds Dark Fiber to CoreSite Santa Clara Data Center Campus
- Bandwidth Infrastructure Group (Bandwidth IG), a metro dark fiber network provider in Northern California and Greater Atlanta serving mission critical data centers, hyperscalers and enterprises with high capacity, dark fiber announces that it is providing services to CoreSite's Santa Clara Data Center Campus. The CoreSite campus is located in one of the largest tech areas in the world, at the epicenter of Silicon Valley's largest data center hub and delivers direct access to the top public cloud onramps.
- 08/13/2020
|
CoreSite Partners with Education & Research Institutions
- CoreSite Realty Corporation (NYSE:COR) (the "Company"), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, helps education and other research institutions and platforms overcome ever-evolving digital challenges.
- 08/12/2020
|
Dividend Champion And Contender Highlights: Week Of August 9
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.
- 08/08/2020
|
4 Construction and Health Care Companies With High Financial Strength
- Companies trading below Peter Lynch value in sectors with good July job growth Continue reading...
- 08/07/2020
|
A Director at Coresite Realty (NYSE: COR) is Selling Shares - Markets
- Yesterday, a Director at Coresite Realty (COR – Research Report), Michael R. Koehler, sold shares of COR for $1.12M. Following
- 08/07/2020
|
Walgreens Boots Alliance, Inc. -- Moody's changes Walgreens outlook to negative; affirms ratings
- Moody's also affirmed Walgreens Boots Alliance's P-2 commercial paper rating. "The disruption caused by the coronavirus pandemic has taken a further toll on Walgreen's already weaker than expected operating performance", Moody's Vice President Mickey Chadha stated.
- 08/07/2020
|
Are Investors Undervaluing AmerisourceBergen Corporation (NYSE:ABC) By 37%?
- How far off is AmerisourceBergen Corporation (NYSE:ABC) from its intrinsic value? Using the most recent financial...
- 08/07/2020
|
AmerisourceBergen earnings and revenue beat estimates
- Steve Collis, AmerisourceBergen CEO, joins Yahoo Finance’s The First Trade with Alexis Christoforous and Brian Sozzi to discuss the company’s third-quarter earnings report, future outlook for the pharmaceutical industry overall including a COVID-19 vaccine and much more.
- 08/06/2020
|
Analysts Offer Insights on Services Companies: Charter Communications (NASDAQ: CHTR), AmerisourceBergen (NYSE: ABC) and Thomson Reuters (NYSE: TRI) - Markets
- Analysts fell to the sidelines weighing in on Charter Communications (CHTR – Research Report), AmerisourceBergen (ABC – Research Report) and
- 08/06/2020
|
August 2020 Stocks - Financials, Real Estate, Industrials, IT And Pharma
- The time has come for us to look at just what sort of companies may be appealing to invest in during August.
- 08/06/2020
|
ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio “Tony” Pera to Board of Directors
- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq:ANIP) today announced the appointments of Jeanne Thoma, President and Chief Executive Offic
- 08/06/2020
|
AmerisourceBergen Corp (ABC) Q3 2020 Earnings Call Transcript
- Good morning, and thank you all for joining us to the conference call to discuss AmerisourceBergen's Fiscal 2020 Third Quarter Results. On today's call, we will be discussing non-GAAP financial measures.
- 08/05/2020
|
CoreSite to Present at Upcoming Investor Conferences
- CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, today announced it will present at two upcoming virtual investor conferences, including:
- 08/05/2020
|
Coronavirus update: Global death toll tops 700,000 with 18.5 million confirmed cases and U.S. accounts for more than a quarter
- The number of confirmed deaths across the globe from the coronavirus illness COVID-19 climbed above 700,000 on Wednesday, according to data aggregated by...
- 08/05/2020
|
AmerisourceBergen (ABC) Q3 Earnings & Revenues Top Estimates
- AmerisourceBergen's (ABC) fiscal third-quarter earnings benefit from segmental growth.
- 08/05/2020
|
AmerisourceBergen's Debt Overview
- Over the past three months, shares of AmerisourceBergen Inc. (NYSE: ABC) moved higher by 19.15%. Before we understand the importance of debt, let's look at how much debt AmerisourceBergen has.AmerisourceBergen's Debt Based on AmerisourceBergen's balance sheet as of May 7, 2020, long-term debt is at $3.62 billion and current debt is at $522.81 million, amounting to $4.15 billion in total debt. Adjusted for $3.69 billion in cash-equivalents, the company's net debt is at $453.26 million.To understand the degree of financial leverage a company has, investors look at the debt ratio. Considering AmerisourceBergen's $42.04 billion in total assets, the debt-ratio is at 0.1. Generally speaking, a debt-ratio more than 1 means that a large portion of debt is funded by assets. As the debt-ratio increases, so the does the risk of defaulting on loans, if interest rates were to increase. Different industries have different thresholds of tolerance for debt-ratios. A debt ratio of 40% might be higher for one industry, whereas average for another.Why Debt Is Important Debt is an important factor in the capital structure of a company, and can help it attain growth. Debt usually has a relatively lower financing cost than equity, which makes it an attractive option for executives.However, interest-payment obligations can have an adverse impact on the cash-flow of the company. Equity owners can keep excess profit, generated from the debt capital, when companies use the debt capital for its business operations.See more from Benzinga * AmerisourceBergen: Q3 Earnings Insights * Stocks That Hit 52-Week Highs On Friday * Stocks That Hit 52-Week Highs On Friday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 08/05/2020
|
AmerisourceBergen (ABC) Q3 Earnings and Revenues Surpass Estimates
- AmerisourceBergen (ABC) delivered earnings and revenue surprises of 17.09% and 1.35%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/05/2020
|
AmerisourceBergen: Q3 Earnings Insights
- Shares of AmerisourceBergen (NYSE:ABC) rose 3.1% in pre-market trading after the company reported Q3 results.Quarterly Results Earnings per share rose 5.11% over the past year to $1.85, which beat the estimate of $1.56.Revenue of $45,367,000,000 higher by 0.28% from the same period last year, which beat the estimate of $44,660,000,000.Guidance The upcoming fiscal year's EPS expected to be between $7.80 and $7.95.Conference Call Details Date: Aug 05, 2020Time: 08:30 AMView more earnings on ABCET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestor.amerisourcebergen.com%2Fpresentations-and-events%2Fdefault.aspx&eventid=2400611&sessionid=1&key=6AE283BC297DACA8011BDE901B09AF02®Tag=&sourcepage=registerRecent Stock Performance Company's 52-week high was at $105.21Company's 52-week low was at $72.06Price action over last quarter: Up 18.86%Company Overview AmerisourceBergen is a leading global third-party logistics provider engaged in wholesale pharmaceutical sourcing and distribution of specialty, brand-name, and generic pharmaceuticals and related services to acute-care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, physician practices, dialysis clinics, and other healthcare customers. By acquiring smaller companies, management has attained the ability to compound sterile preparations, distribute veterinary pharmaceuticals and vaccines, transport biopharmaceuticals, and provide inventory and reimbursement consulting services to providers.See more from Benzinga * Stocks That Hit 52-Week Highs On Friday * Stocks That Hit 52-Week Highs On Friday * Benzinga's Top Upgrades, Downgrades For June 15, 2020(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 08/05/2020
|
AmerisourceBergen's stock surges toward 5-year high after profit and revenue beats, raised outlook
- Shares of AmerisourceBergen Corp. undefined surged 4.8% toward a 5-year high in premarket trading Wednesday, as the pharmaceutical products supplier reported...
- 08/05/2020
|
AmerisourceBergen's stock surges toward 5-year high after profit and revenue beats, raised outlook
- Shares of AmerisourceBergen Corp. surged 4.8% toward a 5-year high in premarket trading Wednesday, as the pharmaceutical products supplier reported fiscal third-quarter earnings that beat expectations and raised its full-year outlook. Net income for the quarter to June 30 fell to $289.4 million, or $1.41 a share, from $302.0 million, or $1.43 a share, in the year-ago period. Excluding non-recurring items, adjusted earnings per share came to $1.85, above the FactSet consensus of $1.58. Revenue rose 0.3% to $45.37 billion, beating the FactSet consensus of $44.64 billion, as pharmaceutical distribution services revenue rose 0.1% to $43.6 billion and other revenue grew 4.4% to $1.8 billion, boosted by growth in its ABCS and World Courier businesses. For fiscal 2020, the company raised its adjusted EPS guidance range to $7.80 to $7.95 from $7.35 to $7.65. Revenue is now expected to grow in the mid-single digit percentage range, compared with previous guidance of low- to mid-single digit growth. The FactSet revenue consensus of $187.5 billion implies 4.4% growth. The stock has soared 23.2% year to date through Tuesday, while the S&P 500 has gained 2.3%.
- 08/05/2020
|
AmerisourceBergen Reports Fiscal 2020 Third Quarter Results
- AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2020 third quarter ended June 30, 2020, revenue increased 0.3 percent year-over-year to $45.4 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $1.41 for the June quarter of fiscal 2020, compared to $1.43 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described below, increased 5.1 percent to $1.85 in the fiscal third quarter.
- 08/05/2020
|
Sumitomo Mitsui Trust Holdings Inc. Purchases 12,745 Shares of CoreSite Realty Corp (NYSE:COR)
- Sumitomo Mitsui Trust Holdings Inc. grew its position in CoreSite Realty Corp (NYSE:COR) by 16.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 89,758 shares of the real estate investment trust’s stock after acquiring an additional 12,745 shares during the […]
- 08/05/2020
|
A Peek Into The Markets: US Stock Futures Climb Ahead Of Earnings, Economic Data
- Pre-open movers
U.S. stock futures traded higher in early pre-market trade, after recording gains in the previous session. Investors are awaiting earnings results from CVS Health...
- 08/05/2020
|
Medical Products Stock Earnings on Aug 5: RMD, ABC & More
- Many Medical Product stocks might have succeeded in mitigating coronavirus-led downsides banking on huge market adoption of their COVID-19-related healthcare-support products in the second quarter.
- 08/04/2020
|
FY2021 EPS Estimates for CoreSite Realty Corp (NYSE:COR) Reduced by William Blair
- CoreSite Realty Corp (NYSE:COR) – Equities researchers at William Blair lowered their FY2021 EPS estimates for CoreSite Realty in a research note issued to investors on Thursday, July 30th. William Blair analyst J. Breen now forecasts that the real estate investment trust will earn $5.58 per share for the year, down from their prior estimate […]
- 08/04/2020
|
CoreSite Realty Corporation Announces Pricing of Sale of Common Stock
- CoreSite Realty Corporation (NYSE:COR) ("CoreSite"), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions across the U.S., today announced the pricing of the previously announced sale of 230,172 shares of its common stock by investment funds affiliated with The Carlyle Group at a price to the public of $128.75. Morgan Stanley is acting as sole underwriter in connection with the offering.
- 08/03/2020
|
AmerisourceBergen (ABC) to Post Q3 Earnings: What's in Store?
- AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
- 08/03/2020
|
CoreSite Realty Corporation Announces Sale of Common Stock by The Carlyle Group
- CoreSite Realty Corporation (NYSE:COR) ("CoreSite"), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions across the U.S., today announced the sale of 230,172 shares of its common stock by investment funds affiliated with The Carlyle Group to Morgan Stanley, as the sole underwriter in connection with the offering.
- 08/03/2020
|
AmerisourceBergen (ABC) Scheduled to Post Earnings on Wednesday
- AmerisourceBergen (NYSE:ABC) is scheduled to be announcing its earnings results before the market opens on Wednesday, August 5th. Analysts expect the company to announce earnings of $1.50 per share for the quarter. AmerisourceBergen has set its FY20 guidance at $7.35-7.65 EPS.Persons that wish to listen to the company’s earnings conference call can do so using […]
- 08/03/2020
|
CoreSite Realty Corporation Announces Sale of Common Stock by The Carlyle Group
- CoreSite Realty Corporation (NYSE:COR) (“CoreSite”), a premier provider of secure, reliable, high-performance data center, cloud and interconnection s
- 08/03/2020
|
Disney, T-Mobile, CVS, Activision Blizzard, and Other Stocks for Investors to Watch This Week
- Second-quarter earnings season continues with results from Disney, T-Mobile, Fox, ViacomCBS, and Clorox. Video-game makers Take-Two and Activision Blizzard also report. Plus, July jobs data.
- 08/02/2020
|
CoreSite Realty (NYSE:COR) Earns Outperform Rating from William Blair
- William Blair restated their outperform rating on shares of CoreSite Realty (NYSE:COR) in a report released on Thursday morning, Zacks.com reports. COR has been the topic of a number of other reports. Robert W. Baird cut shares of CoreSite Realty from an outperform rating to a neutral rating and set a $122.00 target price on […]
- 08/02/2020
|
3,568 Shares in CoreSite Realty Corp (NYSE:COR) Bought by First Quadrant L P CA
- First Quadrant L P CA purchased a new stake in CoreSite Realty Corp (NYSE:COR) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,568 shares of the real estate investment trust’s stock, valued at approximately $432,000. A number of other hedge funds […]
- 08/01/2020
|
Allegiant Flies Above the Pack With Its Budget-Meets-Leisure Formula
- In a year in which airlines have gotten hammered by the pandemic, a carrier with ultralow costs and flexible scheduling takes the lead. Not that the flight may not get a little rough.
- 08/01/2020
|
The jobs report and congressional politics may matter more for markets than earnings in the week ahead
- The market could lose some exuberance as the calendar turns to August, and investors await Friday's July employment report.
- 07/31/2020
|
AmerisourceBergen Corporation : quaterly earnings release | MarketScreener
|
AmerisourceBergen Corporation : publication des résultats trimestriels | Zone bourse
|
CoreSite Realty Corp (COR) Q2 2020 Earnings Call Transcript
- COR earnings call for the period ending June 30, 2020.
- 07/31/2020
|
CoreSite Realty Corporation (COR) CEO Paul Szurek on Q2 2020 Results - Earnings Call Transcript
- CoreSite Realty Corporation (NYSE:COR) Q2 2020 Results Conference Call July 30, 2020 12:00 PM ET Company Participants Kate Ruppe - Investor Relations Paul Szurek - President and Chief Executive Officer Steve Smith - Chief Revenue Officer Jeff Finnin - Chief Financial Officer Conference Call Participants Jordan Sadler - KeyBanc Capital Markets Jonathan Atkin - RBC Colby Synesael - Cowen and Company Nate Crossett - Berenberg Erik Rasmussen - Stifel Frank Louthan - Raymond James Nick Del Deo - MoffettNathanson Richard Choe - JPMorgan Eric Luebchow - Wells Fargo Michael Rollins - Citi David Guarino - Green Street Advisors Presentation Operator Greetings, and welcome to CoreSite Realty's Second Quarter 2020 Earnings Call.
- 07/31/2020
|
10 Biggest Health Care Companies
- With CVS Health in the 1 spot, these are the 10 biggest health care companies by trailing 12-month revenue.
- 07/30/2020
|
Top Stocks for August 2020
- The S&P 500 Index is a market-capitalization-weighted index of the 500 largest publicly traded companies in the U.S. It is widely regarded as the best gauge of large-cap U.S. equities. The S&P 500's total return is 9.5% over the past 12 months. This market performance number and the statistics in the tables below are as of July 29. Here are the top 3 stocks with the best value, the fastest earnings growth, and the most momentum.
- 07/30/2020
|
CoreSite Realty (COR) Tops Q2 FFO and Revenue Estimates
- CoreSite (COR) delivered FFO and revenue surprises of 5.47% and 0.26%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 07/30/2020
|
CoreSite Reports Second Quarter 2020 Financial Results
- CoreSite Realty Corporation (NYSE:COR) ("the Company"), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions across the U.S., today announced financial results for the second quarter ended June 30, 2020.
- 07/30/2020
|
Analysts Estimate AmerisourceBergen (ABC) to Report a Decline in Earnings: What to Look Out for
- AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/29/2020
|
U.S. judge rejects imposing attorney fee levy on opioid lawsuit settlements
- A federal judge overseeing thousands of opioid lawsuits declined on Monday to grant a demand by plaintiffs attorneys for fees that could be worth billions of dollars, a request drug company defendants had said would jeopardize settlement talks. In February, a committee of plaintiffs attorneys requested that U.S. District Judge Dan Polster in Cleveland order a 7% fee assessment against any settlement. The request could amount to $3.3 billion, based on a $48 billion settlement proposal that five companies including Johnson & Johnson have been negotiating with various state attorneys general.
- 07/27/2020
|
6 Health Care Stocks Trading With Low Price-Sales Ratios
- Walgreens Boots Alliance on the list Continue reading...
- 07/27/2020
|
Housing Is Red Hot
- U.S. equity markets snapped a three-week winning streak as escalating tensions with China, mediocre corporate earnings reports, and continued pandemic-related uncertainty counterbalanced another slate of stellar housing market data.
- 07/25/2020
|
Coronavirus: Why your local hospital may also need stimulus checks
- One well-known hospital CEO says the government may need to send stimulus to hospitals to help them get through the COVID-19 pandemic.
- 07/23/2020
|
Healthcare Dashboard For July
- A dashboard with metrics of value, quality and momentum by industries. Value and quality scores relative to historical averages.
- 07/21/2020
|
Hanson & Doremus Investment Management Purchases 112 Shares of AmerisourceBergen Corp. (NYSE:ABC)
- Hanson & Doremus Investment Management grew its position in AmerisourceBergen Corp. (NYSE:ABC) by 45.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 360 shares of the company’s stock after purchasing an additional 112 shares during the quarter. Hanson & Doremus Investment Management’s holdings […]
- 07/19/2020
|
AmerisourceBergen (NYSE:ABC) Sets New 52-Week High at $104.70
- AmerisourceBergen Corp. (NYSE:ABC) hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $104.70 and last traded at $104.50, with a volume of 43360 shares changing hands. The stock had previously closed at $102.74. A number of research analysts have recently issued reports on ABC shares. Zacks Investment […]
- 07/19/2020
|
2,250 Shares in AmerisourceBergen Corp. (NYSE:ABC) Acquired by BKD Wealth Advisors LLC
- BKD Wealth Advisors LLC purchased a new position in shares of AmerisourceBergen Corp. (NYSE:ABC) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 2,250 shares of the company’s stock, valued at approximately $227,000. Several other large investors have also recently made changes […]
- 07/18/2020
|
Did Hedge Funds Make The Right Call On CoreSite Realty Corp (COR) ?
- Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
- 07/17/2020
|
Louisiana State Employees Retirement System Buys 1,000 Shares of CoreSite Realty Corp (NYSE:COR)
- Louisiana State Employees Retirement System increased its stake in shares of CoreSite Realty Corp (NYSE:COR) by 11.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,100 shares of the real estate investment trust’s stock after purchasing an additional 1,000 shares during the period. Louisiana […]
- 07/16/2020
|
July 2020 Dividend Picks - Real Estate, Industrials, Communications And Pharma
- The time has come for us to look at just what sort of companies may be appealing to invest in during this month.
- 07/16/2020
|
CoreSite Realty: A Differentiated REIT By Design
- CoreSite Realty Corp. operates a portfolio of network-dense data centers in eight key markets across the United States.
- 07/16/2020
|
Can CoreSite Realty Corporation (NYSE:COR) Maintain Its Strong Returns?
- One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- 07/15/2020
|
Is AmerisourceBergen (ABC) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 07/15/2020
|
ABC vs. WST: Which Stock Is the Better Value Option?
- ABC vs. WST: Which Stock Is the Better Value Option?
- 07/15/2020
|
AmerisourceBergen: A Value Play With A Resilient Business Model
- AmerisourceBergen is one of the leading drug distributors with a strong balance sheet and a broad customer base.
- 07/15/2020
|
Switch, Inc.: Ready For Takeoff
- The burgeoning data economy is the biggest growth driver for Switch. The company’s diversified customer base and significant revenue visibility makes it a safe bet.
- 07/14/2020
|
CoreSite is the Platform of Choice for Media & Entertainment
- CoreSite Realty Corporation (NYSE:COR) (the "Company"), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, supports the ever expanding needs of the media and entertainment industry as they look to differentiate their digital services and workflows.
- 07/14/2020
|
June Portfolio Dividend Update
- June was a disappointing month in terms of dividend income, as it fell notably short Y/Y due to dividend cuts, suspensions and delays.
- 07/14/2020
|
CoreSite is the Platform of Choice for Media & Entertainment
- CoreSite Realty Corporation (NYSE:COR) (the “Company”), a premier provider of secure, reliable, high-performance data center, cloud and interconnectio
- 07/14/2020
|
Patriot Financial Group Insurance Agency LLC Acquires 349 Shares of AmerisourceBergen Corp. (NYSE:ABC)
- Patriot Financial Group Insurance Agency LLC lifted its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 65.0% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 886 shares of the company’s stock after acquiring an additional 349 shares during the quarter. Patriot Financial Group Insurance Agency LLC’s […]
- 07/13/2020
|
9,060 Shares in CoreSite Realty Corp (NYSE:COR) Purchased by Manning & Napier Group LLC
- Manning & Napier Group LLC bought a new position in shares of CoreSite Realty Corp (NYSE:COR) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 9,060 shares of the real estate investment trust’s stock, valued at approximately $1,096,000. Several other hedge funds also recently made […]
- 07/13/2020
|
Walgreens - Too Soft, Cheap But No Triggers
- Walgreens has seen soft third quarter earnings, even as sales are flattish. The shortfall and dramatic performance in the UK illustrates just how much further COVID-19 stress could hurt the company.
- 07/13/2020
|
State of Alaska Department of Revenue Raises Holdings in AmerisourceBergen Corp. (NYSE:ABC)
- State of Alaska Department of Revenue increased its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 1.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 29,114 shares of the company’s stock after purchasing an additional 518 shares during the quarter. State of Alaska Department of Revenue’s […]
- 07/12/2020
|
Envestnet Asset Management Inc. Has $31.41 Million Stock Holdings in AmerisourceBergen Corp. (NYSE:ABC)
- Envestnet Asset Management Inc. increased its holdings in AmerisourceBergen Corp. (NYSE:ABC) by 5.7% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 311,653 shares of the company’s stock after purchasing an additional 16,899 shares during the period. Envestnet Asset Management Inc. owned approximately 0.15% […]
- 07/12/2020
|
Dividend Champion And Contender Highlights: Week Of July 12
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.
- 07/11/2020
|
Were Hedge Funds Right About AmerisourceBergen Corporation (ABC)?
- How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]
- 07/08/2020
|
Do AmerisourceBergen's (NYSE:ABC) Earnings Warrant Your Attention?
- For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
- 07/08/2020
|
Here Are a Few Sectors and Three Dozen Stocks That Strategists Think Will Rise on a Blue Wave
- Strategists in recent days have been gaming out market implications of a Democratic sweep in November’s elections, with sectors that stand to benefit including infrastructure and green technology.
- 07/07/2020
|
Municipal Employees Retirement System of Michigan Boosts Position in AmerisourceBergen Corp. (NYSE:ABC)
- Municipal Employees Retirement System of Michigan increased its holdings in shares of AmerisourceBergen Corp. (NYSE:ABC) by 424.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,330 shares of the company’s stock after purchasing an additional 9,170 shares during the […]
- 07/07/2020
|
MWI Animal Health Announces New Offerings to Alleviate Financial Burdens of Pet Care
- MWI Animal Health, a part of AmerisourceBergen and a leading distributor of animal health products, today announced two new offerings designed to incr
- 07/06/2020
|
2,172 Shares in CoreSite Realty Corp (NYSE:COR) Acquired by Engineers Gate Manager LP
- Engineers Gate Manager LP bought a new position in CoreSite Realty Corp (NYSE:COR) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,172 shares of the real estate investment trust’s stock, valued at approximately $252,000. Other institutional investors and hedge funds also […]
- 07/03/2020
|
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2020 Earnings Release
- AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter Fiscal 2020 on Wednesday, August 5, 2020, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 5, 2020.
- 07/02/2020
|
US gobbles up nearly all of Gilead Covid-19 drug remdesivir for next 3 months, leaving other nations without
- HHS said it had acquired all the supplies of the drug for July and 90% of supplies for August and September. Many developing countries have access to generic versions, but WTO rules could complicate the ability of wealthy nations to import them.
- 07/02/2020
|
Dividend Champions For July 2020
- Monthly update of the Dividend Champions List. 20 companies declared higher dividends in the past month, with an average increase of 4.30% over their previous p
- 07/02/2020
|
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2020 Earnings Release
- AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter Fiscal 2020 on Wednesday, August
- 07/02/2020
|
US secures almost entire world stock of Covid-19 drug remdesivir
- The Donald Trump administration has secured nearly the entire world stock of antiviral drug remdesivir from US-based Gilead Sciences for the next three months, leaving hardly any stock of the key Covid-19 drug for the rest of the world.
- 07/01/2020
|
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
|
US government buys most of world's supply of COVID-19 drug remdesivir -
- The US government has acquired most of the global supply of Gilead’s COVID-19 drug remdesivir until September as health secretary Alex Azar said that Donald Trump had struck an "amazing deal" with the pharma.
- 07/01/2020
|
CoreSite Realty Corp (NYSE:COR) Shares Purchased by HighTower Advisors LLC
- HighTower Advisors LLC raised its holdings in shares of CoreSite Realty Corp (NYSE:COR) by 4.7% in the first quarter, Holdings Channel.com reports. The institutional investor owned 12,269 shares of the real estate investment trust’s stock after purchasing an additional 555 shares during the quarter. HighTower Advisors LLC’s holdings in CoreSite Realty were worth $1,424,000 at […]
- 07/01/2020
|
The AmerisourceBergen Foundation Hosts Nonprofit Conference to Share Best Practices to Support and Serve Communities Around the Globe
- Last week, the AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization dedicated to supporting health-related cause
- 07/01/2020
|
3 Health Care Companies That Beat the Market in the 1st Half of the Year
- GuruFocus screener identifies top performers amid coronavirus pandemic Continue reading...
- 06/30/2020
|
Top Stocks for July 2020
- The S&P; 500 Index is a market-capitalization-weighted index of the 500 largest publicly traded companies in the U.S. It is widely regarded as the best gauge of large-cap U.S. equities. Some of the largest companies in the index include Microsoft Corp.
- 06/30/2020
|
AmerisourceBergen Corp. (NYSE:ABC) EVP Sells $311,256.06 in Stock
- AmerisourceBergen Corp. (NYSE:ABC) EVP Gina Clark sold 3,098 shares of the company’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $100.47, for a total transaction of $311,256.06. Following the completion of the sale, the executive vice president now directly owns 16,667 shares in the company, valued […]
- 06/30/2020
|
CoreSite Announces Second Quarter 2020 Earnings Conference Call | | IT Business Net
- DENVER--(BUSINESS WIRE)--CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan ar
- 06/30/2020
|
Remdesivir, the first coronavirus drug, gets a price tag
- NEW YORK (NYTIMES) - Remdesivir, the first drug shown to be effective against the coronavirus, will be distributed under an unusual agreement with the federal government that establishes non-negotiable prices and prioritises American patients, health officials announced on Monday (June 29).. Read more at straitstimes.com.
- 06/29/2020
|
CoreSite Realty : Announces Second Quarter 2020 Earnings Conference Call | MarketScreener
|
CoreSite Announces Second Quarter 2020 Earnings Conference Call
- CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, today announced it will host its second quarter 2020 earnings conference call on Thursday, July 30, 2020, at 12:00 p.m. Eastern Time, and will issue its financial results prior to market open on Thursday, July 30, 2020.
- 06/29/2020
|
HHS: 500,000 courses of Gilead Sciences' remdesivir to be available for sale
- Health officials said Monday that it will receive 500,000 treatment courses of Gilead Sciences Inc.'s undefined remdesivir through September that can then be...
- 06/29/2020
|
Coronavirus Treatment: US Government Secures 500,000 Doses Of Gilead's Remdesivir For Next 3 Months
- The deal represents virtually all of Gilead's production through September.
- 06/29/2020
|
CoreSite Announces Second Quarter 2020 Earnings Conference Call
- CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in m
- 06/29/2020
|
Regeneron Used a Charity to Pay Kickbacks, Justice Department Alleges
- Regeneron hiked the price of its drug Eylea and spurred its sales by using a charitable foundation to cover Medicare patients’ out-of-pocket costs for the pricey drug, according to a civil suit.
- 06/26/2020
|
Walgreens Can Do Without British Chemist Boots - BNN Bloomberg
- Walgreens’s Italian billionaire CEO has a chance to do some deals that would make it easier to take the drugstore company private.
- 06/26/2020
|
Walgreens Can Do Without British Chemist Boots
- (Bloomberg Opinion) -- The colossal buyout of Walgreens Boots Alliance Inc. mooted last year may now look like a fantasy. But the pandemic will create opportunities for Chief Executive Officer Stefano Pessina to do preparatory dealmaking that would make it easier to take the drugstore group private. One option for the Italian billionaire could be to remove the company’s middle name by selling the historic Boots business in the U.K.Attention has recently focused on whether the owner of Walgreens and Duane Reade pharmacies could offload its pharmaceuticals wholesale arm. Drug distribution company AmerisourceBergen Corp. approached it about buying the unit for $6 billion, Reuters reported in May. Coincidentally, Walgreens has a 28% stake in AmerisourceBergen that could be worth a similar amount.But Pessina is unlikely to want to part with the division, which mainly operates under the Alliance Healthcare brand. It’s where he began building his empire more than four decades ago. Whereas Boots, the British high-street retailer that began life selling herbal remedies in Nottingham in 1849, didn’t become part of his company until 2006. That makes the chain, with about 2,500 stores in the U.K., a plausible alternative.True, Boots’s sales and profits have declined over the past three years as it grappled with online competition. But it was one of the few retailers allowed to continue operating in Britain during the pandemic. With the Covid-19 crisis expected to spark a surge in spending on health, a buyer might see some turnaround potential in the asset now.That may help Pessina get a decent valuation for the division, which generates two-thirds of its sales from non-prescription health-care and beauty products. According to the most recent accounts available, Boots U.K. had 6.7 billion pounds ($8.3 billion) of revenue in the year to August 2019. Ebitda fell from 572 million pounds in 2018 to 391 million pounds in 2019, hurt by a 70 million-pound increase in costs from a plan to close 200 stores.Given Boots is a largely defensive brick-and-mortar retailer, a useful valuation benchmark would be the U.K. supermarkets, which are valued at between five and eight times their estimated yearly Ebitda. The extent of Boots’s exposure to higher-margin beauty and personal-care items argues for a top-end valuation. That would imply an enterprise value of about 4.2 billion pounds ($5.2 billion), assuming the business can generate annual Ebitda of about 500 million pounds, with another 30 million pounds from its optician services.Boots also operates stores in Ireland, Norway, the Netherlands and Thailand, and it owns 49% of a hearing-care joint venture with Sonova Holding AG. So depending what is included, the exit price may be higher. The question is who might want to buy Boots. A.S. Watson Holdings Ltd., owner of the British Superdrug chain, would be the obvious acquirer, but a combination of the two would likely be prohibited on competition grounds. The same goes for the U.K. supermarkets, even though Tesco Plc has the scale and its incoming CEO Ken Murphy has been a Walgreens lifer.Maybe private equity would be interested in a second go. In 2007, a year after merging his Alliance Unichem chain with Boots, Pessina took the group private with KKR in a $14 billion deal, then Europe’s biggest-ever buyout. This time, an acquirer would need to believe in the opportunity to tap into demand from consumers prioritizing their health and be willing to invest in modernizing Boots’s stores and reinforcing its online offering.Of course, a sale of Boots would be small compared to a transaction encompassing Walgreens as a whole. But it may be the best deal available to Pessina right now, one that could set the stage for even bigger things another day.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Andrea Felsted is a Bloomberg Opinion columnist covering the consumer and retail industries. She previously worked at the Financial Times.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
- 06/26/2020
|
COVID-19: Significant Shift in Strategy of Rural Clinical and Healthcare Logistics Market - Vendor Analysis and Growth Outlook for 2020-2024: Exclusive Report from Technavio
- The Global Rural Clinical and Healthcare Logistics Market will grow by USD 1.73 bn during 2020-2024
- 06/25/2020
|
Analysts' Opinions Are Mixed on These Services Stocks: Cardinal Health (NYSE: CAH) and Kansas City Southern (NYSE: KSU) - Markets
- Analysts have been eager to weigh in on the Services sector with new ratings on Cardinal Health (CAH – Research
- 06/24/2020
|
Two Sigma Advisers LP Has $7.65 Million Stake in CoreSite Realty Corp (NYSE:COR)
- Two Sigma Advisers LP decreased its position in CoreSite Realty Corp (NYSE:COR) by 5.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 66,000 shares of the real estate investment trust’s stock after selling 3,800 shares during the quarter. Two Sigma Advisers LP owned […]
- 06/23/2020
|
Near-Term Outlook Bleak for Medical Dental Supplies Industry
- Near-Term Outlook Bleak for Medical Dental Supplies Industry
- 06/22/2020
|
CoreSite Realty Corp (NYSE:COR) Holdings Raised by Geode Capital Management LLC
- Geode Capital Management LLC grew its position in CoreSite Realty Corp (NYSE:COR) by 2.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 428,851 shares of the real estate investment trust’s stock after acquiring an additional 11,103 shares during the quarter. Geode Capital Management […]
- 06/21/2020
|
Dividend Champion And Contender Highlights: Week Of June 21
|
CoreSite Realty Corp (NYSE:COR) Shares Sold by Wellington Management Group LLP
- Wellington Management Group LLP cut its stake in shares of CoreSite Realty Corp (NYSE:COR) by 0.6% during the 1st quarter, HoldingsChannel.com reports. The fund owned 224,432 shares of the real estate investment trust’s stock after selling 1,374 shares during the period. Wellington Management Group LLP’s holdings in CoreSite Realty were worth $26,012,000 as of its […]
- 06/20/2020
|
Detroit Police & Fire sues Tesla, Walmart
|
Hedge Funds Keep Buying CoreSite Realty Corp (COR)
- Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
- 06/18/2020
|
Wal-Mart Faces Pension-Fund Suits Over Internal Opioid Files - BNN Bloomberg
- Wal-Mart Inc. illegally mishandled opioid painkillers sold through its stores for years, two pension funds contend in lawsuits seeking access to internal records of the world’s second-largest retailer.Media reports and information revealed in a mass of opioid lawsuits in federal court show how Wal-Mart failed to comply with laws mandating monitoring of sales of the highly addictive painkillers, attorneys for the Norfolk County Retirement System and the Police and Fire Retirement System of Detroi
- 06/18/2020
|
Wal-Mart faces pension-fund suits over internal opioid files
- Wal-Mart and several U.S. pharmacy chains face a November trial before a federal jury in Cleveland in which states and municipalities will seek billio...
- 06/18/2020
|
CoreSite Announces Access to Oracle Cloud Via FastConnect
- CoreSite Realty Corporation (NYSE:COR) (the "Company), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions across the U.S., and a member of Oracle PartnerNetwork (OPN), today announced it will offer on-demand connectivity to Oracle Cloud through Oracle Cloud Infrastructure FastConnect on the CoreSite Open Cloud Exchange. CoreSite’s cloud-enabled data center campuses now offer low-latency connectivity to each of the Oracle Cloud regions in the United States located in Ashburn, VA and Phoenix, AZ. Oracle customers can harness the power of scalable, low-latency, hybrid architectures at CoreSite to unlock innovation and drive business growth.
- 06/16/2020
|
CoreSite Announces Access to Oracle Cloud Via FastConnect
- CoreSite Realty Corporation (NYSE:COR) (the “Company), a premier provider of secure, reliable, high-performance data center, cloud and interconnection
- 06/16/2020
|
Opioid Deal May Be Sped Up Amid State Shortfalls, Analyst Says - BNN Bloomberg
- Companies tied to the opioid epidemic could see a smaller settlement with U.S. states in return for faster payments as local governments hit by the coronavirus face a fiscal crisis and dwindling tax base, according to Morgan Stanley analysts.
- 06/15/2020
|
11 Defensive Dividend Blue - Chips To Help You Sleep Well At Night During The Next Market Decline
- Market volatility is back, exactly as I've been warning readers about for weeks now. The reality of our 24 to 30 month pandemic induced economic crisis means th
- 06/15/2020
|
Short Interest in AmerisourceBergen Corp. (NYSE:ABC) Declines By 8.0%
- AmerisourceBergen Corp. (NYSE:ABC) was the target of a large decline in short interest in May. As of May 29th, there was short interest totalling 3,820,000 shares, a decline of 8.0% from the May 14th total of 4,150,000 shares. Based on an average trading volume of 1,790,000 shares, the days-to-cover ratio is presently 2.1 days. Approximately […]
- 06/15/2020
|
'The Bachelor' casts its first black male lead as Hollywood responds to anti-racism movement
- In light of recent protests against police brutality following the death of George Floyd, Hollywood is continuing to respond and make big changes in order to help combat systemic racism and aid the Black Lives Matter movement. Yahoo Finance's Alexandra Canal breaks down the latest.
- 06/12/2020
|
Best colocation providers of 2020
- Host your server in a fast, reliable and secure data center
- 06/10/2020
|
Insider Selling: AmerisourceBergen Corp. (NYSE:ABC) CAO Sells 19,386 Shares of Stock
- AmerisourceBergen Corp. (NYSE:ABC) CAO Lazarus Krikorian sold 19,386 shares of AmerisourceBergen stock in a transaction that occurred on Monday, June 8th. The shares were sold at an average price of $99.90, for a total transaction of $1,936,661.40. AmerisourceBergen stock opened at $99.90 on Wednesday. The company has a market cap of $20.81 billion, a PE […]
- 06/10/2020
|
Why Is AmerisourceBergen (ABC) Up 11.5% Since Last Earnings Report?
- AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 06/06/2020
|
Stocks That Hit 52-Week Highs On Friday
|
West Virginia sues Walgreens, Rite-aid over painkillers flood
- Rite-Aid and Walgreens failed to monitor and report suspicious orders of prescription painkillers in West Virginia while inundating their retail pharmacies...
- 06/05/2020
|
Here's Why You Should Retain AmerisourceBergen Stock Now
- Investor confidence is high on AmerisourceBergen (ABC) stock, thanks to solid prospects.
- 06/05/2020
|
June 2020 Dividend Picks From Every Sector - Part 2
- My first portion of this month's dividend picks was released a short time ago. In this article, we follow up the other 5 sectors not yet covered. Market recover
- 06/05/2020
|
Got $1,000? Buy These 3 Medical Distributor Stocks
- The industry's big three -- McKesson (NYSE: MCK), AmerisourceBergen (NYSE: ABC), and Cardinal Health (NYSE: CAH) -- have an advantage of scale that make them great long-term ideas for anyone looking for a solid investment. McKesson has raised its quarterly dividend for seven consecutive years, bumping its quarterly payout 5% this year to reach $0.41 per share. It has a 1% yield -- less than the S&P; average of about 2%, but still solid -- and a conservative 11% payout ratio over the trailing 12 months (TTM).
- 06/05/2020
|
West Virginia sues Rite-Aid, Walgreens over pain pill flood
- West Virginia's attorney general has filed a lawsuit accusing Rite-Aid and Walgreens of failing to monitor and report suspicious orders of prescription painkillers
- 06/04/2020
|
Cardinal Health Is Wealth: A Mission-Critical Business On Sale (NYSE:CAH)
- Cardinal Health has a recession-resistant business and is providing essential goods to front-line medical staff. Solid quarterly performance and continued delev
- 06/04/2020
|
CoreSite Completes SV8 Data Center in Santa Clara
- CoreSite Realty Corporation (NYSE:COR) (the "Company"), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, today announced completion of Phase 3, the final phase of its new ground-up data center development on its Santa Clara campus.
- 06/04/2020
|
Edited Transcript of ABC earnings conference call or presentation 7-May-20 12:30pm GMT
- Q2 2020 AmerisourceBergen Corp Earnings Call
- 06/04/2020
|
Stocks That Hit 52-Week Highs On Wednesday
|
Road To Financial Independence: May Dividend Income Hurt By COVID-19
- May was a decent month in terms of dividend income but fell notably short Y/Y due to dividend cuts, suspensions and delays. I managed to open multiple new savin
- 06/03/2020
|
CoreSite Expands in Chicago with Opening of CH2 Data Center
- CoreSite Realty Corporation (NYSE:COR) (the "Company"), a premier provider of secure, reliable, high-performance data center, cloud and interconnection solutions in major U.S. metropolitan areas, today announced opening of Phase 1 of its new ground-up data center development in Chicago.
- 06/02/2020
|
CoreSite Expands in Chicago with Opening of CH— Data Center
|
Markets Live Recap: Stocks Start June in the Green
- Here's what our experts - Chris Johnson, Tom Gentile, D.R. Barton, Jr., and Shah Gilani - are watching today.
- 06/01/2020
|
McKesson: Poised To Thrive With Double-Digit Annual Returns (NYSE:MCK)
- McKesson is the largest of the 3 drug distributors and has entrenched relationships with healthcare providers. During the pandemic, its recession-resistant busi
- 06/01/2020
|
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q1 2020 Update
- Glenview Capital Management’s 13F portfolio value decreased around two-thirds from $11.42B to $3.68B this quarter. The number of positions decreased from 50 to
- 06/01/2020
|
New economy REITs offer healthy income for yield-seeking investors
- Two fund managers say there are opportunities in companies that provide data centres for cloud computing and storage facilities for so-called last mile deliveries of goods
- 06/01/2020
|
Hedge Funds Are Nibbling On AmerisourceBergen Corporation (ABC)
- In this article we will check out the progression of hedge fund sentiment towards AmerisourceBergen Corporation (NYSE:ABC) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and 20 […]
- 05/30/2020
|
Top Stocks for June 2020
- NRG Energy Inc.: NRG Energy is an integrated power company that produces, sells, and distributes energy and provides energy services in the U.S. NRG reported a 75% decline in net income on a 7% drop in revenue in Q1 2020, which ended March 31, 2020. Vornado Realty Trust: Vornado Realty Trust is a real estate investment trust (REIT) that owns office, retail, merchandise mart properties, and other real estate and related investments. The company reported a 48% decline in funds from operations (FFO) per diluted share for Q1 2020, which ended March 31, 2020.
- 05/29/2020
|
Why Big Pharma Is Betting on Blockchain
- The pandemic has exposed major cracks in medical supply chains.
- 05/29/2020
|
Deciphera Prepares To Collect Revenue After First FDA Approval: 'We Are Well-Positioned'
- After 17 years of clinical work, Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) finally has a marketable product. The Food and Drug Administration approved Qinlock as a fourth-...
- 05/29/2020
|
With M&A Hit, Wall Street Bankers Keep Busy With Stock Sales
- (Bloomberg) -- Wall Street bankers are a lot less busy these days, what with the pandemic-induced drop-off in mergers and acquisitions and initial public offerings.But there’s a gritty, less glamorous dealmaking realm that has held up, and it’s helping banks offset some of that lost M&A; and IPO revenue. A variety of companies, looking for liquidity in the weak economy, are selling off big stakes they’ve long held in public corporations.The latest came Monday when French pharmaceutical giant Sanofi launched a $13 billion sale of its 16-year-old, 21% stake in Regeneron Pharmaceuticals Inc. Regeneron, a New York-based biopharmaceutical firm, agreed to buy back about $5 billion of stock while the remaining $7 billion was sold to public investors in the largest public equity offering in the heath-care industry on record, according to data compiled by Bloomberg.Sanofi’s move came a few weeks after the pandemic’s first big deal of this kind, PNC Financial Services Group Inc.’s sale of its quarter-century-old stake of more than $13 billion in BlackRock Inc. The sale was the second-largest equity offering in the U.S. since Alibaba Group Holding Ltd.’s $25 billion IPO in 2014, according to data compiled by Bloomberg.PNC’s BlackRock stake was picked up by existing investors including Wellington Management, Capital Group Cos. and Fidelity Investments, according to people familiar with the matter. At least four state investment vehicles from the Middle East also took part in the offering, the people said.More such sales are coming. SoftBank Group Corp. raised $11.5 billion from transactions related to its stake in Alibaba Group Holding Ltd. which it bought in 2000, and another $2.9 billion capitalizing a 5% stake in its wireless arm. It is also closing in on a deal to sell its roughly 25% T-Mobile US Inc. stake, worth about $20 billion, with a portion being sold to Deutsche Telekom AG, people familiar with the matter have said.These transactions so far account for some of the biggest-ever announced of their kind. All told, there’s been $80.6 billion over 21 secondary offerings announced this year, which beats $53.1 billion over 36 such deals during the same period last year, according to data compiled by Bloomberg.That compares with a 33% drop to $22 billion in volume this year for IPOs in the U.S., the data shows. M&A; activity involving U.S.-based targets plummeted 62% during the same period, sinking to $241 billion, according to the data.For Wall Street, the secondary offerings aren’t as lucrative as other dealmaking but they require less work. Banks usually receive about 1% to 2% of the deal size for advisers fees, compared with 5% to 7% for handling an IPO. But IPOs often involve intensive road shows lasting weeks.Jim Cooney, head of equity capital markets for the Americas at Bank of America Corp., said selling stakes can make sense in the current economy. “The market prefers that companies stick to their core mission and monetize non-strategic assets before selling their own equity,” he said.The offerings mark another way that companies, distressed or not, have been hunting for liquidity since the beginning of the pandemic. Some have drawn down revolving credit lines, sold bonds or new shares and sold stakes to private equity firms. Investors have been willing buyers of shares, attracted by the discounts since shares are marketed at prices below where the stock is trading.These stake sales have investors speculating on what holdings could be unwound next. Here are some sizable ones to watch based on Bloomberg’s data. Bloomberg News isn’t aware of talks about potential sales of these stakes.SoftBank, UberSoftBank is Uber Technologies Inc.’s largest shareholder with a 13% stake worth $7.7 billion. The Japanese conglomerate, led by founder Masayoshi Son, forecasts an operating loss of 1.4 trillion yen ($13 billion) for the fiscal year ended in March after writing down values of the Vision Fund’s investments including WeWork and OneWeb, a satellite operator that filed for bankruptcy.While it isn’t SoftBank’s oldest or most sizable investment, it could help to recoup some losses.Walgreens Boots, AmerisourceBergenWalgreens Boots Alliance Inc. is the largest shareholder in AmerisourceBergen Corp. with a 28% stake, worth about $5.3 billion. AmerisourceBergen recently made an offer to buy the Walgreens pharmaceutical wholesale division, Reuters reported earlier this month.The news had analysts speculating it could be part of a transaction related to Walgreens exiting part of its stake in AmerisourceBergen. The two companies first saw their paths intertwine in 2013 through a $400 million distribution deal that was supposed to last a decade.Nestle, L’OrealSanofi’s deal to sell Regeneron stock also had analysts speculating it could buy back L’Oreal SA’s 9.4% stake in the drug company.That, in turn, raises the possibility that L’Oreal would buy back a 23% stake worth $35.5 billion that Nestle SA holds in the French cosmetics maker. Since this is a 40-year plus relationship, the deal idea has been long pitched by bankers. Over the years, both sides have said that the investment is long-term.HKEx, Kweichow MoutaiHong Kong Exchanges & Clearing Ltd., owner of the Hong Kong Stock Exchange, has a 8.5% stake worth $20 billion in distiller Kweichow Moutai Co.Kweichow Moutai has become a favorite stock in mainland China, and is up 15% this year, while the Shanghai Shenzhen CSI 300 Index fell 6.7%. Cashing out could help fuel HKEx’s ambitions as a dealmaker. It made a surprise bid for the London Stock Exchange last year.Mondelez, Dr PepperMondelez International Inc., the maker of Oreo cookies and Triscuit crackers, holds about about 13% of Keurig Dr Pepper, following a deal in 2018 when Keurig took control of the soda maker. In early March, right as the pandemic led to lockdowns in North America, Mondelez, and another investor connected to JAB Holdings BV called Maple Holdings BV,sold a $1.1 billion stake in Dr Pepper.The broader question for investors is whether Mondelez could sell more of its shares, Bank of America analyst Bryan Spillane said at the time. Mondelez could tap its equity stakes as a source of liquidity to fund acquisitions, he said.Coke, MonsterThe Coca-Cola Co. owns more than 18% of Monster Beverage Corp.’s stock, making it the Corona, California-based company’s largest shareholder, and Monster also uses Coke’s distribution network. While Coke took the minority stake back in 2014 in a push to capitalize on promising new brands, the beverage giant is getting more aggressive with its own offerings, which has sparked tensions with Monster. Analysts have been trying to figure out what Coke’s energy products mean for the future of the partnership.Liberty Broadband, CharterA 26% stake in Charter Communications Inc. has become a crown jewel for John Malone’s Liberty Broadband Corp. which has guided the company on acquisitions since it invested in 2013. But Malone, a savvy dealmaker, has not stopped reshaping his portfolio even in a pandemic and helped pull off a merger of Liberty Global’s U.K. business with Telefonica SA’s earlier this month.(Updates with BlackRock investors in fifth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
- 05/28/2020
|
Here’s Why CoreSite Realty (COR) Stock is an Attractive Pick
- Mairs and Power recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Mairs and Power Growth Fund posted a return of -18.84% for the quarter, outperforming its benchmark, the S&P; 500 Index which returned -19.60% in the same quarter. You should check out Mairs and Power's top 5 […]
- 05/28/2020
|
'Master Thief' behind Ocean's Eleven-style heist fights for freedom
- Sean Murphy, 55, was described by the FBI as one of the best burglars around. Now he is arguing for his freedom, claiming that he has already served his time and should be released.
- 05/28/2020
|
Brink : 'Master Thief' burglar hopes to catch break on sentence | MarketScreener
|
'Master Thief' burglar hopes to catch break on sentence
- COLUMBUS, Ohio (AP) — A self-described “master thief” career criminal is hoping to catch a break on his prison sentence from burglarizing a Brink’s warehouse during which he accidentally set millions of dollars on fire. Sean Murphy and two other men were convicted of breaking into the Brink’s facility in Columbus in January 2009. Murphy received a 20-year sentence in that case, eventually reduced to 13 years on appeal. Before that sentence began, however, he spent a decade in jail awaiting trial for a 2008 Massachusetts burglary during which he stole several New York Giants Super Bowl rings, along with jewels and precious metals. Murphy believes he’s already served the bulk of his federal time and should be out by next year. He notes he was arrested on Jan. 23, 2009, for the Super Bowl ring theft, and finally sentenced for that more than 10 years later, on Dec. 5, 2019. “Everything in between goes toward the federal sentence,” Murphy said in a letter to The Associated Press. Federal prosecutors take a different view. The judge who oversaw the Brink's case said that Murphy's federal sentence is to run on top of any unserved Massachusetts prison term, said Sal Dominguez, an assistant U.S. attorney in Columbus. Murphy, who has yet to formally argue for his release on time served, is awaiting transfer to a Massachusetts prison to serve his time for the Super Bowl ring theft. The 2008 break-in at E.A. Dion Co. in Attleboro, Massachusetts, attracted attention beyond the theft of the Super Bowl rings and the approximately $2.5 million in other goods taken. Murphy and his accomplices' trademark garb of all-black outfits and their access through the roof earned them media mentions as “Ocean's Eleven”-style burglars after the 2001 heist movie. Murphy was in...
- 05/28/2020
|
Stocks That Hit 52-Week Highs On Thursday
|
Shell Asset Management Co. Has $1.02 Million Stake in AmerisourceBergen Corp. (NYSE:ABC)
- Shell Asset Management Co. decreased its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 5.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,551 shares of the company’s stock after selling 700 shares during the period. Shell Asset Management Co.’s […]
- 05/27/2020
|
AmerisourceBergen Selected By Deciphera Pharmaceuticals To Support QINLOCK
|
AmerisourceBergen Selected by Deciphera Pharmaceuticals to Support QINLOCK™
- AmerisourceBergen, a global healthcare solutions leader, announced today that it has been selected by Deciphera Pharmaceuticals (Deciphera) to support QINLOCK (ripretinib). AmerisourceBergen is providing a unified commercialization approach for QINLOCK which was approved by the U.S. Food and Drug Administration (FDA) on Friday, May 15, 2020. QINLOCK is an orally administered kinase switch control inhibitor approved for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
- 05/26/2020
|
AmerisourceBergen Selected by Deciphera Pharmaceuticals to Support QINLOCK™
- AmerisourceBergen, a global healthcare solutions leader, announced today that it has been selected by Deciphera Pharmaceuticals (Deciphera) to support
- 05/26/2020
|
Dividend Champion And Contender Highlights: Week Of May 24
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
- 05/23/2020
|
Top Health Care Stocks for June 2020
- Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as hospitals and health care providers. Health care stocks, as represented by the Health Care Select Sector SPDR ETF (XLV), have outperformed the broader market, providing investors with a total return of 16.3% compared to the S&P; 500's total return of 5.9% over the past 12 months. In 2020, health care stocks have recouped nearly all of their losses since their March plunge while the broader market continues to suffer from the global coronavirus pandemic. The market performance numbers and the statistics in the tables in this story are as of May 20.
- 05/21/2020
|
CoreSite Realty Corporation Declares Second-Quarter 2020 Dividend on Common Stock
- CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center, cloud access and interconnection solutions in major U.S. metropolitan areas, today announced a cash dividend of $1.22 per share on common stock and common stock equivalents for the second quarter of 2020, consistent with the previous quarter.
- 05/20/2020
|
Shares of several healthcare companies are trading higher in sympathy with the overall market amid strength in oil, strong earnings from Lowe's and optimism towards a US economic rebound.
|
Prescription drug costs would have been a major campaign issue, so what will happen now that coronavirus is center stage?
- (The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
Simon F. Haeder, Pennsylvania State University
(THE CONVERSATION) It's no secret that Americans pay more for prescription drugs than any other developed nation in the world. Per capita spending exceeds US$1,000 a year; the Germans and French pay about half that. For many drugs, prices are dramatically higher than the international average: Dulera, an asthma drug, costs 50 times more, while Januvia, a drug for diabetes, and Combigan, a glaucoma drug, cost about 10 times more.
Politicians on both sides of the aisle have recognized this problem. President Donald Trump has called the situation "wrong" and "unfair"; presumptive Democratic presidential nominee Joe Biden has called to end the "abuse of power" by drug companies while his former competitor Sen. Bernie Sanders has complained about "unfettered capitalism" and "greed."
So why aren't prescription drug prices coming down? As a health policy scholar and political scientist, I believe the roadblock to change is the immense political power wielded by the enormously wealthy - and politically powerful - entities within the pharmaceutical supply chain. For decades, they have been reaping tremendous profits. It is not surprising they are now ready to invest those resources to defend their turf. Their power is and will remain a formidable obstacle to reform. And, coronavirus may have given them an assist by diverting attention away from the problem.
US prescription drug prices: Higher than anywhere
Countless studies have shown that Americans pay much more than other citizens of other development nations for their prescription drugs. This high spending on prescription drugs happens even though it does not use more drugs than other...
- 05/20/2020
|
CoreSite Realty Corporation Declares Second-Quarter 2020 Dividend on Common Stock
- CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center, cloud access and interconnection solutio
- 05/20/2020
|
Global Cosmetic Airless Packaging Market —…—… – Industry Analysis, Segments, Value ...
|
AmerisourceBergen Closes $500 Million Senior Note Offering
- AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $500 million aggregate principal amount of its 2.800% Senior Notes due May 15, 2030 (the "Notes"), in an underwritten registered public offering. The offering was made pursuant to an effective shelf registration statement AmerisourceBergen filed with the Securities and Exchange Commission (the "SEC") on November 20, 2018.
- 05/19/2020
|
These U.S. Companies Are Extremely Undervalued - Part 1
- Normally I focus on only the highest-quality undervalued stocks on the market - in this article, I revisit the concept of the most undervalued stocks on the mar
- 05/19/2020
|
Wolf's Corona Discounts: Bristol-Myers Squibb (NYSE:BMY)
- It's finally time to write about my favorite pharma stock in the corona-discount model. Bristol-Myers Squibb has gone from being a rather insignificant holding
- 05/19/2020
|
AmerisourceBergen Closes $500 Million Senior Note Offering
- AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $500 million aggregate principal amount of its 2.800%
- 05/19/2020
|
CoreSite to Present at Upcoming Investor Conferences
- CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center, cloud access and interconnection solutions in major U.S. metropolitan areas, today announced it will present at two upcoming investor conferences, including:
- 05/18/2020
|
Shares of several healthcare companies are trading higher in sympathy with the overall market as optimism around a coronavirus vaccine increased following news from Moderna.
|
CoreSite to Present at Upcoming Investor Conferences
|
Buy Drug Distributors’ Stocks Now, Analyst Says. McKesson and 2 More Potential Winners
- The Covid-19 downturn may be an opportunity for the three big U.S. drug distributors, UBS analyst Kevin Caliende says.
- 05/15/2020
|
UBS Maintains Buy on AmerisourceBergen, Lowers Price Target to $99
|
Beck Capital Management, Llc Buys Vanguard S&P 5……, PowerShares QQQ Trust Ser –, ...
|
Oracle Investment Management Inc Buys Agenus Inc, Antares Pharma Inc, Y-mAbs Therapeutics Inc, ...
|
Data Centre Interconnect Market 2019 - Challenges, Drivers, Outlook, Growth Opportunities - Analysis to 2025
- May 14, 2020 (Heraldkeepers) --
New York, May 14, 2020: The scope of the report includes a detailed study of Data Centre Interconnect Market with the reasons...
- 05/14/2020
|
Iron Mountain: An Undervalued Play On Data Centers
- Iron Mountain continues to grow their data center portfolio to be a major player in the DC space moving forward. IRM has a portfolio that will grow to a capacit
- 05/14/2020
|
Yotta Infrastructure Appoints Jarrett Appleby as Strategic Advisor to CEO
- Yotta Infrastructure announced the appointment of global Internet & Data Center industry veteran Jarrett Appleby as the Strategic Advisor to CEO.
- 05/14/2020
|
Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C. and Los Angeles County.
|
Eubel Brady & Suttman Asset Management Inc Buys AmerisourceBergen Corp, Steel Dynamics Inc, ...
|
AmerisourceBergen Prices $500 Million 2.800% Senior Notes Due 2030
- AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $500 million aggregate principal amount of its 2.800% Senior Notes due May 15, 2030 (the "Notes"), in an underwritten registered public offering. The offering is being made pursuant to an effective shelf registration statement AmerisourceBergen filed with the Securities and Exchange Commission (the "SEC") on November 20, 2018. The offering is expected to close on May 19, 2020, subject to customary closing conditions. AmerisourceBergen intends to use the net proceeds from the offering to redeem all of its 3.500% Senior Notes due November 15, 2021 and for general corporate purposes.
- 05/12/2020
|
AmerisourceBergen Corporation -- Moody's rates AmerisourceBergen's new senior unsecured bonds at Baa2
- Moody's Investors Service ("Moody's") assigned a Baa2 rating to AmerisourceBergen Corporation's ("AmerisourceBergen") new senior unsecured bonds. Moody's expects that proceeds from the company's new $500 million bond issuance will be used for general corporate purposes, including refinancing activities.
- 05/12/2020
|
AmerisourceBergen Corporation (NYSE:ABC) Passed Our Checks, And It's About To Pay A US$0.42 Dividend
- It looks like AmerisourceBergen Corporation (NYSE:ABC) is about to go ex-dividend in the next 2 days. You can purchase...
- 05/12/2020
|
AmerisourceBergen Prices $500 Million 2.800% Senior Notes Due 2030
- AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $500 million aggregate principal amount of its 2.800% Senior Notes due May 15
- 05/12/2020
|
S&P 500 and Nasdaq Gain on Monday
- Coty shares sink as revenue declined due to pandemic Continue reading...
- 05/11/2020
|
U.S. RESEARCH ROUNDUP-Acushnet Holdings, Equity Residential, Fiserv
- Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Acushnet Holdings, Equity Residential and Fiserv, on
Monday.
HIGHLIGHTS
* Acushnet Holdings Corp : Stephens raises target price to $27 from $24
* Equity Residential : Evercore ISI raises to in-line from underperform
* Fiserv Inc : Keybanc raises target price to $115 from $108
* GTT Communications Inc : SunTrust Robinson cuts to hold from buy
* UDR Inc : Evercore ISI raises to in-line from underperform
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
* Abbvie Inc : SVB Leerink raises price target to $122 from $107
* Accelerate Diagnostics Inc : Piper Sandler cuts target price to $14 from $16
* Acushnet Holdings Corp : Compass Point raises TP to $22.25 from $21.50
* Acushnet Holdings Corp : Keybanc raises target price to $31 from $28
* Acushnet Holdings Corp : Stephens raises target price to $27 from $24
* Advance Auto Parts Inc : UBS raises target price to $140 from $135
* AIG : UBS cuts target price to $45 from $49
* Air Lease Corp : Deutsche Bank cuts target price to $36 from $45
* Air Lease Corp : Stephens raises target price to $36 from $30
* Airgain Inc : Northland Capital Markets raises target price to $23
* Alarm.Com Holdings Inc : Credit Suisse cuts target price to $62 from $64
* Albemarle Corp : RBC raises target price to $66 from $64
* Albemarle Corp : SunTrust Robinson cuts target price to $65 from $90
* Allegiant Travel Co : Evercore ISI cuts target price to $95 from $100
* Allscripts Healthcare Solutions : Canaccord Genuity cuts TP to $11 from $13
* Amdocs Ltd : Citigroup cuts price target to $76 from $83
* Amedisys Inc : Raymond James cuts price target to $210 from $225
* Amedisys Inc : UBS cuts target price to $190 from $208
* American Axle & Manufacturing Holdings : Citigroup raises TP to $7.5 from $6
* American Axle & Manufacturing Holdings : RBC raises target price to $7 from $5
* American Homes 4 Rent : Evercore ISI raises target price to $27 from $25
* Ameriprise Financial Inc : RBC raises target price to $155 from $145
* Amerisourcebergen Corp : Deutsche Bank raises target price to $98 from $93
* Amphastar Pharmaceuticals Inc : BMO raises price target to $21 from $20
* Angi Homeservices Inc : Citigroup raises price target to $10 from $6.5
* Aon Plc : Citigroup cuts price target to $230 from $240
* Aon Plc : KBW raises target price to $192 from $184
* Aon Plc : UBS cuts target price to $197 from $202
* Apache Corp : CFRA cuts to sell from hold; raises price target to $9
* Apache Corp : MKM Partners cuts target price by $1 to $19
* Aptiv Plc : Benchmark cuts price target to $87 from $90
* Arch Capital Group Ltd : UBS cuts target price to $39 from $43
* Atara Biotherapeutics Inc : Jefferies cuts target price to $11 from $13
* Athene Holding Ltd : BMO cuts price target to $60 from $63
* Atricure Inc : BTIG raises target price to $56 from $45
* Atricure Inc : Needham raises target price to $63 from $49
* Atricure Inc : Oppenheimer raises price target to $52 from $45
* Atricure Inc : SVB Leerink raises price target to $55 from $50
* Autonation Inc : CFRA cuts price target by $10 to $50
* Avalonbay Communities Inc : Evercore ISI cuts target price to $181 from $189
* Avista Corp : Guggenheim cuts target price to $38 from $39
* Bain Capital Specialty Finance : Citigroup raises price target to $10 from $7.5
* Ball Corp : Citigroup cuts price target to $86 from $89
* Ball Corp : Northland Capital Markets cuts target price to $80
* Baudax Bio Inc : Oppenheimer cuts price target to $14 from $16
* Bellring Brands Inc : Stifel cuts target price to $23 from $25
* BJ's Restaurants Inc : Deutsche Bank raises target price to $27 from $26
* Bloomin' Brands Inc : BMO raises price target to $10 from $9
* Bloomin' Brands Inc : Deutsche Bank raises target price to $15 from $14
* Bloomin' Brands Inc : Guggenheim raises target price to $15 from $11
* Bloomin' Brands Inc : Raymond James cuts target price to $14 from $15
* BP Midstream Partners LP : Mizuho raises target price to $14 from $13
* Broadridge Financial Solutions : Piper Sandler cuts TP to $120 from $124
* Broadridge Financial Solutions : Rosenblatt Securities ups TP to $115 from $101
* Brookfield Infrastructure Partners LP : BMO raises price target to $46 from $45
* Brookfield Infrastructure Partners LP : Scotiabank cuts Tp to $50 from $51
* Brookfield Property Partners LP : Canaccord Genuity cuts TP to $12 from $13
* Brookfield Property Partners LP : CIBC cuts target price to $18 from $20.50
* Brookfield Property Partners LP : RBC cuts target price to $18 from $22
* Bruker Corp : BTIG cuts price target to $50 from $57
* Cabot Oil & Gas Corp : Tudor Pickering Holt cuts to hold from buy
* Calithera Biosciences Inc : Citigroup raises price target to $10 from $7
* Callaway Golf Co : >: Compass Point cuts target price to $17.50 from $20
* Callaway Golf Co : Compass Point cuts target price to $17.50 from $20
* Camden Property Trust : Evercore ISI cuts target price to $98 from $102
* Camden Property Trust : Stifel raises target price to $96 from $91
* Cardtronics Plc : D.A. Davidson cuts target price to $34 from $40
* Cardtronics Plc : SunTrust Robinson raises target price to $29 from $23
* Cargurus Inc : RBC raises target price to $25 from $22
* Carnival : HSBC raises to buy from hold; cuts target price to $15.9 from $45.3
* Carrier Global Corp : Citigroup raises price target to $20 from $17
* Carvana Co : Oppenheimer raises price target to $127 from $95
* Carvana Co : Oppenheimer raises target price to $127 from $95
* Casella Waste Systems Inc : Jefferies raises target price to $56 from $52
* Casella Waste Systems Inc : Raymond James raises target price to $56 from $49
* Casella Waste Systems Inc : Stifel raises target price to $47 from $45
* Cellectis : Citigroup cuts price target to $15 from $16
* Centurylink Inc : SunTrust Robinson cuts target price to $9 from $10
* Ceridian Hcm Holding Inc : Jefferies raises target price to $65 from $60
* Chevron Corp : Independent Research raises target price to $98 from $90; hold
* CNX Resources Corp : Tudor Pickering Holt cuts to hold from buy
* Cognizant Technology Solutions : Evercore ISI cuts target price to $53 from $55
* Cognizant Technology Solutions Corp : HSBC cuts target price to $56 from $70
* Coherus Biosciences Inc : Citigroup cuts price target to $30 from $31
* Conagra Brands Inc : SunTrust Robinson cuts to hold from buy
* Consolidated Edison Inc : Evercore ISI cuts target price to $85 from $86
* Continental Resources : TD Securities raises target price to $14.50 from $13.50
* Cooper Tire & Rubber Co : JP Morgan cuts target price to $29 from $30
* Corporate Office Properties Trust : SunTrust Robinson raises TP to $28 from $26
* Corteva Inc : RBC raises target price to $31 from $27
* Covanta Holding : Stifel raises to hold from sell; raises TP to $9.50 from $6.50
* Crocs Inc : Piper Sandler raises target price to $28 from $24
* Cross Country Healthcare Inc : BMO cuts price target to $8 from $11
* Cryoport Inc : Stephens raises target price to $23 from $21
* CVR Energy Inc : Credit Suisse raises target price to $19 from $16
* Cytomx Therapeutics Inc : Wedbush raises target price to $16 from $11
* Danaher Corp : Evercore ISI raises target price to $175 from $150
* Danaher Corp : RBC raises target price to $173 from $159
* Datadog Inc : RBC raises target price to $50 from $43
* Dentsply Sirona : Barrington Research cuts to market perform from outperform
* Dentsply Sirona Inc : UBS cuts target price to $44 from $59
* Dicerna Pharmaceuticals : SunTrust Robinson raises target price to $33 from $28
* Diebold Nixdorf Inc : JP Morgan raises target price to $7 from $6
* Diebold Nixdorf Inc : JP Morgan raises to neutral from underweight
* Discovery Inc : Rosenblatt Securities cuts price target to $24 from $27
* Dish Network Corp : RBC cuts target price to $32 from $39
* Domtar : D.A. Davidson cuts to neutral from buy; cuts TP to $26 from $44
* Domtar Corp : Scotiabank cuts target price to $29 from $30
* Domtar Corp : TD Securities raises target price to $26 from $22
* E. W. Scripps Co : Benchmark cuts target price to $15 from $24
* E. W. Scripps Co : Guggenheim raises target price to $8 from $6.50
* Edison Intl.
- 05/11/2020
|
Deutsche Bank Maintains Hold on AmerisourceBergen, Raises Price Target to $98
|
CoreSite Announces New Fiber Interconnection at its Los Angeles Campus To Oracle Cloud Infrastructure Via FastConnect
- CoreSite Realty Corporation (NYSE:COR) (the "Company), a premier provider of secure, reliable, high-performance data center and interconnection solutions across the U.S., and a member of Oracle PartnerNetwork (OPN), today announced the immediate availability of new fiber interconnection to Oracle Cloud through Oracle Cloud Infrastructure FastConnect at its Los Angeles Campus.
- 05/11/2020
|
14 questions for Fauci, Redfield, and the other Trump officials on Covid-19
- Until now, the Trump officials who’ve led the federal government’s coronavirus response have escaped the wrath of Congress. Here’s what STAT would ask.
- 05/11/2020
|
Dividend Increases: May 2-8, 2020
- This weekly article series covers dividend increase announcements. A summary table provides relevant data and key statistics. As a bonus, I include ex-dividend
- 05/11/2020
|
CoreSite Announces New Fiber Interconnection at its Los Angeles Campus To Oracle Cloud Infrastructure Via FastConnect
- CoreSite Realty Corporation (NYSE:COR) (the “Company), a premier provider of secure, reliable, high-performance data center and interconnection soluti
- 05/11/2020
|
S&P 5…… and Nasdaq Gain on Monday
|
Dividend Champion And Contender Highlights: Week Of May 10
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which declared increased dividends. Companies with upcoming ex-dividend d
- 05/09/2020
|
Infectious-disease doctors ask government to explain how it decides who gets Gilead’s remdesivir
- Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to clarify how it is selecting which hospitals get access to the drug.
- 05/09/2020
|
Plan to distribute Covid-19 drug unveiled amid concerns over allocation
- The federal government’s new plan would deliver remdesivir to state health departments and allow them to determine which hospitals should receive it.
- 05/09/2020
|
REITs Rally Despite Mounting Dividend Cuts
- The rebound continued for U.S. equity markets this week despite another brutal week of unemployment data. Nearly a fifth of the American workforce has filed for
- 05/09/2020
|
UCSF medical workers question federal distribution of COVID-19 medicine
- University pharmacists were shocked when they learned that they would not be getting any of the 1.5 million doses of the drug remdesivir, which is being distributed to hospitals nationwide.
- 05/09/2020
|
Newsflash: Even After COVID-19 The Market Is Not Cheap
- As time has passed analysts have had the opportunity to assess the Covid-19 potential damage to the S&P 500’s earnings. Because of this updated forecast, I no l
- 05/08/2020
|
Road To Financial Independence: Best April Ever
- April 2020 was a great month from a dividend perspective, unfortunately, it very likely will also be the last great month this year following a series of divide
- 05/08/2020
|
AmerisourceBergen Corp (NYSE: ABC) Q2 2020 Earnings Call Transcript | AlphaStreet
- Final earnings conference call transcript of AmerisourceBergen Corp. - ABC stock
- 05/08/2020
|
Morgan Stanley Maintains Equal-Weight on AmerisourceBergen, Raises Price Target to $94
|
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
- Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Computer Programs and Systems Inc : Cantor Fitzgerald raises to overweight from neutral
* Epam Systems Inc : Citigroup raises price target to $265 from $245
* PayPal Holdings Inc : Citigroup raises price target to $145 from $131
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical
order.
* Aaron's Inc : Keybanc cuts target price to $55 from $66
* Aaron's Inc : Raymond James cuts target price to $50 from $60
* Aaron's Inc : Stephens raises target price to $45 from $26
* Abeona Therapeutics Inc : RBC cuts target price to $7 from $11
* Acceleron pharma Inc : Credit Suisse raises target price to $123 from $99
* ACI Worldwide Inc : Canaccord Genuity cuts target price to $35 from $44
* Acushnet Holdings Corp : Jefferies raises target price to $25 from $24
* Acushnet Holdings Corp : JP Morgan raises target price to $30 from $27
* Adtran Inc : Cowen and Company raises price target to $13 from $9
* Aeglea Bio Therapeutics Inc : Needham cuts price target to $11 from $14
* Aerie Pharmaceuticals Inc : Citigroup cuts price target to $38 from $39
* Agco Corp : Citigroup cuts price target to $55 from $57
* AIG : KBW raises target price to $36 from $35
* Alaska Air Group Inc : Credit Suisse cuts target price to $51 from $82
* Allison Transmission Holdings Inc : Citigroup raises price target to $39 from $38
* Allscripts Healthcare Solutions : Cantor Fitzgerald cuts PT to $6 from $8
* Alteryx Inc : Guggenheim cuts target price to $130 from $160
* American Airlines : Credit Suisse cuts target price to $4 from $26
* Ameriprise Financial Inc : Credit Suisse raises target price to $165 from $153
* Ameriprise Financial Inc : Piper Sandler raises target price to $150 from $130
* Amerisourcebergen Corp : Baird raises target price to $115 from $109
* Amerisourcebergen Corp : Mizuho raises target price to $90 from $85
* Amtech Systems Inc : Cowen and Company raises target price to $7.50 from $7
* Angi Homeservices Inc : Needham raises target price to $11 from $8
* Ani Pharmaceuticals Inc : Guggenheim cuts target price to $48 from $58
* Ansys Inc : RBC raises target price to $260 from $230
* Anthem Inc : Bernstein raises target price to $357 from $342
* Appian Corp : Cowen and Company raises price target to $44 from $39
* Applied Optoelectronics Inc : D.A. Davidson raises target price to $12 from $10
* Applied Optoelectronics Inc : Piper Sandler raises target price to $10 from $7.50
* Aptiv Plc : Citigroup raises price target to $84 from $67
* ArcelorMittal SA : Keybanc raises target price to $15 from $13
* Arcturus Therapeutics Holdings Inc : Baird raises target price to $44 from $26
* Arcturus Therapeutics Holdings Inc : Guggenheim raises target price to $51 from $41
* Ares Capital Corp : Citigroup raises price target to $15 from $13
* Athersys Inc : Needham cuts price target to $5 from $6
* Atlas Air Worldwide Holdings Inc : Cowen and Company raises PT to $44 from $40
* Avalara Inc : Canaccord Genuity raises target price to $115 from $105
* Avalara Inc : JP Morgan raises target price to $120 from $104
* Avalara Inc : Mizuho raises price target to $120 from $85
* Avalara Inc : Piper Sandler raises target price to $113 from $90
* Avalonbay Communities Inc : Stifel raises target price to $176 from $171
* Avrobio Inc : Guggenheim raises target price to $50 from $49
* Axalta Coating Systems Ltd : RBC raises target price to $21 from $20
* Bausch Health Companies Inc : Piper Sandler cuts target price to $32 from $34
* Beacon Roofing Supply Inc : SunTrust Robinson raises target price to $26 from $24
* Beacon Roofing Supply Inc : Wedbush raises target price to $23 from $16
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Becton Dickinson and Co : Evercore ISI raises target price to $270 from $255
* Beyond Meat Inc : Berenberg raises price target to $125 from $115
* Bill.Com Holdings Inc : Canaccord Genuity raises target price to $65 from $50
* Bill.Com Holdings Inc : Jefferies raises target price to $70 from $45
* Bill.Com Holdings Inc : Keybanc raises target price to $76 from $60
* Bill.Com Holdings Inc : Needham raises target price to $90 from $55
* Biomarin Pharmaceutical Inc : Canaccord Genuity raises PT to $119 from $108
* BJ's Restaurants Inc : Wedbush cuts target price to $32 from $39
* Booking Holdings Inc : Credit Suisse raises target price to $1,810 from $1,790
* Booking Holdings Inc : Jefferies cuts target price to $1300 from $1350
* Booking Holdings Inc : Mizuho cuts price target to $1700 from $1720
* Booking Holdings Inc : RBC raises target price to $1,550 from $1,535
* Booking Holdings Inc : RBC raises target price to $1550 from $1535
* BorgWarner Inc : Citigroup raises price target to $30 from $23
* BorgWarner Inc : Credit Suisse raises target price to $33 from $31
* Bottomline Technologies (De) Inc : Citigroup raises price target to $46 from $43
* Bright Horizons Family Solutions Inc : Citigroup raises PT to $122 from $80
* Brightsphere Investment Group Inc : Evercore ISI raises target to $9 from $6
* Brightsphere Investment Group Inc : KBW raises target price to $9.50 from $7.25
* Brightview Holdings Inc : Credit Suisse cuts target price to $14 from $18
* Brightview Holdings Inc : Jefferies raises target price to $14 from $12
* Cabot Microelectronics Corp : Citigroup cuts price target to $140 from $175
* Cactus Inc : zephirin Group raises price objective to $12 from $8
* Calithera Biosciences Inc : Jefferies raises target price to $9 from $6
* Calyxt Inc : BMO cuts price target to $7 from $13
* Calyxt Inc : BMO cuts to market perform from outperform
* Camping World Holdings Inc : Credit Suisse raises target price to $12 from $11
* Camping World Holdings Inc : JP Morgan raises price target to $11 from $10
* Capstar Financial Holdings Inc : KBW raises target price to $11 from $10.50
* Cargurus Inc : BTIG raises target price to $26 from $23
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Castlight Health Inc : Cantor Fitzgerald cuts target price to $1 from $2
* Catasys Inc : Canaccord Genuity raises target price to $36 from $35
* CBRE Group Inc : Evercore ISI cuts target price to $48 from $50
* CBRE Group Inc : KBW cuts target price to $51 from $52
* Centerpoint Energy Inc : Guggenheim raises target price to $26 from $25
* Centerpoint Energy Inc : Keybanc raises target price to $16 from $12
* Centurylink Inc : RBC cuts target price to $10 from $14
* CF Industries Holdings Inc : Citigroup cuts price target to $29 from $31
* CF Industries Holdings Inc : Scotiabank raises target price to $32 from $31
* ChannelAdvisor Corp : Needham raises price target to $14 from $11
* Charles River Laboratories International : Credit Suisse cuts PT to $159 from $162
* Charles River Laboratories International : Evercore ISI ups PT to $176 from $154
* Charles River Laboratories International : Jefferies raises PT to $161 from $139
* Charles River Laboratories International Inc : Citigroup raises price target to $190 from $165
* Chart Industries Inc : zephirin Group raises price objective to $25 from $17
* Charter Communications Inc : Benchmark raises price target to $600 from $523
* Chemours Co : Citigroup raises price target to $13 from $8
* Cimarex Energy Co : MKM Partners raises target price to $34 from $31
* City Holding Co : Stephens cuts target price to $63 from $64.
- 05/08/2020
|
Carnegie Capital Asset Management, LLC Buys Schwab Short-Term U.S. ...
|
Edited Transcript of ABC earnings conference call or presentation 7-May-20 12:30pm GMT
- Q2 2020 AmerisourceBergen Corp Earnings Call
- 05/07/2020
|
Infectious-disease doctors ask government to explain how it decides who gets Gilead’s remdesivir
- Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to clarify how it is selecting which hospitals get access to the drug.
- 05/07/2020
|
AmerisourceBergen Corp (ABC) Q2 2020 Earnings Call Transcript
- Good morning, and thank you all for joining us for this conference call to discuss AmerisourceBergen's Fiscal 2020 Second Quarter results. On today's call, we will be discussing non-GAAP financial measures.
- 05/07/2020
|
U.S. Doctors want details on federal distribution of Gilead coronavirus drug
- The Infectious Disease Society of America (IDSA) is asking for more information on the federal government's plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus.
- 05/07/2020
|
U.S. Doctors want details on federal distribution of Gilead coronavirus drug
- The Infectious Disease Society of America (IDSA) is asking for more information on the federal government's plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus.
- 05/07/2020
|
Doctors want details on federal distribution of Gilead coronavirus drug
- The Infectious Disease Society of America (IDSA) is asking for more information on the federal government's plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus.
- 05/07/2020
|
Doctors want details on federal distribution of Gilead coronavirus drug
- The Infectious Disease Society of America (IDSA) is asking for more information on the federal government's plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus.
- 05/07/2020
|
Travel Sites Take a Hit from the Pandemic -- -2-
|
Infectious disease doctors ask government to explain how it decides who gets Gilead’s remdesivir
- Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to...
- 05/07/2020
|
AmerisourceBergen's (ABC) CEO Steve Collis on Q2 2020 Results - Earnings Call Transcript
- AmerisourceBergen Corporation (NYSE:ABC) Q2 2020 Earnings Conference Call May 07, 2020, 08:30 AM ET Company Participants Bennett Murphy – Head-Investor Relation
- 05/07/2020
|
The Case For AmerisourceBergen Corporation (NYSE:ABC): Could It Be A Nice Addition To Your Dividend Portfolio?
- Is AmerisourceBergen Corporation (NYSE:ABC) a good dividend stock? How can we tell? Dividend paying companies with...
- 05/07/2020
|
U.S. RESEARCH ROUNDUP-Ashland Global, Lyft, Solaredge Technologies
- Wall Street securities analysts on Thursday revised their ratings and
price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and
Solaredge Technologies.
HIGHLIGHTS
* Ashland Global Holdings Inc. : JP Morgan raises to neutral from underweight
* Lyft Inc : Piper Sandler cuts to neutral from overweight
* Natera Inc : JP Morgan raises to overweight from neutral
* Occidental Petroleum Corp : SunTrust Robinson raises to hold from sell
* Solaredge Technologies : Canaccord Genuity cuts to hold from buy
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order.
* A. O. Smith Corp : Stephens raises target price to $40 from $37
* Acadia Healthcare Company Inc : Citigroup cuts price target to $34 from $37
* Acadia Healthcare Company Inc : Deutsche Bank cuts target price to $28 from $32
* Activision Blizzard Inc : Keybanc raises target price to $80 from $68
* Adient Plc : Deutsche Bank raises target price to $20 from $15
* ADMA Biologics Inc : Oppenheimer cuts target price to $7 from $14
* Advanced Energy Industries Inc : Citigroup raises price target to $63 from $40
* Advanced Energy Industries Inc : Cowen and Company raises PT to $58 from $51
* Advanced Energy Industries Inc : D.A. Davidson raises target to $60 from $50
* Advanced Energy Industries Inc : Susquehanna cuts target price to $85 from $90
* Aerie Pharmaceuticals Inc : H.C. Wainwright cuts target price to $31 from $37
* Aerie Pharmaceuticals Inc : Mizuho cuts target price to $29 from $34
* Aerie Pharmaceuticals Inc : Piper Sandler cuts target price to $35 from $45
* Aerie Pharmaceuticals Inc : SunTrust Robinson cuts price target to $22 from $26
* Agco Corp : Stephens raises target price to $65 from $60
* Air Transport Services Group Inc : Cowen and Company raises PT to $26 from $25
* Albemarle Corp : UBS cuts target price to $90 from $98
* Alexion Pharmaceuticals Inc : BMO cuts target price to $142 from $147
* Alexion Pharmaceuticals Inc : Credit Suisse cuts target price to $142 from $147
* Alexion Pharmaceuticals Inc : Jefferies cuts price target to $111 from $112
* Alexion Pharmaceuticals Inc : Raymond James cuts target price to $156 from $159
* Alexion Pharmaceuticals Inc : SunTrust Robinson cuts target to $135 from $141
* Alexion Pharmaceuticals Inc : SVB Leerink cuts target price to $150 from $156
* Allegiant Travel Co : Cowen and Company cuts price target to $74 from $100
* Allete Inc : Guggenheim cuts price target to $65 from $70
* Allogene Therapeutics Inc : Jefferies raises target price to $37 from $36
* Allstate Corp : Piper Sandler raises target price to $112 from $108
* Alnylam Pharmaceuticals Inc : Guggenheim raises price target to $166 from $155
* Alnylam Pharmaceuticals Inc : BMO raises target price to $171 from $145
* Alnylam Pharmaceuticals Inc : Jefferies raises price target to $165 from $142
* Alnylam Pharmaceuticals Inc : JP Morgan cuts to neutral from overweight
* Alnylam Pharmaceuticals Inc : JP Morgan raises target price to $137 from $133
* Alnylam Pharmaceuticals Inc : Needham raises target price to $160 from $135
* Alnylam Pharmaceuticals Inc : Oppenheimer raises target price to $162 from $140
* Alnylam Pharmaceuticals Inc : Piper Sandler raises target to $169 from $142
* Alteryx Inc : Citigroup cuts price target to $147 from $160
* Alteryx Inc : Cowen and Company cuts target price to $135 from $145
* Alteryx Inc : Needham cuts target price to $140 from $152
* Alteryx Inc : Wedbush cuts price target to $138 from $146
* Amedisys Inc : Benchmark cuts to hold rating
* Ameriprise Financial Inc : Evercore ISI raises target price to $139 from $136
* Ametek Inc : Berenberg raises target price to $93 from $86
* Ametek Inc : Stephens cuts target price to $92 from $94
* Anaptysbio Inc : Credit Suisse raises target price to $16 from $14
* Apache Corp : Credit Suisse raises target price to $10 from $4
* Aptiv Plc : Deutsche Bank raises target price to $75 from $59
* Arcus Biosciences Inc : Wedbush raises target price to $40 from $26
* Ares Capital Corp : BMO cuts target price by $5 to $16
* Ares Capital Corp : Citigroup raises price target to $15 from $13
* Ares Management Corp : BMO raises target price to $40 from $30
* Ares Management Corp : Credit Suisse raises target price to $40 from $38
* Ares Management Corp : Jefferies raises target price to $42 from $39
* Ares Management Corp : KBW raises target price to $45 from $44
* ASGN Inc : Jefferies raises target price to $54 from $31
* Ashland Global Holdings Inc : Deutsche Bank raises target price to $70 from $65
* Ashland Global Holdings Inc. : JP Morgan cuts target price to $62 from $68
* Ashland Global Holdings Inc. : JP Morgan raises to neutral from underweight
* Ashland Global Holdings Inc. : SunTrust Robinson cuts price target to $75 from $87
* Aspen Technology Inc : Benchmark cuts target price to $130
* Aspen Technology Inc : Keybanc raises target price to $120 from $110
* Assetmark Financial Holdings Inc : BMO cuts target price to $23 from $26
* Assurant Inc : SunTrust Robinson cuts price target to $145 from $155
* Astronics Corp : Canaccord Genuity cuts target price to $10 from $14
* Astronics Corp : SunTrust Robinson cuts price target to $6 from $7
* Atkore International Group Inc : Citigroup raises price target to $26 from $24
* Atlas Corp (British Columbia) : Citigroup cuts price target to $7 from $12
* Avanos Medical Inc : Berenberg raises target price to $33 from $30
* Avanos Medical Inc : Stephens raises target price to $38 from $30
* Axalta Coating Systems Ltd : Citigroup raises price target to $21 from $18
* Axalta Coating Systems Ltd : Credit Suisse cuts target price to $27 from $29
* Axalta Coating Systems Ltd : Jefferies raises target price to $18 from $15
* Axalta Coating Systems Ltd : Keybanc raises target price to $24 from $23
* Axcelis Technologies Inc : D.A. Davidson raises price target to $25 from $20
* Axcella Health Inc : BTIG raises target price to $12 from $10
* Axogen Inc : Canaccord Genuity cuts target price to $12 from $22
* Axogen Inc : Jefferies cuts target price to $21 from $30
* Bank of N.T. Butterfield & Son Ltd : Citigroup raises target to $21 from $15
* Barrett Business Services Inc : Barrington Research raises PT to $52 from $48
* Barrick Gold Corp : Deutsche Bank raises target price to $34 from $25
* Benefitfocus Inc : Piper Sandler cuts target price to $26 from $35
* Bio Rad Laboratories Inc : Citigroup raises price target to $525 from $480
* Bio Rad Laboratories Inc : Jefferies raises target price to $525 from $500
* Biocryst Pharmaceuticals Inc : Jefferies raises price target to $9 from $8
* Biocryst Pharmaceuticals Inc : Piper Sandler raises target price to $10 from $8
* Biotelemetry Inc : Benchmark cuts target price to $52 from $55
* Black Knight Inc : KBW raises target price to $70 from $68
* Black Knight Inc : Stephens raises target price to $88 from $84
* Black Knight Inc : Wedbush raises target price to $70 from $66
* Black Stone Minerals LP : Simmons Energy raises target price to $8 from $5
* Blackbaud Inc : Evercore ISI cuts target price to $48 from $55
* Blucora Inc : Benchmark cuts price target to $25 from $37
* BMC stock Holdings Inc : Stephens raises target price to $25 from $22
* BMC stock Holdings Inc : SunTrust Robinson raises price target to $26 from $22
* BorgWarner Inc : Jefferies raises target price to $33 from $30
* BorgWarner Inc : JP Morgan raises price target to $35 from $32
* BorgWarner Inc : Oppenheimer cuts target price to $44 from $45
* BorgWarner Inc : RBC raises target price to $31 from $29
* Boston Private Financial Holdings Inc : Piper Sandler raises PT to $7 from $6.
- 05/07/2020
|
AmerisourceBergen (ABC) Q2 Earnings & Revenues Top Estimates
- AmerisourceBergen's (ABC) fiscal second-quarter earnings benefit from segmental growth.
- 05/07/2020
|
Who Paid The Rent? Earnings Halftime Report
- We're at the halfway point of the most newsworthy and consequential REIT earnings season in a decade. Rent collection and dividend plans have been the primary f
- 05/07/2020
|
Reaves W H & Co Inc Buys CMS Energy Corp, Comcast Corp, Eversource Energy, Sells TELUS ...
|
CoreSite Realty Corporation Announces Closing of $150 million of 3.75% Senior Notes Offering
- CoreSite Realty Corporation (NYSE:COR) ("CoreSite"), a premier provider of secure, reliable, high-performance data center, cloud access and interconnection solutions across the U.S., today announced that its operating partnership, CoreSite, L.P. (the "Operating Partnership"), agreed to issue and sell an aggregate principal amount of $150 million of its 3.75% senior notes due May 6, 2027 (the "Notes"), in a private placement to certain "accredited investors" pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act").
- 05/06/2020
|
CoreSite Realty Prices Sale of 2,62M Shares of Common Stock by The Carlyle Group @$119.50/Share
|
CoreSite Realty Corporation Announces Pricing of Sale of Common Stock by The Carlyle Group
- CoreSite Realty Corporation (NYSE:COR) ("CoreSite"), a premier provider of secure, reliable, high-performance data center, cloud access and interconnection solutions across the U.S., today announced the pricing of the previously announced sale of 2,620,000 shares of its common stock by investment funds affiliated with The Carlyle Group at a price to the public of $119.50. This reflects an increase of 500,000 shares from the previously announced sale of 2,120,000 shares of CoreSite’s common stock. Morgan Stanley is acting as sole underwriter in connection with the offering.
- 05/05/2020
|
CoreSite Realty Corporation Announces Pricing of Sale of Common Stock by The Carlyle Group
- CoreSite Realty Corporation (NYSE:COR) (“CoreSite”), a premier provider of secure, reliable, high-performance data center, cloud access and interconne
- 05/05/2020
|
CoreSite Realty Reports 2.12M Shares Sold By Investment Funds Affiliated With Carlyle To Morgan Stanley
|
CoreSite Realty Corporation Announces Sale of Common Stock by The Carlyle Group
- CoreSite Realty Corporation (NYSE:COR) ("CoreSite"), a premier provider of secure, reliable, high-performance data center, cloud access and interconnection solutions across the U.S., today announced the sale of 2,120,000 shares of its common stock by investment funds affiliated with The Carlyle Group to Morgan Stanley, as the sole underwriter in connection with the offering.
- 05/04/2020
|
U.S. RESEARCH ROUNDUP-Berkshire Hathaway, DHT Holdings, Novo Nordisk
- Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies, including Berkshire Hathaway, DHT Holdings and Novo Nordisk, on Monday.
HIGHLIGHTS
* Berkshire Hathaway Inc : KBW raises target price to $325,000 from $310,000
* CyrusOne Inc : Jefferies raises to buy from hold
* DHT Holdings Inc : Evercore ISI cuts to in line from outperform
* Frontline Ltd : Evercore ISI cuts to in line from outperform
* Novo Nordisk : Cowen and Company initiates with market perform, $72 target price
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in
alphabetical order.
* 2U Inc : Barrington Research raises price target to $30 from $25
* Abbvie Inc : Mizuho raises target price to $101 from $100
* Abbvie Inc : RBC raises price target to $98 from $93
* Abbvie Inc : SVB Leerink raises target price to $107 from $103
* Activision Blizzard Inc : Credit Suisse raises target price to $79 from $69
* Allegiance Bancshares Inc : KBW raises target price to $32 from $31
* Allscripts Healthcare Solutions Inc : Cowen and Company cuts PT to $8 from $15
* Alteryx Inc : Rosenblatt Securities cuts price target to $115 from $145
* Amarin Corporation Plc : SVB Leerink raises target price to $9 from $7
* Amazon.Com Inc : Independent Research raises PT to $2900 from $2400; rating buy
* American Airlines : Citigroup cuts price target to $9 from $10
* American Tower Corp : Citigroup cuts price target to $266 from $280
* American Tower Corp : RBC raises target price to $261 from $240
* Angi Homeservices Inc : SunTrust Robinson cuts target price to $10 from $14
* Antero Midstream Corp : Citigroup cuts to neutral from buy; cuts PT to $4 from $7
* Apollo Global Management Inc : BMO raises target price to $43 from $39
* Apollo Global Management Inc : Citigroup cuts price target to $55 from $61
* Apollo Global Management Inc : Credit Suisse cuts target price to $44 from $45
* Apollo Global Management Inc : Evercore ISI raises target price to $43 from $41
* Apollo Global Management Inc : Jefferies raises target price to $45 from $44
* Apollo Global Management Inc : KBW cuts target price to $47 from $49
* Apollo Investment Corp : SunTrust Robinson cuts target price to $12 from $19
* Ardmore Shipping Corp : Evercore ISI cuts target price to $10 from $11
* Ares Capital Corp : SunTrust Robinson cuts target price to $15 from $20
* Arthur J Gallagher & Co : KBW cuts target price to $97 from $100
* Asgn Inc : BMO raises target price to $66 from $51
* Avadel Pharmaceuticals Plc : Piper Sandler raises target price to $18 from $14
* Bain Capital Specialty Finance Inc : Credit Suisse cuts PT to $15.50 from $20.50
* Balchem Corp : H.C. Wainwright cuts price target to $104 from $116
* Bank of America Corp : UBS raises price target to $21 from $20
* Bank of N.T. Butterfield & Son Ltd : KBW raises target price to $28 from $24
* Bank of N.T. Butterfield & Son Ltd : Raymond James raises PT to $24 from $20
* Bank7 Corp : Piper Sandler raises target price to $12 from $11
* Barings BDC Inc : Compass Point raises to buy from neutral
* Barings BDC Inc : KBW cuts target price to $8 from $8.5
* Bcb Bancorp Inc : D.A. Davidson cuts target price to $10 from $11
* Berkshire Hathaway Inc : KBW raises target price to $325,000 from $310,000
* Berkshire Hathaway Inc : UBS cuts target price to $350000 from $358000
* Berry Global Group Inc : Citigroup raises price target to $47 from $42
* Beyond Meat Inc : Jefferies raises target price to $83 from $72
* Big Lots Inc : Talsey Advisory Group raises to outperform from market perform
* Big Lots Inc : Telsey Advisory Group raises price target to $31 from $20
* Biomarin Pharmaceutical Inc : Wedbush cuts target price to $145 from $164
* Black Diamond Therapeutics Inc : HC Wainwright initiates at rating buy and $53 PT
* Bloomin' Brands Inc : MKM Partners raises target price to $13 from $11
* Booking Holdings Inc : Credit Suisse cuts target price to $1,790 from $1,870
* Brigham Minerals Inc : SunTrust Robinson cuts target price to $16 from $19
* Brookline Bancorp Inc : KBW cuts target price to $11 from $12
* Brooks Automation Inc : Stephens raises target price to $40 from $37
* Brunswick Corp : BMO raises target price to $37 from $34
* Brunswick Corp : Keybanc raises target price to $52 from $47
* Builders Firstsource Inc : Barclays raises target price to $19 from $16
* Builders Firstsource Inc : Benchmark cuts target price to $22 from $32
* Builders Firstsource Inc : BTIG cuts target price to $23 from $31
* Builders Firstsource Inc : D.A. Davidson raises target price to $22 from $20
* Builders Firstsource Inc : Evercore ISI raises target price to $21 from $15
* Builders Firstsource Inc : RBC raises target price to $20 from $15
* Builders Firstsource Inc : Stifel raises price target to $21 from $18
* Builders Firstsource Inc : SunTrust Robinson raises target price to $20 from $17
* Builders Firstsource Inc : Wedbush raises target price to $23 from $19
* Cabot Oil & Gas Corp : Piper Sandler cuts target price to $21 from $22
* Cabot Oil & Gas Corp : Susquehanna raises target price to $24 from $23
* Caci International Inc : JP Morgan raises target price to $270 from $220
* Callon Petroleum Co : Tudor Pickering Holt cuts to sell from hold
* Camping World Holdings Inc : Jefferies cuts target price to $8 from $12
* Carlyle Group Inc : Citigroup cuts price target to $33 from $34
* Carter Bank and Trust : Raymond James cuts target price to $10 from $13
* Carter'S Inc : Monness Crespi Hardt cuts target price to $100 from $115
* Charter Communications Inc : Cowen and Company raises PT to $597 from $593
* Charter Communications Inc : JP Morgan raises target price to $575 from $550
* Charter Communications Inc : Keybanc raises target price to $604 from $576
* Charter Communications Inc : Rosenblatt Securities raises PT to $620 from $600
* Charter Communications Inc : TD Securities raises price target to $560 from $515
* Cheniere Energy Inc : Scotiabank raises target price to $68 from $67
* Cheniere Energy Partners LP : Scotiabank raises target price to $33 from $32
* Chevron Corp : Citigroup raises price target to $85 from $65
* Chevron Corp : Cowen and Company raises target price to $90 from $88
* Chevron Corp : Credit Suisse raises target price to $100 from $81
* Chevron Corp : Jefferies raises target price to $100 from $90
* Chevron Corp : JP Morgan raises target price to $103 from $97
* Choice Hotels International Inc : UBS cuts price target to $89 from $100
* Choice Hotels International Inc : UBS raises to buy from neutral
* Cigna Corp : Bernstein cuts to market-perform from outperform
* Cigna Corp : Raymond James raises target price to $240 from $210
* Citigroup Inc : UBS raises price target to $64 from $50
* Citizens Financial Group Inc : UBS raises price target to $26 from $18
* Citizens Financial Group Inc : UBS raises to buy from neutral
* Clorox Co : Citigroup raises price target to $206 from $182
* Clorox Co : Credit Suisse raises target price to $180 from $172
* Clorox Co : UBS raises price target to $168 from $155
* CNX Midstream Partners LP : Citigroup cuts price target to $8 from $17
* CNX Midstream Partners LP : Citigroup cuts to neutral from buy
* Coastal Financial Corp (Everett) : KBW raises target price to $16 from $15
* Cognex Corp : Berenberg raises target price to $60 from $52
* Cognizant Technology Solutions Corp : BMO cuts to market perform from outperform
* Cognizant Technology Solutions Corp : BMO raises target price to $59 from $58
* Colgate-Palmolive Co : Citigroup cuts price target to $75 from $78
* Colgate-Palmolive Co : Stifel raises price target to $75 from $72
* Columbia Banking System Inc : KBW cuts target price to $34 from $37
* Community Bankers Trust Corp : Stephens cuts target price to $7.50 from $9
* Community Health Systems Inc : Oppenheimer cuts target price to $7 from $8
* Concho Resources Inc : MKM Partners cuts price target by $5 to $75
* Concho Resources Inc : Simmons Energy raises target price to $59 from $54
* Concho Resources Inc : TD Securities raises price target to $53 from $49
* Conocophillips : MKM Partners raises target price by $1 to $58
* Consolidated Communications Holdings Inc : Citigroup raises PT to $6 from $5
* Consolidated Communications Holdings Inc : Guggenheim raises PT to $4 from $3.
- 05/04/2020
|
CoreSite Realty Corporation Announces Sale of Common Stock by The Carlyle Group
- CoreSite Realty Corporation (NYSE:COR) (“CoreSite”), a premier provider of secure, reliable, high-performance data center, cloud access and interconne
- 05/04/2020
|
CoreSite Realty Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next
- The quarterly results for CoreSite Realty Corporation (NYSE:COR) were released last week, making it a good time to...
- 05/03/2020
|
REITs Rebound As Earnings Heat Up
- Despite another week of downright ugly economic data, U.S. equity markets delivered their best month since 1987 in April amid rising optimism of an impending ec
- 05/02/2020
|
Wells Fargo Maintains Equal-Weight on CoreSite Realty, Raises Price Target to $120
|
Data Center Dividends: Tailwind Yields Up To 10%
- The data center industry has been one of the few bright spots in the 2020 market pullback, with many hitting new 52-week highs. This article covers 14 different
- 05/01/2020
|
Credit Suisse Maintains Neutral on CoreSite Realty, Raises Price Target to $124
|
Three Data Center REITs Report Solid Q1, Minimal Pandemic Impact
- CoreSite, CyrusOne, and QTS had a successful leasing quarter, but the lockdowns didn’t start until late in the period.
- 05/01/2020
|
CoreSite Realty Corp Forecasted to Post FY2020 Earnings of $5.12 Per Share (NYSE:COR)
- CoreSite Realty Corp (NYSE:COR) – Analysts at KeyCorp issued their FY2020 earnings per share estimates for shares of CoreSite Realty in a note issued to investors on Sunday, April 26th. KeyCorp analyst J. Sadler forecasts that the real estate investment trust will post earnings of $5.12 per share for the year. CoreSite Realty (NYSE:COR) last […]
- 05/01/2020
|
CoreSite Realty Corp (COR) Q1 2020 Earnings Call Transcript
- COR earnings call for the period ending March 31, 2020.
- 05/01/2020
|
Edited Transcript of COR earnings conference call or presentation 30-Apr-20 4:00pm GMT
- Q1 2020 CoreSite Realty Corp Earnings Call
- 05/01/2020
|
CoreSite Realty Corporation (COR) CEO Paul Szurek on Q1 2020 Results - Earnings Call Transcript
- CoreSite Realty Corporation (NYSE:COR) Q1 2020 Earnings Conference Call April 30, 2020 1:00 PM ET Company Participants Carole Jorgensen - Vice President of Inve
- 05/01/2020
|
Iron Mountain Is The Next Big Data Center REIT
- Data center REITs are strong, but expensive. Much of their value comes from their acquisition/development pipelines. IRM's pipeline in the data center space is
- 04/30/2020
|
BMO Capital Keeps Their Hold Rating on Coresite Realty (COR)
- In a report released today, Ari Klein from BMO Capital maintained a Hold rating on Coresite Realty (COR), with a price target of $115.00. The company's
- 04/30/2020
|
BMO Capital Keeps Their Hold Rating on Coresite Realty (COR)
- In a report released today, Ari Klein from BMO Capital maintained a Hold rating on Coresite Realty (COR – Research
- 04/30/2020
|
CoreSite Realty (COR) Beats Q1 FFO and Revenue Estimates
- CoreSite (COR) delivered FFO and revenue surprises of 1.57% and 1.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 04/30/2020
|
CoreSite Realty (COR) Beats Q1 FFO and Revenue Estimates
- CoreSite (COR) delivered FFO and revenue surprises of 1.57% and 1.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 04/30/2020
|
CoreSite Realty reports Q1 FFO $1.29, consensus $1.27 COR
- CoreSite Realty reports Q1 FFO $1.29, consensus $1.27 COR
- 04/30/2020
|
CoreSite: 1Q Earnings Snapshot
- DENVER (AP) _ CoreSite Realty Corp. (COR) on Thursday reported a key measure of profitability in its first quarter. The results topped Wall Street expectations. The real estate investment trust, based in Denver, said it had funds from operations of $62.4 million, or $1.29 per share, in the period.
- 04/30/2020
|
CoreSite Realty Q1 FFO $1.290 Up From $1.250 YoY, EPS $0.48, Sales $147.362M Beat $146.450M Estimate
|
CoreSite Reports First Quarter 2020 Financial Results
- CoreSite Realty Corporation (NYSE:COR) ("the Company"), a premier provider of secure, reliable, high-performance data center, cloud access and interconnection solutions across the U.S., today announced financial results for the first quarter ended March 31, 2020.
- 04/30/2020
|
CoreSite Realty Corp to Post FY2021 Earnings of $5.44 Per Share, KeyCorp Forecasts (NYSE:COR)
- CoreSite Realty Corp (NYSE:COR) – Equities research analysts at KeyCorp issued their FY2021 earnings per share estimates for shares of CoreSite Realty in a report issued on Sunday, April 26th. KeyCorp analyst J. Sadler expects that the real estate investment trust will earn $5.44 per share for the year. COR has been the topic of […]
- 04/30/2020
|
CoreSite Realty (COR) Beats Q1 FFO and Revenue Estimates
|
Notable earnings before Thursday's open
- AAL, ABMD, AGIO, AIMC, AIT, AMRN, ARW, ASPS, AUY, BAX, BC, BEN, BPOP, CFR, CG, CHD, CI, CMCSA, COLB, COP, COR, CRS, CWT, DAN, DNKN, DOW, EME, ESI, ETN, FBP, FCN, FLWS, GNRC, GRA, GT, HBI, HGV, HUBB, I
- 04/29/2020
|
SBA Communications (SBAC) to Post Q1 Earnings: What to Expect
- Solid demand for tower leasing in both domestic and international markets is likely to have driven SBA Communications' (SBAC) site leasing revenues in first-quarter 2020.
- 04/29/2020
|
What's in Store for Equity Residential's (EQR) Q1 Earnings?
- While Equity Residential's (EQR) Q1 results will likely reflect benefits from a healthy rental housing demand, seasonality and high supply might have partly curbed its growth tempo.
- 04/29/2020
|
What's in Store for Equity Residential's (EQR) Q1 Earnings?
- While Equity Residential's (EQR) Q1 results will likely reflect benefits from a healthy rental housing demand, seasonality and high supply might have partly curbed its growth tempo.
- 04/29/2020
|
What to Expect From New Residential (NRZ) in Q1 Earnings
- New Residential (NRZ) is expected to have witnessed a decline in book value and significant loss on disposal in Q1 due to coronavirus-induced dislocations and volatility in the mortgage industry.
- 04/29/2020
|
REIT Q1 Earnings to Watch Out on Apr 30: PSA, VICI & More
- As performance of REITs depends on the underlying asset types and location of properties, not all companies suffered pandemic-related setbacks in the second half of Q1.
- 04/29/2020
|
REIT Q1 Earnings to Watch Out on Apr 30: PSA, VICI & More
- As performance of REITs depends on the underlying asset types and location of properties, not all companies suffered pandemic-related setbacks in the second half of Q1.
- 04/29/2020
|
American Tower (AMT) Q1 AFFO Tops Estimate, Revenues Up Y/Y
- American Tower (AMT) witnesses robust growth in the property segment's revenues and organic tenant billing in Q1. Yet a decline in the service segment's revenues plays a spoilsport.
- 04/29/2020
|
Is a Surprise Coming for CoreSite (COR) This Earnings Season?
- CoreSite (COR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 04/29/2020
|
Is a Surprise Coming for CoreSite (COR) This Earnings Season?
- CoreSite (COR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 04/29/2020
|
Zacks: Brokerages Anticipate CoreSite Realty Corp (NYSE:COR) Will Post Quarterly Sales of $145.89 Million
- Equities analysts expect CoreSite Realty Corp (NYSE:COR) to post sales of $145.89 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for CoreSite Realty’s earnings. The lowest sales estimate is $142.37 million and the highest is $148.53 million. CoreSite Realty posted sales of $138.90 million during the same quarter […]
- 04/29/2020
|
REIT Q1 Earnings to Watch Out on Apr 30: PSA, VICI & More
|
Stocks That Hit 52-Week Highs On Tuesday
|
What's in the Cards for Realty Income's (O) Q1 Earnings?
- Realty Income's (O) Q1 results will likely reflect gains from strategic investments and focus on tenants from non-discretionary and low-price retail businesses, though a choppy market is a concern.
- 04/28/2020
|
What's in the Cards for Realty Income's (O) Q1 Earnings?
- Realty Income's (O) Q1 results will likely reflect gains from strategic investments and focus on tenants from non-discretionary and low-price retail businesses, though a choppy market is a concern.
- 04/28/2020
|
Key Factors to Impact Vornado (VNO) This Earnings Season
- Vornado's (VNO) Q1 results are expected to reflect declining revenues due to the impacts of the pandemic on its properties based in New York City.
- 04/28/2020
|
Key Factors to Impact Omega Healthcare's (OHI) Q1 Earnings
- Omega Healthcare's (OHI) Q1 results likely to reflect top-line growth on the company's diversification efforts and strategic investments.
- 04/28/2020
|
What's in the Cards for Realty Income's (O) Q1 Earnings?
|
What's in Store for Boston Properties (BXP) in Q1 Earnings?
- Although the U.S. office market has been unstable in Q1 due to the pandemic, Boston Properties' (BXP) results are expected to reflect revenue growth on premium office assets in strategic markets.
- 04/27/2020
|
What's in the Cards for Public Storage's (PSA) Q1 Earnings?
- While Public Storage (PSA) Q1 results will likely reflect solid demand and benefits from its expansion efforts, high supply and elevated marketing expenses might have played spoilsport.
- 04/27/2020
|
What's in the Cards for Public Storage's (PSA) Q1 Earnings?
- While Public Storage (PSA) Q1 results will likely reflect solid demand and benefits from its expansion efforts, high supply and elevated marketing expenses might have played spoilsport.
- 04/27/2020
|
JPMorgan positive on data center demand, Equinix top large cap pick EQIX;QTS;DLR;CONE;SWCH;COR
- JPMorgan positive on data center demand, Equinix top large cap pick JPMorgan EQIX QTS DLR CONE SWCH COR
- 04/27/2020
|
$1.27 EPS Expected for CoreSite Realty Corp (NYSE:COR) This Quarter
- Equities analysts expect CoreSite Realty Corp (NYSE:COR) to post $1.27 earnings per share for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for CoreSite Realty’s earnings, with the lowest EPS estimate coming in at $1.20 and the highest estimate coming in at $1.36. CoreSite Realty posted earnings of $1.25 per share […]
- 04/27/2020
|
What's in the Cards for Public Storage's (PSA) Q1 Earnings?
|
The US data center market is expected to grow at a CAGR of over 1% during the period 2019-2025
- Read the full report: https://www.reportlinker.com/p05373410/?utm_source=PRN The US data center market is expected to grow at a CAGR of over 1% during the period 2019–2025.A few major criteria for the growth of data centers in the US are the availability of tax incentives, renewable energy sources, and
- 04/24/2020
|
What's in Store for Crown Castle (CCI) This Earnings Season?
- While high demand for infrastructure and healthy leasing activities might have driven Crown Castle International's (CCI) Q1 performance, pricing power and high-leveraged balance sheet are concerns.
- 04/24/2020
|
American Tower (AMT) to Report Q1 Earnings: What's in Store?
- American Tower (AMT) is likely to have benefited from its continued focus on expansion efforts, though the slowdown of U.S. new business might have played spoilsport in Q1.
- 04/24/2020
|
The Best, And Worst, REITs For Social Distancing
- Landlords and lenders have taken it on the chin since the world shut down.
- 04/23/2020
|
Mairs and Power Growth Fund Comments on CoreSite
- Mairs and Power Growth Fund Comments on CoreSite, Stocks: COR, Mairs and Power, release date:Apr 23, 2020
- 04/23/2020
|
Mairs and Power Growth Fund 1st-Quarter Shareholder Letter
- Mairs and Power Growth Fund 1st-Quarter Shareholder Letter, Stocks: RHHBY,PFC,HRL,COR,WK,ATVI,GNRC,BMI,ASB, Mairs and Power, release date:Apr 23, 2020
- 04/23/2020
|
What's in the Offing for Duke Realty's (DRE) Q1 Earnings?
- Duke Realty's (DRE) Q1 performance likely to reflect benefits from the company's efforts to leverage on the industrial real estate market's healthy fundamentals.
- 04/23/2020
|
CoreSite Realty (COR) Scheduled to Post Quarterly Earnings on Thursday
- CoreSite Realty (NYSE:COR) is set to release its earnings data before the market opens on Thursday, April 30th. Analysts expect CoreSite Realty to post earnings of $1.28 per share for the quarter. CoreSite Realty has set its FY 2020 Pre-Market guidance at 5.10-5.20 EPS and its FY20 guidance at $5.10-5.20 EPS.Persons that are interested in […]
- 04/23/2020
|
Mairs and Power Growth Fund Comments on CoreSite
|
The Data Center Market in US to Generate Revenues of Over $75 Billion During the Period 2020 −2025 - Market Research by Arizton
- According to Arizton's recent research report, Data Center Market in US - Industry Outlook and Forecast 2020-2025 is expected to grow at a CAGR of over 1% during the period 2019−2025.
- 04/22/2020
|
Digital Realty Unit Begins Paris Digital Park Construction
- Digital Realty's (DLR) Interxion will fortify the company's presence in Paris banking on Europe's robust digital landscape.
- 04/22/2020
|
Digital Realty Unit Begins Paris Digital Park Construction
- Digital Realty's (DLR) Interxion will fortify the company's presence in Paris banking on Europe's robust digital landscape.
- 04/22/2020
|
“Pick and Shovel” Plays On The Social Distancing Economy
- Stocks Analysis by Contrarian Outlook (Brett Owens) covering: S&P 500, Amazon.com Inc, American Tower Corp, Simon Property Group Inc. Read Contrarian Outlook (Brett Owens)'s latest article on Investing.com
- 04/22/2020
|
‘Freeze Time:’ How Long Can Data Center Supply Chains Hold Out?
- The longer the global lockdown, the harder it will be to keep data centers running without failure.
- 04/20/2020
|
Bailard Inc. Sells 3,200 Shares of CoreSite Realty Corp (NYSE:COR)
- Bailard Inc. trimmed its position in CoreSite Realty Corp (NYSE:COR) by 64.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,750 shares of the real estate investment trust’s stock after selling 3,200 shares during the quarter. Bailard Inc.’s holdings in CoreSite […]
- 04/20/2020
|
Head to Head Comparison: Lexington Realty Trust (NYSE:LXP) versus CoreSite Realty (NYSE:COR)
- Lexington Realty Trust (NYSE:LXP) and CoreSite Realty (NYSE:COR) are both mid-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, valuation, institutional ownership, earnings and dividends. Valuation & Earnings This table compares Lexington Realty Trust and CoreSite Realty’s gross revenue, […]
- 04/20/2020
|
CoreSite Realty Corp to Post Q3 2020 Earnings of $1.18 Per Share, Jefferies Financial Group Forecasts (NYSE:COR)
- CoreSite Realty Corp (NYSE:COR) – Jefferies Financial Group lowered their Q3 2020 earnings per share (EPS) estimates for shares of CoreSite Realty in a research note issued on Friday, April 17th. Jefferies Financial Group analyst J. Petersen now expects that the real estate investment trust will post earnings per share of $1.18 for the quarter, […]
- 04/20/2020
|
Farmers & Merchants Investments Inc. Raises Stake in CoreSite Realty Corp (NYSE:COR)
- Farmers & Merchants Investments Inc. increased its stake in CoreSite Realty Corp (NYSE:COR) by 1.0% during the first quarter, according to its most recent filing with the SEC. The fund owned 19,152 shares of the real estate investment trust’s stock after buying an additional 189 shares during the quarter. Farmers & Merchants Investments Inc. owned […]
- 04/19/2020
|
Shareholders Of CoreSite Realty (NYSE:COR) Must Be Happy With Their 184% Total Return
- When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...
- 04/17/2020
|
Investment Analysts' Weekly Ratings Changes for CoreSite Realty (COR)
- CoreSite Realty (NYSE: COR) recently received a number of ratings updates from brokerages and research firms: 4/16/2020 – CoreSite Realty was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating. 4/16/2020 – CoreSite Realty was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” […]
- 04/17/2020
|
U.S. Data Center Colocation (Retail & Wholesale) Industry Forecast to 2025
- The "US Data Center Colocation Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.
- 04/16/2020
|
Is CoreSite Realty’s (NYSE:COR) Share Price Gain Of 136% Well Earned?
- The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
- 04/16/2020
|
United States Data Center Colocation Market Assessment 2019-2025 by Solution Type, Vertical and Company - ResearchAndMarkets.com
- The "US Data Center Colocation Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.
- 04/16/2020
|
CoreSite Realty downgraded to Market Perform from Outperform at Raymond James COR
- CoreSite Realty downgraded to Market Perform from Outperform at Raymond James Raymond James COR
- 04/16/2020
|
CoreSite Realty Corp (NYSE:COR) Shares Sold by Guggenheim Capital LLC
- Guggenheim Capital LLC cut its position in shares of CoreSite Realty Corp (NYSE:COR) by 1.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 83,508 shares of the real estate investment trust’s stock after selling 1,223 shares during the quarter. Guggenheim Capital LLC owned […]
- 04/16/2020
|
Brookstone Capital Management Boosts Holdings in CoreSite Realty Corp (NYSE:COR)
- Brookstone Capital Management grew its position in shares of CoreSite Realty Corp (NYSE:COR) by 6.4% during the first quarter, HoldingsChannel reports. The firm owned 5,073 shares of the real estate investment trust’s stock after buying an additional 307 shares during the period. Brookstone Capital Management’s holdings in CoreSite Realty were worth $588,000 as of its […]
- 04/16/2020
|
6 Meridian Makes New Investment in CoreSite Realty Corp (NYSE:COR)
- 6 Meridian acquired a new stake in CoreSite Realty Corp (NYSE:COR) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,668 shares of the real estate investment trust’s stock, valued at approximately $657,000. Several other large investors have also […]
- 04/16/2020
|
Access Financial Services, Inc. Buys Vanguard Short-Term Corporate Bond ETF, PIMCO Enhanced Low ...
|
CoreSite Realty Corporation Announces Change to a Virtual 2020 Annual Meeting of Stockholders
- In light of public health concerns regarding the coronavirus (COVID-19) outbreak and to support the health and well-being of the Company’s directors, employees, stockholders and other stakeholders, CoreSite Realty Corporation (NYSE: COR) (the "Company") hereby announces that the location of
- 04/13/2020
|
CoreSite, Digital Realty cut on scant upside to FV estimate: Baird
- Seeing "little or no upside" to Baird's fair value estimate for data center REITs, analyst David Rodgers downgrades CoreSite Realty (COR -3.6%) and Digital Realty Trust (DLR -4.9%) to Neutral.
- 04/13/2020
|
CoreSite: A Robust Business Model That Cares For Shareholders
- CoreSite is a specialized data center REIT paying a consistent above average dividend yield. The company's business model aims at achieving deeper market penetr
- 04/13/2020
|
CoreSite Realty (NYSE:COR) Downgraded by Robert W. Baird
- CoreSite Realty (NYSE:COR) was downgraded by investment analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating in a note issued to investors on Monday, The Fly reports. They currently have a $122.00 price objective on the real estate investment trust’s stock. Robert W. Baird’s price target would suggest a potential upside […]
- 04/13/2020
|
Baird Downgrades CoreSite Realty to Neutral
|
CoreSite Realty downgraded to Neutral from Outperform at Baird COR
- CoreSite Realty downgraded to Neutral from Outperform at Baird Baird COR
- 04/13/2020
|
